Clinical Trials - JNJ

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT04883619A Study of Nipocalimab in Adult Participants With Active Lupus NephritisNOT_YET_RECRUITINGPHASE22026-01-152028-02-282028-02-28
NCT05521087A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWITHDRAWNPHASE12025-12-262030-01-292026-09-11
NCT07196722A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE2, PHASE32025-10-232032-10-062028-09-19
NCT07196748A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisRECRUITINGPHASE32025-10-232032-01-132028-01-14
NCT07174596Evaluation of Approved Contact LensesNOT_YET_RECRUITINGNA2025-09-122025-10-242025-10-24
NCT06919965A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerRECRUITINGPHASE32025-09-102032-03-162027-08-13
NCT07149857A Study to Evaluate Efficacy and Safety of Ciltacabtagene AutoleucelRECRUITINGPHASE22025-09-082028-12-292028-01-03
NCT07164443A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)RECRUITINGPHASE32025-09-022028-05-302028-05-30
NCT07141004A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)RECRUITINGPHASE42025-08-122027-09-112027-06-05
NCT07076160Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact LensesRECRUITINGNA2025-07-242025-09-242025-09-24
NCT07107230A Study of JNJ-95437446 in Participants With Advanced-Stage Solid TumorsRECRUITINGPHASE12025-07-152027-11-282027-11-18
NCT07082920A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerRECRUITINGPHASE12025-07-072027-09-152027-09-15
NCT07053345A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant DepressionRECRUITINGPHASE42025-06-092027-06-252027-06-25
NCT06852222A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Acute Myeloid Leukemia (AML)RECRUITINGPHASE32025-06-042029-08-152029-06-22
NCT07030517A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaRECRUITINGPHASE42025-05-222027-06-202026-11-03
NCT06967129Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration ProcessCOMPLETEDNA2025-04-252025-07-142025-07-14
NCT06934226A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITINGPHASE32025-04-152027-08-202026-03-30
NCT06864858Clinical Evaluation of Two Cosmetic Contact LensesCOMPLETEDNA2025-03-302025-05-052025-05-05
NCT06651229A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsRECRUITINGPHASE12025-03-212028-12-012027-08-05
NCT06881251A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)RECRUITINGPHASE22025-02-262026-08-142026-07-15
NCT06878404A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisRECRUITINGPHASE32025-02-212028-11-212026-05-27
NCT06533098A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RECRUITINGPHASE32025-02-102029-12-052027-12-15
NCT06852742A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged SkinCOMPLETEDNA2025-01-202025-05-012025-05-01
NCT06798441Determination of the Oral Irritation Potential of a Fluoride Rinse in ChildrenCOMPLETEDNA2025-01-202025-02-202025-02-20
NCT06618001A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsRECRUITINGPHASE12025-01-142028-08-152027-07-15
NCT06807424A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic ArthritisRECRUITINGPHASE32025-01-092028-10-182027-02-10
NCT06749496Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearCOMPLETEDNA2025-01-072025-03-202025-03-20
NCT05090787Clinical Investigation of the TECNIS 1-Piece Intraocular LensWITHDRAWNNA2025-01-012025-07-012025-07-01
NCT06788509A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringENROLLING_BY_INVITATIONPHASE12024-12-302028-01-212028-01-19
NCT06778057Clinical Performance of Three Daily Disposable Silicone Hydrogel Contact LensesRECRUITINGNA2024-12-292025-10-132025-10-13
NCT06785012A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderRECRUITINGPHASE22024-12-262026-06-262026-06-26
NCT06604715A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE12024-12-192028-11-302027-11-03
NCT06667076A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)RECRUITINGPHASE22024-12-162030-12-262029-05-23
NCT06750094A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyRECRUITINGPHASE32024-12-122029-04-132027-12-15
NCT04662580ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerRECRUITINGPHASE12024-12-092028-12-292027-06-30
NCT06667908A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)RECRUITINGPHASE22024-12-062028-12-312028-12-31
NCT06649019Evaluation of Lens Rotation in Habitual Wearers of Toric, Soft Contact LensesCOMPLETEDNA2024-12-062024-12-162024-12-16
NCT06734299A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin TonesCOMPLETEDNA2024-12-062025-02-142025-02-14
NCT06768489A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple MyelomaRECRUITINGPHASE12024-12-042028-03-312028-03-31
NCT06741969Nipocalimab in Moderate to Severe Sjogren's DiseaseRECRUITINGPHASE32024-12-042030-04-172028-01-01
NCT06449651A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RECRUITINGPHASE32024-11-112029-12-112029-12-05
NCT06658847A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Using Non-invasive MeasurementsCOMPLETEDNA2024-11-072025-04-292025-04-29
NCT06663332A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsRECRUITINGPHASE32024-10-292031-12-122031-12-12
NCT06654102A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light ExposureCOMPLETEDNA2024-10-232024-11-262024-11-26
NCT06660563A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)RECRUITINGPHASE12024-10-222026-09-212026-09-21
NCT06662786A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerRECRUITINGPHASE32024-10-182032-12-152028-12-15
NCT06663319A Study of JNJ-89402638 for Metastatic Colorectal CancerRECRUITINGPHASE12024-10-152028-07-282028-02-25
NCT06646289A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)RECRUITINGPHASE22024-10-102030-10-242030-10-24
NCT06635148A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)RECRUITINGPHASE22024-09-192030-06-272029-08-24
NCT06635135A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and PleasureTERMINATEDPHASE32024-09-192025-04-252025-04-09
NCT06550895A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple MyelomaRECRUITINGPHASE22024-09-162026-08-312026-08-31
NCT06500884A Study to Evaluate Preventive Treatments for Talquetamab-related Oral ToxicityRECRUITINGPHASE22024-08-262027-10-182026-04-15
NCT06577025A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple MyelomaRECRUITINGPHASE22024-08-202030-09-022030-07-31
NCT06559306Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsRECRUITINGPHASE32024-07-252027-11-302026-12-30
NCT06532032A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-07-232026-06-092025-10-21
NCT06544616A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseRECRUITINGPHASE22024-07-222034-06-072031-07-17
NCT06479096Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic MouthwashCOMPLETEDNA2024-07-152024-09-122024-09-12
NCT06514742A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With AticaprantTERMINATEDPHASE32024-06-262025-04-242025-04-08
NCT06425991A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12024-06-072027-03-032027-02-28
NCT06377514Clinical Investigation of the TECNIS® Next-Generation Intraocular LensCOMPLETEDNA2024-06-032025-04-232025-04-23
NCT06616558A Study to Assess the Effectiveness of Sunscreen on Oil Control, Moisturization, and Skin Barrier Integrity in Adults With Oily SkinCOMPLETEDNA2024-06-032024-07-302024-07-30
NCT05963074A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaRECRUITINGPHASE22024-05-302029-03-192028-09-29
NCT06470438A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's LymphomaRECRUITINGPHASE12024-05-282028-10-182027-10-29
NCT06544889A Study to Assess the Safety and Efficacy of a Sunscreen on Acne-Prone Skin With Inflammatory and Non-Inflammatory Acne VulgarisCOMPLETEDNA2024-05-092024-06-182024-06-18
NCT06385080A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck CancerRECRUITINGPHASE1, PHASE22024-04-222028-04-172026-07-17
NCT06377488Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact LensesCOMPLETEDNA2024-04-222024-06-242024-06-24
NCT06319820A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerRECRUITINGPHASE32024-04-182028-06-282028-06-28
NCT06318637Evaluation of the Acceptability and Feasibility of a Bedtime Routine for NeonatesCOMPLETEDNA2024-04-182025-08-122025-08-12
NCT06408935Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease PatientsRECRUITINGPHASE32024-04-172028-03-262027-06-08
NCT06311578A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsRECRUITINGPHASE12024-04-102032-08-262028-11-08
NCT06211764A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)ACTIVE_NOT_RECRUITINGPHASE32024-04-092031-04-142030-11-27
NCT06333613Evaluation of Acuvue Oasys 1-Day Contact Lenses in New WearersCOMPLETEDNA2024-03-262024-05-222024-05-22
NCT05923073A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE32024-03-132028-07-122027-10-27
NCT06220604A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)ACTIVE_NOT_RECRUITINGPHASE32024-03-092027-09-202024-11-15
NCT06120140Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibRECRUITINGPHASE22024-02-162032-01-312027-05-31
NCT06295692A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisACTIVE_NOT_RECRUITINGPHASE32024-02-092027-10-142025-04-15
NCT06255665A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid TumorsCOMPLETEDPHASE12024-02-092025-06-232025-06-23
NCT06143878A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITINGPHASE32024-02-012027-06-012024-09-17
NCT06208150A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideRECRUITINGPHASE32024-01-222027-06-272026-04-23
NCT06260163A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisRECRUITINGPHASE32024-01-192028-08-142028-05-22
NCT05845008A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic PainWITHDRAWNPHASE32024-01-152024-07-262024-07-15
NCT05530889Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular AllergiesWITHDRAWNNA2024-01-152024-05-132024-05-13
NCT06194578A Study of Sterile Saline Infusion in Healthy VolunteersCOMPLETEDEARLY_PHASE12024-01-122024-04-232024-04-23
NCT06150157A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsRECRUITINGPHASE12023-12-202026-12-042026-12-04
NCT05912517A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)RECRUITINGPHASE32023-12-202029-07-102027-08-05
NCT06178614A Study of JNJ-87890387 for Advanced Solid TumorsRECRUITINGPHASE12023-12-142028-07-212027-03-16
NCT06139406A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) CancerRECRUITINGPHASE12023-12-062027-11-192027-11-19
NCT06116786A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerRECRUITINGPHASE12023-11-272029-06-072027-04-14
NCT06161012Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of WearCOMPLETEDNA2023-11-162024-02-132024-02-13
NCT06136455A Study to Investigate Salivary Flow and Potential of Hydrogen (pH) Following Use of Essential-Oil Containing MouthwashesCOMPLETEDPHASE42023-11-132023-11-162023-11-16
NCT05784441A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)RECRUITINGPHASE12023-11-062039-02-252037-10-30
NCT06095089A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate CancerRECRUITINGPHASE12023-11-012027-10-272027-06-21
NCT06134804A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or OlderCOMPLETEDPHASE32023-10-242024-07-262024-02-19
NCT06095115A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITINGPHASE32023-10-122027-04-062024-07-29
NCT06095102A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)ACTIVE_NOT_RECRUITINGPHASE32023-10-122027-06-102024-06-19
NCT06049017A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE22023-10-092026-01-162024-09-26
NCT06243627A Study to Assess Safety and Improvement in Skin Barrier After Using 2 Facial Sunscreens in Adults With Sensitive SkinCOMPLETEDNA2023-09-272023-12-112023-11-30
NCT05844995A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With PainCOMPLETEDPHASE12023-09-132024-02-142024-02-12
NCT05926583A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis PigmentosaRECRUITINGPHASE32023-09-122030-11-122025-09-16
NCT05868122A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following BunionectomyCOMPLETEDPHASE32023-09-072024-05-302024-05-30
NCT05884398A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCACTIVE_NOT_RECRUITINGPHASE32023-08-312026-08-312026-08-31
NCT06039189Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque PsoriasisCOMPLETEDPHASE32023-08-242025-04-142025-04-14
NCT06028438A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid ArthritisCOMPLETEDPHASE22023-08-152024-10-292024-08-29
NCT06010758A Two-Week Study of an Anticavity Low pH MouthwashCOMPLETEDPHASE42023-07-172023-08-032023-08-03
NCT05896683A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult ParticipantsCOMPLETEDPHASE12023-05-302023-09-012023-09-01
NCT05602623Characterizing the Intraocular Scattering at Different WavelengthsCOMPLETEDNA2023-05-252024-05-022024-05-02
NCT05761574A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental PainCOMPLETEDPHASE32023-05-222024-05-302024-05-17
NCT05884242A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin ChallengeCOMPLETEDPHASE12023-05-222023-08-072023-08-01
NCT05663866Premedication to Reduce Amivantamab Associated Infusion Related ReactionsACTIVE_NOT_RECRUITINGPHASE22023-05-182026-07-302024-03-29
NCT05908734A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-05-182026-09-262026-01-30
NCT05901636A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy AdultsCOMPLETEDPHASE1, PHASE22023-05-172024-08-192024-08-19
NCT05252520A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese ParticipantsWITHDRAWNPHASE12023-05-012023-11-202023-11-20
NCT05818683A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate CancerRECRUITINGPHASE12023-04-262027-09-012026-06-30
NCT05827874A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy ParticipantsCOMPLETEDPHASE12023-04-122023-10-042023-10-04
NCT05757869A Study of Milvexian Versus Apixaban in Participants With Atrial FibrillationACTIVE_NOT_RECRUITINGPHASE32023-04-112027-05-052027-03-05
NCT05754957A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeRECRUITINGPHASE32023-04-072026-12-092026-09-07
NCT05814367Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye DropsCOMPLETEDPHASE22023-04-062023-05-062023-05-06
NCT05972434A Study of Two Facial Sunscreens to Assess Its Effect in Improving Hydration, Skin Barrier Function, and Skin Tone Uniformity Under Controlled and Normal Conditions of Use on the Face by Adult ParticipantsCOMPLETEDNA2023-04-032023-07-212023-06-23
NCT05572515A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE32023-03-292031-08-312026-02-13
NCT05786209A Study of a Whole-Body Balm on Newborn BabiesCOMPLETEDNA2023-03-272023-10-062023-10-06
NCT05714202A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)ACTIVE_NOT_RECRUITINGPHASE32023-03-232029-09-182029-09-18
NCT05864417A Study to Assess Effect of Two Facial Sunscreens in Improving Wrinkles, Fine Lines and Melasma in Adult ParticipantsCOMPLETEDNA2023-03-222023-07-102023-07-10
NCT05778786Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking ChromophoreCOMPLETEDNA2023-03-132023-05-242023-05-24
NCT05811351A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)ACTIVE_NOT_RECRUITINGPHASE22023-03-062026-02-262026-02-26
NCT05567185A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder CancerACTIVE_NOT_RECRUITINGPHASE12023-03-032027-09-242026-10-16
NCT05661851Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing PatientsCOMPLETEDPHASE22023-02-232023-04-272023-04-27
NCT05201794A Study of JNJ-64281802 for the Prevention of Dengue InfectionTERMINATEDPHASE22023-02-222024-06-262024-06-26
NCT05784129A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical ResectionTERMINATEDPHASE32023-02-212023-10-102023-09-29
NCT05702034A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKERECRUITINGPHASE32023-02-152026-12-092026-11-11
NCT05703841A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult ParticipantsCOMPLETEDPHASE12023-02-142023-04-122023-04-07
NCT05756673A Study of Virtually Supervised Mouthwash and Interdental BrushesCOMPLETEDPHASE42023-02-092023-10-032023-10-03
NCT05713253A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEMTERMINATEDNA2023-02-022025-02-212025-02-21
NCT05713552Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative LidstockCOMPLETEDNA2023-01-302023-02-092023-02-09
NCT05706753A Study of Milvexian in Healthy Adult FemalesCOMPLETEDPHASE12023-01-252023-07-202023-07-20
NCT05742594A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult ParticipantsCOMPLETEDPHASE12023-01-032023-04-032023-03-31
NCT05634408Evaluating ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia ManagementCOMPLETEDNA2022-12-242025-08-202025-08-20
NCT05438043A Study of DaratumumabRECRUITINGPHASE32022-12-152029-01-312026-01-30
NCT05488314A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-12-132026-04-272026-04-27
NCT05601544The Effects of Contact Lenses With UV/HEV-Filter on Visual FunctionCOMPLETEDNA2022-12-092023-11-172023-11-17
NCT05653427A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular CarcinomaTERMINATEDPHASE22022-12-082023-10-102023-10-10
NCT05564052A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell LymphomaCOMPLETEDPHASE22022-12-062024-09-262023-12-06
NCT05550532A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyCOMPLETEDPHASE32022-12-062024-11-132024-11-08
NCT05645705A Two-Week Study of Clinical Safety and Saliva Flow QuantificationCOMPLETEDPHASE42022-11-282022-12-162022-12-16
NCT05652335A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisRECRUITINGPHASE12022-11-222027-04-192027-04-19
NCT05531292PROOF-OF-CONCEPT STUDY FOR NEW INTRAOCULAR LENS, MODEL C0002COMPLETEDNA2022-11-222025-05-202025-05-20
NCT05441501A Study of JNJ-80038114 in Participants With Advanced Stage Prostate CancerCOMPLETEDPHASE12022-11-152024-03-312024-03-26
NCT05167825A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial HypertensionCOMPLETEDPHASE32022-11-142025-03-052024-08-23
NCT05498428A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerRECRUITINGPHASE22022-11-112027-08-172027-08-17
NCT05575063Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD)COMPLETEDNA2022-11-082023-12-212023-12-21
NCT05550519A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) TreatmentWITHDRAWNEARLY_PHASE12022-10-312025-08-282025-08-25
NCT05582304Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot StudyCOMPLETEDNA2022-10-312022-12-082022-12-08
NCT05552222A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaRECRUITINGPHASE32022-10-252033-10-282031-04-30
NCT05589038A Study of a Baby Wash/Shampoo and Baby Lotion Versus Baby Wash/Shampoo Alone for Impact on Skin Barrier and Microbiome on NewbornsTERMINATEDNA2022-10-252023-06-282023-06-28
NCT05574959Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00VTERMINATEDNA2022-10-242023-10-242023-10-24
NCT05554640Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact LensesCOMPLETEDNA2022-10-242022-12-012022-12-01
NCT05461209A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple MyelomaWITHDRAWNPHASE32022-10-202024-10-312022-11-15
NCT05552196A Study of Ponesimod in Healthy Adult ParticipantsCOMPLETEDPHASE12022-10-182023-03-292023-03-05
NCT05455320A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentACTIVE_NOT_RECRUITINGPHASE32022-10-132029-06-302026-02-06
NCT05453903A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed TherapiesRECRUITINGPHASE12022-10-042027-03-192024-10-08
NCT05347095A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE32022-09-272027-03-252027-03-25
NCT05327114Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RECRUITINGPHASE2, PHASE32022-09-232028-09-302027-05-14
NCT05518149A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)ACTIVE_NOT_RECRUITINGPHASE32022-09-222025-04-252025-04-11
NCT05242484A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE22022-09-192029-03-272025-05-15
NCT05541315A Single Ascending Dose Study of JNJ-88260237 in Healthy ParticipantsCOMPLETEDPHASE12022-09-142023-05-092023-05-09
NCT05528510A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE32022-09-132028-10-062024-04-02
NCT05268497A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant DepressionWITHDRAWNPHASE12022-09-012023-06-072023-06-07
NCT05526586A Twelve Week Study of Prototypes Mouth RinsesCOMPLETEDPHASE42022-08-312022-12-082022-12-08
NCT05083182A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic ArthritisRECRUITINGPHASE32022-08-302027-08-092026-12-10
NCT05480514Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses (2022)COMPLETEDNA2022-08-272022-11-162022-11-16
NCT05522517A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4COMPLETEDPHASE12022-08-222022-11-022022-11-02
NCT05502289Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearCOMPLETEDNA2022-08-192022-10-172022-10-17
NCT05424822A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)ACTIVE_NOT_RECRUITINGPHASE12022-08-182027-07-302026-06-12
NCT05421663A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaRECRUITINGPHASE1, PHASE22022-08-122028-12-292028-12-29
NCT05388669A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32022-08-052026-06-302024-01-03
NCT05197075A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected ChildrenCOMPLETEDPHASE12022-08-032022-09-232022-09-23
NCT05379595A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerRECRUITINGPHASE1, PHASE22022-07-292029-05-212027-04-27
NCT05242471A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE22022-07-222029-11-052025-05-23
NCT05444530A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative NeoplasmsCOMPLETEDPHASE12022-07-212025-06-242025-06-24
NCT05265273A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisRECRUITINGPHASE2, PHASE32022-07-202026-06-262026-06-26
NCT05272150Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp PsoriasisCOMPLETEDPHASE32022-07-132025-05-302025-05-30
NCT05427539Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration ProcessCOMPLETEDNA2022-07-122022-09-302022-09-30
NCT04919512A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the BladderACTIVE_NOT_RECRUITINGPHASE22022-07-072027-03-072025-01-31
NCT05379634A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory MyopathiesACTIVE_NOT_RECRUITINGPHASE22022-07-052026-09-162025-09-04
NCT05423106A Single and Multiple Ascending Dose Study of JNJ-64457744TERMINATEDPHASE12022-07-042023-03-202023-03-14
NCT05275023An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B ParticipantsCOMPLETEDPHASE22022-06-302024-05-312023-12-12
NCT05396599A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.TERMINATEDNA2022-06-302023-04-072023-04-07
NCT05433571Evaluation of Rotation With a Multifocal Toric Contact LensCOMPLETEDNA2022-06-282022-07-222022-07-22
NCT05407818A Study of JNJ-63733657 in Healthy Chinese ParticipantsCOMPLETEDPHASE12022-06-272022-11-072022-08-02
NCT05455684A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyCOMPLETEDPHASE32022-06-222024-09-182024-09-18
NCT05357755A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE22022-06-132023-04-102023-03-23
NCT05364554A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE22022-06-102023-09-292023-09-29
NCT05378906A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy ParticipantsCOMPLETEDPHASE12022-06-072022-09-282022-09-28
NCT05328297A Study of JNJ-55308942 in the Treatment of Bipolar DepressionCOMPLETEDPHASE22022-06-032024-05-172024-05-17
NCT05387759A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult ParticipantsCOMPLETEDPHASE12022-05-302022-10-042022-10-04
NCT05151692A Study of JNJ-80202135 in Healthy Chinese Adult ParticipantsCOMPLETEDPHASE12022-05-302022-09-092022-09-09
NCT05338775A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12022-05-252027-05-032025-05-22
NCT05252533A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or PsoriasisCOMPLETEDPHASE12022-05-242024-01-262024-01-26
NCT05307692A Study of Seltorexant in Participants With Probable Alzheimer's DiseaseCOMPLETEDPHASE22022-05-192023-11-102023-11-10
NCT05361304Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.COMPLETEDNA2022-05-162022-07-052022-07-05
NCT05347485A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple MyelomaCOMPLETEDPHASE22022-05-132023-12-152023-11-30
NCT05344560Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible LightCOMPLETEDNA2022-05-092022-08-092022-08-09
NCT05242445A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE12022-04-192023-05-092023-05-09
NCT05600231A Study of Virtually Supervised Mouth Rinses and FlossingCOMPLETEDPHASE42022-04-182022-07-252022-07-25
NCT05327816A Study of Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and OlderTERMINATEDPHASE1, PHASE22022-04-132023-02-142023-01-16
NCT05316155Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerRECRUITINGPHASE1, PHASE22022-04-112029-10-012028-03-30
NCT05242432A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese ParticipantsTERMINATEDPHASE32022-04-012023-03-202023-03-20
NCT05291936Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of WearCOMPLETEDNA2022-03-302022-05-272022-05-27
NCT05295927A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)TERMINATEDPHASE12022-03-232022-09-302022-09-30
NCT05300763Clinical Performance of Senofilcon A Investigational LensCOMPLETEDNA2022-03-212022-05-252022-05-25
NCT05182047A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study VolunteersWITHDRAWNPHASE12022-03-182022-05-052022-05-05
NCT05272787Clinical Trial to Evaluate Safety and Efficacy of a Facial and Lip Moisturizer in Adult Subjects Undergoing a Facial Dermatologic Procedure With Fractional CO2 LaserCOMPLETEDNA2022-03-102022-06-162022-04-13
NCT05201781A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelRECRUITINGPHASE42022-03-092037-10-302037-07-29
NCT05250973A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisACTIVE_NOT_RECRUITINGPHASE22022-03-012027-03-022026-03-03
NCT04782661A Study of JNJ-70075200 in Healthy ParticipantsWITHDRAWNPHASE12022-03-012022-09-232022-05-09
NCT05201937A Study of JNJ-64281802 in Healthy Adult ParticipantsCOMPLETEDPHASE12022-02-232022-12-112022-12-11
NCT05226143A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin AreaCOMPLETEDNA2022-02-212022-03-092022-03-09
NCT05258149Comparison of a Silicone Hydrogel Daily Disposable Multifocal Contact Lens to a Marketed ProductCOMPLETEDNA2022-02-182022-04-292022-04-29
NCT05223868A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque PsoriasisCOMPLETEDPHASE22022-02-032022-12-152022-12-15
NCT05236868A Study of JNJ-42847922 (Seltorexant) in Healthy ParticipantsCOMPLETEDPHASE12022-02-032022-03-012022-03-01
NCT04906980A Study of JNJ-64281802 in Participants With Confirmed Dengue FeverTERMINATEDPHASE22022-01-242023-03-212022-09-24
NCT05231278Confocal Laser Endomicroscopy Nodule Localization by Robotic BronchoscopyCOMPLETEDNA2022-01-202024-09-062023-10-12
NCT05197049A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE32022-01-192028-10-302023-07-04
NCT05197062A Study of 14C JNJ-67953964 in Healthy Adult Male ParticipantsCOMPLETEDPHASE12022-01-142022-03-022022-03-02
NCT05201807Evaluation of Marketed Soft Contact LensesCOMPLETEDNA2022-01-142022-02-242022-02-24
NCT05222880Evaluation of a Daily Disposable Silicone Hydrogel Multifocal Contact Lens in Myopes and HyperopesCOMPLETEDNA2022-01-062022-02-282022-02-28
NCT04892173JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRECRUITINGPHASE32022-01-042027-12-312026-06-30
NCT05565625A Study to Evaluate the Whitening Effect of Mineral Sunscreens in Multi-Cultural Skin TonesCOMPLETEDNA2021-12-292022-03-302022-03-30
NCT05090826A Real-World Study for the TECNIS Synergy™ Intraocular LensCOMPLETEDNA2021-12-282024-04-302024-04-30
NCT05090813A Real-World Study in China for the TECNIS Eyhance™ Intraocular LensCOMPLETEDNA2021-12-242024-04-222024-04-22
NCT05148780A Study of Acute Respiratory Infections in Global Outpatient SettingCOMPLETEDEARLY_PHASE12021-12-202023-02-222023-02-20
NCT05106153A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and ZolpidemCOMPLETEDPHASE12021-12-172023-05-122023-05-12
NCT05029921A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE42021-12-102025-05-182025-05-18
NCT05155007A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on RilematovirCOMPLETEDPHASE12021-12-102022-02-042022-02-04
NCT05123599A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE12021-12-062024-06-262023-07-31
NCT05112952A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937)COMPLETEDPHASE12021-11-302022-07-112022-07-11
NCT05053399Evaluation of the TECNIS Symfony® Toric Intraocular LensCOMPLETEDNA2021-11-242024-04-302024-04-30
NCT05120128Changes in Inflammatory Biomarkers When Symptomatic Contact Lens Wearers Are Refit in Acuvue Oasys 1-Day LensesCOMPLETEDNA2021-11-242022-12-132022-12-13
NCT05125679Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque PsoriasisTERMINATEDPHASE42021-11-232023-07-282023-07-28
NCT05141448Visual Performance of Soft Contact Lenses With Myopia Control OpticsCOMPLETED2021-11-222022-04-012022-04-01
NCT05036070Proof-of-concept Study for a New Intraocular Lens, MODEL C0001COMPLETEDNA2021-11-182024-04-242024-04-24
NCT04988295A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib FailureACTIVE_NOT_RECRUITINGPHASE32021-11-172026-09-302023-07-10
NCT04978337A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) InfectionTERMINATEDPHASE22021-11-172022-03-312022-03-31
NCT05112939A Study of a Rilpivirine Extended-Release Suspension in Healthy ParticipantsCOMPLETEDPHASE12021-11-162024-05-232024-05-23
NCT05159128A Study of JNJ-75105186 in Healthy Japanese and Chinese ParticipantsWITHDRAWNPHASE12021-11-152022-04-022022-04-02
NCT05121909A Study of Experimental MouthwashesCOMPLETEDPHASE42021-11-152022-04-142022-04-14
NCT05123911A Study of 3 Investigational Products on the Microbiome and Scalp Attributes in Children With Curly HairCOMPLETEDNA2021-11-132022-03-182022-01-20
NCT05014360A Study of JNJ-64251330 in Participants With Familial Adenomatous PolyposisCOMPLETEDPHASE12021-11-102023-02-152023-02-15
NCT05039710A Study of JNJ-75220795 in Japanese ParticipantsTERMINATEDPHASE12021-11-082023-02-172023-02-17
NCT05083078A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic ArthritisTERMINATEDPHASE12021-11-042022-07-012022-07-01
NCT05005507A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus InfectionTERMINATEDPHASE22021-11-032021-12-292021-12-29
NCT05091307A Study of Ad26.COV2.S and Influenza Vaccines in Healthy AdultsCOMPLETEDPHASE32021-11-022022-11-152022-06-17
NCT05101486A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 YearsCOMPLETEDPHASE32021-11-012022-09-202022-03-28
NCT05062213A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.COMPLETEDNA2021-11-012022-05-042022-05-04
NCT05071664A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE22021-10-252024-08-062024-05-14
NCT05062200A Study of JNJ-77242113 in Healthy Japanese and Chinese ParticipantsCOMPLETEDPHASE12021-10-252022-09-282022-09-28
NCT04995055Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual FunctionCOMPLETEDNA2021-10-252022-04-142022-04-14
NCT05094700A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin ParticipantsCOMPLETEDNA2021-10-252021-11-302021-11-30
NCT04991740A Study of JNJ-78306358 in Participants With Advanced Stage Solid TumorsCOMPLETEDPHASE12021-10-242023-02-092023-02-09
NCT05092269A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsRECRUITINGPHASE32021-10-182027-09-292027-09-29
NCT04985812A Study of JNJ-67484703 in Participants With Active Rheumatoid ArthritisCOMPLETEDPHASE12021-10-182023-05-182023-05-18
NCT04991753A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid ArthritisCOMPLETEDPHASE22021-10-142022-08-102022-08-10
NCT05083169A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE32021-10-142028-12-082025-08-01
NCT04988308A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis SuppurativaTERMINATEDPHASE22021-10-122022-11-232022-10-14
NCT05101252Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed ProductCOMPLETEDNA2021-10-112021-11-292021-11-29
NCT05083585A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Adults Aged 60 - 75 Years OldCOMPLETEDPHASE32021-10-082022-09-222022-03-07
NCT05099380Validation of Senofilcon A With New UV / HEV FilterCOMPLETEDNA2021-10-052021-11-242021-11-24
NCT05071313A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and OlderCOMPLETEDPHASE32021-10-042022-10-112022-04-20
NCT05070546A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV InfectionCOMPLETEDPHASE32021-09-292022-08-122022-08-12
NCT04936308Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha AgentACTIVE_NOT_RECRUITINGPHASE32021-09-282026-07-162024-10-28
NCT05022849A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsACTIVE_NOT_RECRUITINGPHASE12021-09-282037-10-302037-10-30
NCT05007080A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years InclusiveCOMPLETEDPHASE22021-09-272023-08-142023-08-14
NCT05050097A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12021-09-222027-04-072025-03-31
NCT04963738A Study of JNJ-73763989 in Adult Participants With Renal ImpairmentCOMPLETEDPHASE12021-09-222022-10-172022-10-17
NCT04968912A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)COMPLETEDPHASE22021-09-212023-11-302023-10-23
NCT05076877A Study of Lazertinib (JNJ-73841937) in Healthy ParticipantsCOMPLETEDPHASE12021-09-172022-02-102022-02-10
NCT04882072A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)TERMINATEDPHASE32021-09-152023-05-252023-05-25
NCT05056870Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low AstigmatsCOMPLETEDNA2021-09-152022-03-032022-03-03
NCT05045183A Study to Assess Wound Healing Efficacies of Different Clean, Treat, and Protect Wound Care Regimens Compared to Standard of Care and UntreatedCOMPLETEDNA2021-09-082021-10-152021-10-06
NCT04583280A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)TERMINATEDPHASE32021-09-062022-03-182022-03-18
NCT04951609A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and PsychotherapyTERMINATEDPHASE12021-09-022024-04-082024-04-08
NCT05025345Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular LensesCOMPLETEDNA2021-09-022022-06-172022-06-17
NCT04990440A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTERMINATEDPHASE22021-09-022022-03-092022-03-09
NCT04973566A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy ParticipantsCOMPLETEDPHASE12021-08-312022-05-272022-05-27
NCT04929210A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseRECRUITINGPHASE42021-08-302027-04-132026-08-04
NCT04945733A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal CancerTERMINATEDPHASE22021-08-302023-07-032023-07-03
NCT04765384A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)COMPLETEDPHASE22021-08-272023-11-242023-11-24
NCT04914429A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE42021-08-252023-09-262023-09-26
NCT05021081Visual Performance of Senofilcon A With and Without a New UV/HEV-filterCOMPLETEDNA2021-08-232021-10-202021-10-20
NCT04882878A Study of Nipocalimab in Adult Participants With Active Systemic Lupus ErythematosusCOMPLETEDPHASE22021-08-202024-12-262024-04-30
NCT04923893A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial TherapyACTIVE_NOT_RECRUITINGPHASE32021-08-192034-12-132029-02-14
NCT04954898Post-market Evaluation of Clinical Outcomes in China for the TECNIS Model ZMTCOMPLETEDNA2021-08-112024-01-102024-01-10
NCT04999111A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2COMPLETEDPHASE22021-08-062022-11-222021-10-27
NCT04960124A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult ParticipantsCOMPLETEDPHASE12021-08-052021-11-192021-11-19
NCT05000164Evaluation of Visual Acuity With a Reusable Toric Multifocal Contact LensCOMPLETEDNA2021-08-022022-01-132022-01-13
NCT04985955A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3COMPLETEDPHASE12021-07-302021-09-212021-09-21
NCT04876092A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLLCOMPLETEDPHASE12021-07-282025-02-132025-02-13
NCT04950374A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.WITHDRAWNNA2021-07-262021-12-102021-11-26
NCT04940039A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare SettingsCOMPLETEDPHASE42021-07-222024-04-162024-04-16
NCT04908683A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and OlderCOMPLETEDPHASE32021-07-212023-07-212023-07-21
NCT04974697Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact LensesCOMPLETEDNA2021-07-192021-10-292021-10-29
NCT05012735A Study of a Hydrocolloid Bandage on PimplesCOMPLETEDPHASE12021-07-192021-09-132021-09-13
NCT04951622A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisACTIVE_NOT_RECRUITINGPHASE32021-07-152026-04-172023-11-17
NCT04811079The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity AnalyzerCOMPLETEDNA2021-07-142022-05-162022-05-16
NCT05007756A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of InterestCOMPLETEDEARLY_PHASE12021-07-142021-11-042021-11-04
NCT04898634A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerACTIVE_NOT_RECRUITINGPHASE12021-07-132026-02-162026-02-13
NCT04968925Evaluation of Comfort for Two Marketed Daily Disposable Contact LensesCOMPLETEDNA2021-07-122021-10-252021-10-25
NCT04899336A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 YearsCOMPLETEDPHASE32021-06-302025-08-272025-08-27
NCT04890249Clinical Investigation of Two Tecnis Investigational LensesCOMPLETEDNA2021-06-232023-01-312023-01-31
NCT04911543A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male ParticipantsCOMPLETEDPHASE12021-06-232022-02-012022-02-01
NCT04908722A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsCOMPLETEDPHASE32021-06-182023-07-102023-07-10
NCT04882098A Study of Guselkumab in Participants With Active Psoriatic ArthritisACTIVE_NOT_RECRUITINGPHASE32021-06-172030-07-122024-12-30
NCT04704843A Study of Guselkumab in Adult Participants With Celiac DiseaseWITHDRAWNPHASE12021-06-172021-09-132021-09-13
NCT04920578A Study of JNJ-69095897 in Healthy ParticipantsTERMINATEDPHASE12021-06-162023-02-272023-01-27
NCT04954833Evaluating Visual Acuity and Initial Fit Performance of Two Soft Contact LensesCOMPLETED2021-06-142021-08-162021-08-16
NCT04388501A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy ParticipantsCOMPLETEDPHASE12021-06-072021-10-272021-10-25
NCT03890341Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440WITHDRAWNPHASE12021-06-012021-11-012021-08-01
NCT04712006A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult ParticipantsWITHDRAWNPHASE12021-05-302021-10-302021-08-27
NCT04844463A Study of JNJ-68179280 in Healthy ParticipantsCOMPLETEDPHASE12021-05-262023-03-132023-03-07
NCT04848558A Study of Nipocalimab in Healthy Male and Female ParticipantsCOMPLETEDPHASE12021-05-252022-05-262022-05-26
NCT04894305A Study of Ad26.COV2.S in Healthy Adults (COVID-19)COMPLETEDPHASE12021-05-252021-12-082021-12-08
NCT04889625Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing Processes in MyopesCOMPLETEDNA2021-05-212021-07-212021-07-21
NCT04773522A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12021-05-202025-09-042022-10-14
NCT04811560A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)RECRUITINGPHASE1, PHASE22021-05-192028-05-262026-02-16
NCT04836559A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in EpilepsyCOMPLETEDPHASE22021-05-182024-02-082024-02-08
NCT04869189Non-Invasive Assessment of Contact Lens Performance During Use of a Digital DisplayCOMPLETEDNA2021-05-102022-06-282022-06-28
NCT04885296Evaluation of Prototype Lenses With Experimental UV/HEV BlockerCOMPLETEDNA2021-05-102021-08-092021-08-09
NCT04264806A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)WITHDRAWNPHASE22021-05-062025-01-282022-04-19
NCT04853524A Study of JNJ-56136379 in Healthy ParticipantsWITHDRAWNPHASE12021-05-062021-07-302021-06-15
NCT04791319A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic DermatitisTERMINATEDPHASE22021-05-032022-03-312022-02-02
NCT04791332A Study of JNJ-67953964 in Healthy Japanese Adult Male ParticipantsCOMPLETEDPHASE12021-04-302021-07-282021-07-28
NCT04540744A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and TadalafilCOMPLETEDPHASE12021-04-302021-08-302021-08-08
NCT04844450A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795COMPLETEDPHASE12021-04-292023-03-312023-03-31
NCT04844411A Study of JNJ-67835989 in Healthy ParticipantsCOMPLETEDPHASE12021-04-272022-05-182022-05-18
NCT04829318A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray TreatmentCOMPLETEDPHASE42021-04-262024-07-222024-07-22
NCT04849780Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact LensCOMPLETEDNA2021-04-172021-08-122021-08-12
NCT04844424A Study of JNJ-70033093 (Milvexian) in Healthy Adult ParticipantsCOMPLETEDPHASE12021-04-142022-07-122022-05-06
NCT04816513A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy ParticipantsCOMPLETEDPHASE12021-04-142022-01-262022-01-07
NCT04673357A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE32021-04-062025-03-032024-11-28
NCT04616677A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult ParticipantsCOMPLETEDPHASE12021-03-312022-10-182022-10-18
NCT05120141A Twelve Week Study of Experimental Mouth RinsesCOMPLETEDPHASE42021-03-292021-07-232021-07-23
NCT04740970A Study of JNJ-64304500 in Participants With Alopecia AreataWITHDRAWNPHASE22021-03-242022-07-202022-06-02
NCT04630028A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)COMPLETEDPHASE32021-03-172025-06-052025-05-08
NCT04794751Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing ProcessesCOMPLETEDNA2021-03-132021-06-102021-06-10
NCT04722146A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12021-03-122027-04-072027-04-07
NCT04585789A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE22021-03-112024-01-092023-02-08
NCT04821323A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific AppendixCOMPLETEDEARLY_PHASE12021-03-102021-05-072021-05-07
NCT04569695A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult ParticipantsCOMPLETEDPHASE12021-03-082021-12-162021-12-04
NCT04655807A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's DiseaseWITHDRAWNPHASE22021-03-032023-09-042023-05-24
NCT04794270Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing LineCOMPLETEDNA2021-03-022021-04-132021-04-13
NCT04657224A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaCOMPLETEDPHASE12021-02-252025-01-162025-01-16
NCT04683029A Study of Guselkumab in Participants With Systemic SclerosisCOMPLETEDPHASE22021-02-242024-07-092023-05-17
NCT04696809A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE1, PHASE22021-02-222026-04-222026-04-22
NCT04736147A Study of JNJ-64300535 in Healthy ParticipantsCOMPLETEDPHASE12021-02-032021-12-072021-12-07
NCT04634552A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE22021-02-012029-03-302026-03-31
NCT04667104A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE22021-02-012023-04-172022-05-16
NCT04677530A Study of JNJ-40411813 in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12021-01-292021-05-212021-05-21
NCT04713930A Study of JNJ-61393215 in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12021-01-292021-05-312021-05-31
NCT04718805A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed ConditionsCOMPLETEDPHASE12021-01-262021-03-012021-03-01
NCT04740892A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and ChildrenCOMPLETEDNA2021-01-212023-02-062023-02-06
NCT04667052A Study to Compare Two Different Subcutaneously-administered JNJ-64304500 Formulations in Healthy ParticipantsCOMPLETEDPHASE12021-01-132021-06-152021-06-15
NCT04630145A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)ACTIVE_NOT_RECRUITINGPHASE2, PHASE32021-01-082025-12-022025-02-18
NCT04619420A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITINGPHASE22021-01-062032-12-302026-02-27
NCT04661397A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate AgentsCOMPLETEDPHASE12021-01-052021-07-022021-07-02
NCT04108286Ex-vivo Adhesion of Bacteria to Different Contact Lens MaterialsWITHDRAWNNA2021-01-012021-01-062021-01-06
NCT04640623A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical CystectomyACTIVE_NOT_RECRUITINGPHASE22020-12-182027-07-022026-11-20
NCT04662619A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic DermatitisCOMPLETEDNA2020-12-182024-11-192023-12-07
NCT04586426A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE1, PHASE22020-12-152026-10-272025-03-18
NCT04633447A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell ArteritisTERMINATEDPHASE22020-12-102024-05-222024-05-22
NCT04658862A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the BladderACTIVE_NOT_RECRUITINGPHASE32020-12-072028-12-312026-12-30
NCT04671433Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneCOMPLETEDPHASE32020-12-042024-09-302024-09-30
NCT04794101Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneACTIVE_NOT_RECRUITINGPHASE32020-12-042029-12-192029-09-20
NCT04617691A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy ParticipantsCOMPLETEDPHASE12020-11-302021-07-202021-07-20
NCT04609826A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)COMPLETEDPHASE12020-11-262025-08-252025-08-25
NCT04288778A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With DiabetesCOMPLETEDPHASE42020-11-252022-07-262022-07-26
NCT04586439A Study of JNJ-73763989 in Healthy Chinese Adult ParticipantsCOMPLETEDPHASE12020-11-242021-02-182021-02-18
NCT04540796A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)ACTIVE_NOT_RECRUITINGPHASE12020-11-202025-10-312025-09-30
NCT04577833A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate CancerACTIVE_NOT_RECRUITINGPHASE12020-11-132025-12-052021-10-15
NCT04557059A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerACTIVE_NOT_RECRUITINGPHASE32020-11-122029-08-272029-08-27
NCT04644770A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate CancerRECRUITINGPHASE12020-11-122028-11-282028-11-28
NCT04614948A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in AdultsCOMPLETEDPHASE32020-11-122023-06-182023-06-18
NCT04606381A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid MalignanciesACTIVE_NOT_RECRUITINGPHASE12020-11-102026-12-312024-07-11
NCT04447040Acetaminophen/Naproxen Sodium Dose Ranging StudyCOMPLETEDPHASE22020-11-092021-05-032021-04-09
NCT04599855A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionCOMPLETEDPHASE42020-11-042024-01-312024-01-31
NCT04611971A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2COMPLETEDPHASE12020-10-272021-05-062021-05-06
NCT04750005A Twelve Week Study of Virtually Supervised Mouth Rinse and FlossingCOMPLETEDPHASE42020-10-232021-02-012021-02-01
NCT04589026A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 1COMPLETEDPHASE12020-10-212021-05-062021-05-06
NCT04544826A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous DosesCOMPLETEDPHASE12020-10-162021-08-052021-08-05
NCT04538664A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 InsertionsACTIVE_NOT_RECRUITINGPHASE32020-10-132026-01-312023-05-03
NCT04544813A Study of JNJ-77474462 in Healthy ParticipantsCOMPLETEDPHASE12020-10-132021-05-302021-05-30
NCT04615507Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2COMPLETEDNA2020-10-092020-12-092020-12-09
NCT04556526A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant WomenCOMPLETEDPHASE32020-10-052023-03-022023-03-02
NCT04500821Evaluation of the LipiFlow System With a New ActivatorCOMPLETEDNA2020-10-022020-10-302020-10-30
NCT04487080A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32020-09-302027-06-292023-08-11
NCT04566926A Study of JNJ-64140284 in Healthy Male ParticipantsTERMINATEDPHASE12020-09-292021-04-052021-04-05
NCT04332640Clinical Evaluation of the Next Generation Phaco SystemCOMPLETEDNA2020-09-282021-05-012021-05-01
NCT04497844A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)ACTIVE_NOT_RECRUITINGPHASE32020-09-232027-11-012025-01-07
NCT04557098A Study of Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE22020-09-172027-05-282025-11-30
NCT04535544A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusCOMPLETEDPHASE22020-09-172025-03-052023-10-19
NCT04533529A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With SeltorexantCOMPLETEDPHASE32020-09-162024-04-302023-04-25
NCT06131476Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye DropCOMPLETEDPHASE12020-09-162020-10-102020-10-10
NCT04513912A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant TherapyCOMPLETEDPHASE32020-09-152023-10-032023-10-03
NCT04532749A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant TherapyTERMINATEDPHASE32020-09-152022-07-142022-05-24
NCT04376827A Study of Guselkumab in Participants With Active Lupus NephritisTERMINATEDPHASE22020-09-152023-02-012023-02-01
NCT04439539A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) InfectionCOMPLETEDPHASE22020-09-142024-02-132023-08-29
NCT04553042A Study of Seltorexant in Healthy ParticipantsCOMPLETEDPHASE12020-09-142020-12-302020-12-20
NCT04410094A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult ParticipantsCOMPLETEDPHASE12020-09-142021-02-022020-12-30
NCT04476446An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment AlternativesCOMPLETEDPHASE32020-09-082023-06-162023-06-16
NCT04505722A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult ParticipantsCOMPLETEDPHASE32020-09-072023-03-312023-03-31
NCT04567186Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic PopulationCOMPLETEDNA2020-09-062020-11-252020-11-25
NCT04552197A Study of JNJ-64251330 in Healthy ParticipantsCOMPLETEDPHASE12020-09-022020-12-292020-12-29
NCT04535453A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and AdolescentsCOMPLETEDPHASE22020-08-282022-03-092022-03-09
NCT04338321A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive DisorderCOMPLETEDPHASE32020-08-212022-07-152022-01-20
NCT04523207A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for MetastasesCOMPLETEDPHASE22020-08-192023-10-252023-10-23
NCT04474210A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult ParticipantsTERMINATEDPHASE12020-08-192020-11-302020-11-30
NCT04332523A Study of JNJ-53718678 in Participants With Hepatic ImpairmentTERMINATEDPHASE12020-08-172022-03-162022-03-16
NCT04508023A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) InfectionTERMINATEDPHASE32020-08-132022-06-012022-06-01
NCT04529109Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact LensesCOMPLETEDNA2020-08-132020-09-152020-09-15
NCT04509947A Study of Ad26.COV2.S in Adults (COVID-19)COMPLETEDPHASE12020-08-112021-11-162021-02-22
NCT04534517Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic PopulationCOMPLETEDNA2020-08-072020-09-292020-09-29
NCT04531241Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing TechnologyCOMPLETEDNA2020-08-052020-09-252020-09-25
NCT04534764Evaluation of Visual Performance of Two Types of Cosmetic Contact LensesCOMPLETEDNA2020-07-312020-08-122020-08-12
NCT04480736A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult ParticipantsWITHDRAWNPHASE22020-07-282027-12-092027-09-02
NCT04543383A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy ParticipantsCOMPLETEDPHASE12020-07-272023-06-092023-06-07
NCT04500808A Study of Macitentan, in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12020-07-212020-12-142020-12-14
NCT04453189A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy ParticipantsCOMPLETEDPHASE12020-07-202020-09-142020-09-14
NCT04453202A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older AdultsCOMPLETEDPHASE22020-07-162021-04-092020-09-24
NCT04451187A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive DisorderCOMPLETEDPHASE12020-07-162023-03-162023-03-16
NCT04436276A Study of Ad26.COV2.S in Adults (COVID-19)COMPLETEDPHASE1, PHASE22020-07-152023-02-212023-02-21
NCT04060888A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus ErythematosusWITHDRAWNPHASE32020-07-142026-03-312022-01-31
NCT04410081A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male ParticipantsCOMPLETEDPHASE12020-07-142021-03-022021-03-02
NCT04397276A Study of JNJ-70218902 in Participants With Advanced Stage Solid TumorsACTIVE_NOT_RECRUITINGPHASE12020-07-102025-10-302025-09-30
NCT04426357A Study to Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult ParticipantsTERMINATEDPHASE12020-07-032020-11-122020-11-12
NCT04210219A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaCOMPLETEDPHASE12020-07-022025-05-282025-05-28
NCT04442737A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight GainCOMPLETEDPHASE42020-07-012023-08-302023-08-07
NCT04457960A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative ColitisTERMINATEDPHASE12020-07-012021-10-132021-10-13
NCT04448964A Study of JNJ-70033093 in Healthy ParticipantsCOMPLETEDPHASE12020-06-262020-11-142020-11-14
NCT04300621A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy ParticipantsCOMPLETEDPHASE12020-06-192020-08-102020-08-10
NCT04181827A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE32020-06-122029-04-092024-05-01
NCT04327518Evaluation of the Rotational Stability of the Tecnis Toric II IOLCOMPLETEDNA2020-06-112021-06-012021-04-06
NCT04397263A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE32020-06-102025-09-302024-02-29
NCT04354480A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and OlderCOMPLETEDPHASE12020-05-152021-01-202021-01-20
NCT04380961A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19COMPLETEDPHASE22020-04-242021-06-242021-04-09
NCT04325828A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland CarcinomaACTIVE_NOT_RECRUITINGPHASE22020-04-072027-12-312021-06-09
NCT04330248A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult ParticipantsCOMPLETEDPHASE12020-03-312022-06-142022-06-14
NCT04306302A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese AdultsCOMPLETEDPHASE12020-03-132020-12-242020-12-24
NCT04252287A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart FailureCOMPLETEDPHASE32020-03-102021-11-092021-11-09
NCT04172675A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)COMPLETEDPHASE22020-02-282025-02-272024-07-12
NCT04108195A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12020-02-212027-04-072025-08-22
NCT04310566Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic PopulationCOMPLETEDNA2020-02-212020-03-282020-03-28
NCT04228783A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult ParticipantsCOMPLETEDPHASE32020-02-182022-04-252022-04-25
NCT04282746A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy ParticipantsCOMPLETEDPHASE12020-02-182020-08-172020-08-11
NCT04287036Objective Vision Evaluation of Two Cosmetic Contact LensesCOMPLETEDNA2020-02-122020-02-262020-02-26
NCT04258189A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy ParticipantsCOMPLETEDPHASE12020-02-112020-08-052020-08-05
NCT04156737A Comparative Study of TECNIS Symfony Plus IOL and a Trifocal IOLCOMPLETEDNA2020-01-242021-07-142021-07-14
NCT04236453A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat When Administered as a Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared to the Co-administration of the Separate AgentsTERMINATEDPHASE12020-01-232020-04-102020-04-10
NCT04225078A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult ParticipantsCOMPLETEDPHASE12020-01-172022-01-122021-12-21
NCT04235270A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult ParticipantsCOMPLETEDPHASE12020-01-172020-07-172020-07-17
NCT04210232Post-market Study to Obtain Surgeon Feedback on Clinical Outcome in Eyes Implanted With TECNIS Toric II IOLCOMPLETEDNA2020-01-142020-09-112020-09-11
NCT04223349A Study of JNJ-70033093 (BMS-986177) in Healthy Adult ParticipantsCOMPLETEDPHASE12020-01-102020-04-082020-04-08
NCT04206488A Study of JNJ-70033093 and Digoxin in Healthy ParticipantsCOMPLETEDPHASE12020-01-092021-06-092021-06-09
NCT04208399A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379COMPLETEDPHASE12020-01-092021-03-262021-03-26
NCT04208386A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989COMPLETEDPHASE12020-01-082020-07-202020-07-20
NCT04230252A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy ParticipantsCOMPLETEDPHASE12020-01-072020-03-232020-02-10
NCT04200898Clinical Investigation of the CHEETAH SYSTEM FOR THE CORRECTION OF MYOPIA WITH AND WITHOUT ASTIGMATISMCOMPLETEDNA2019-12-312024-12-062024-12-06
NCT04056611Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)TERMINATEDPHASE22019-12-262022-02-042022-02-04
NCT04121260A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple MyelomaCOMPLETEDPHASE12019-12-252023-10-132021-04-27
NCT04208373A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult ParticipantsCOMPLETEDPHASE12019-12-202020-03-102020-03-10
NCT04042376A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)COMPLETEDPHASE42019-12-182024-03-192024-03-19
NCT04208061A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy ParticipantsCOMPLETEDPHASE12019-12-182021-04-012021-03-25
NCT04108208A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)ACTIVE_NOT_RECRUITINGPHASE42019-12-172026-06-052023-06-01
NCT04185051A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female ParticipantsCOMPLETEDPHASE12019-12-172021-05-052021-04-21
NCT04214691A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy ParticipantsCOMPLETEDPHASE12019-12-172020-02-072020-01-16
NCT04193046A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)COMPLETEDEARLY_PHASE12019-12-162022-02-182021-12-20
NCT04186936A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy VolunteersCOMPLETEDPHASE12019-12-052019-12-262019-12-26
NCT04449952A Study of Mouth Rinses in Type 1 and Type 2 Diabetic ParticipantsCOMPLETEDPHASE42019-12-022020-03-062020-03-06
NCT03852160A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant DepressionWITHDRAWNPHASE32019-12-012021-07-252021-07-25
NCT04030533Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy Chinese ParticipantsCOMPLETEDPHASE12019-11-292020-12-312020-12-31
NCT04083976A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene AlterationsACTIVE_NOT_RECRUITINGPHASE22019-11-202026-10-302023-12-04
NCT04189224Evaluation of a Reusable Silicone Hydrogel Multifocal Contact LensCOMPLETEDNA2019-11-152020-03-102020-03-10
NCT04133636A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple MyelomaRECRUITINGPHASE22019-11-072028-01-172026-08-04
NCT04154774A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic FunctionCOMPLETEDPHASE12019-11-072025-02-102025-02-10
NCT04129554A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE22019-11-062022-06-092021-07-08
NCT04178772Characterizing Successful Myopic Multifocal Contact Lens WearersTERMINATEDNA2019-11-042021-01-192021-01-19
NCT03964415A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender IndividualsCOMPLETEDPHASE32019-10-312023-08-102023-08-10
NCT04147338A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy ParticipantsCOMPLETEDPHASE12019-10-302021-12-072021-09-13
NCT04132570A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne PollutionCOMPLETEDPHASE42019-10-222020-01-222020-01-22
NCT04075396A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE1, PHASE22019-10-162022-11-142021-01-08
NCT04021862A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE22019-10-162020-11-192020-06-30
NCT04068792A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract DiseaseCOMPLETEDPHASE22019-10-102021-05-152021-05-15
NCT04006704Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo TabletsCOMPLETEDPHASE12019-10-102020-03-062020-03-06
NCT04921371Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and PlaqueCOMPLETEDPHASE12019-10-082019-12-192019-12-19
NCT04121052A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as TabletsCOMPLETEDPHASE12019-10-082019-12-232019-12-23
NCT04033445A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE2, PHASE32019-09-262027-10-272023-09-19
NCT04062448A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)COMPLETEDPHASE22019-09-252023-03-022021-08-24
NCT04102111A Study Evaluating Participants With Moderately to Severely Active Crohn's DiseaseTERMINATEDPHASE22019-09-232021-12-222021-11-17
NCT04072575A Study of Paliperidone Palmitate 6-Month FormulationCOMPLETEDPHASE32019-09-192022-05-032022-05-03
NCT04080752A Study of JNJ-61393215 in the Treatment of DepressionCOMPLETEDPHASE22019-09-172021-09-022021-09-02
NCT04087759A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult ParticipantsCOMPLETEDPHASE12019-09-162020-01-072020-01-07
NCT04090086A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy ParticipantsCOMPLETEDPHASE12019-09-162019-12-102019-12-10
NCT04019041A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis SuppurativaCOMPLETEDPHASE22019-09-162020-11-172020-05-19
NCT04077463A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE12019-09-042026-06-032026-06-03
NCT03998683A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular PsoriasisCOMPLETEDPHASE32019-09-032021-11-302021-03-02
NCT04093258Comparison of Two Silicone Hydrogel Multifocal Contact LensesCOMPLETEDNA2019-08-262019-12-112019-12-11
NCT03929757A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in InfantsCOMPLETEDPHASE22019-08-192022-09-282022-08-22
NCT04119050Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic AnemiaRECRUITINGPHASE2, PHASE32019-08-152028-04-102025-02-02
NCT04040933A Study to Assess Wound Healing Efficacies of Different Adhesive BandagesCOMPLETEDNA2019-08-092019-10-302019-10-18
NCT04073186Evaluation of A Marketed Silicone Hydrogel Spherical Lens Used for Monovision Correction of PresbyopiaCOMPLETEDNA2019-08-072020-03-202020-03-20
NCT03923010A Study of Itraconazole in the Management of Superficial Fungal Infections in IndiaTERMINATEDPHASE42019-08-062020-03-272020-03-25
NCT03982199A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and OlderTERMINATEDPHASE22019-08-012023-05-262022-06-06
NCT03982186A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE22019-08-012022-04-262021-03-29
NCT03949335Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular LensCOMPLETEDNA2019-07-312020-06-182020-06-18
NCT04033458A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male ParticipantsTERMINATEDPHASE12019-07-292019-08-012019-08-01
NCT03981744A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care TreatmentsTERMINATEDPHASE32019-07-262022-07-122022-01-24
NCT04006301First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C MutationCOMPLETEDPHASE12019-07-262020-07-132020-07-13
NCT04012931A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically SuppressedCOMPLETEDPHASE22019-07-182023-02-232023-02-17
NCT04017195A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginning of Shelf Life in Healthy WomenCOMPLETEDPHASE12019-07-122019-12-132019-12-13
NCT04002752A Study of JNJ-73763989 in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12019-07-042019-08-232019-08-23
NCT03947814A Study of Orally Administered Pimodivir in Adult Participants With Renal ImpairmentTERMINATEDPHASE12019-07-022020-09-092020-09-09
NCT03190330A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p DeletionCOMPLETEDPHASE42019-06-262023-05-032023-05-03
NCT03995355Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing PatientsCOMPLETED2019-06-262019-09-202019-09-20
NCT03990519A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy ParticipantsCOMPLETEDPHASE12019-06-242020-02-192020-02-19
NCT03891524A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement SurgeryCOMPLETEDPHASE22019-06-172021-04-062021-04-06
NCT03767244A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyACTIVE_NOT_RECRUITINGPHASE32019-06-112029-07-192026-02-10
NCT03768960A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory AgentCOMPLETEDPHASE42019-06-102022-07-162022-07-16
NCT03819049A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable HealthCOMPLETEDPHASE1, PHASE22019-06-062024-12-182021-06-08
NCT03871829Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With DaratumumabTERMINATEDPHASE22019-05-312023-01-102022-10-24
NCT03816631A Study of Orally Administered Pimodivir in Adult Participants With Hepatic ImpairmentCOMPLETEDPHASE12019-05-282020-04-272020-04-27
NCT03879408Naproxen Sodium/Acetaminophen Proof of Concept Dosing StudyCOMPLETEDPHASE22019-05-282019-11-132019-11-07
NCT03796052Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer PatientsCOMPLETEDNA2019-05-232019-12-182019-12-18
NCT03952507A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy ParticipantsCOMPLETEDPHASE12019-05-152019-06-222019-06-22
NCT03945539A Study to Evaluate the Effect of Itraconazole on JNJ-56136379 in Healthy Adult ParticipantsCOMPLETEDPHASE12019-05-152019-10-042019-10-04
NCT03962790Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing TechnologyCOMPLETEDNA2019-05-152019-07-102019-07-10
NCT03926013A Study of JNJ-63898081 in Participants With Advanced Stage Solid TumorsCOMPLETEDPHASE12019-05-012021-09-022021-08-23
NCT03931447A Safety and Tolerability Study of JNJ-72537634 in Healthy ParticipantsCOMPLETEDPHASE12019-04-302020-02-102020-02-10
NCT03901963A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell TransplantACTIVE_NOT_RECRUITINGPHASE32019-04-262026-05-292024-04-04
NCT03915886A Study of JNJ-64530440 in Healthy Japanese Male ParticipantsTERMINATEDPHASE12019-04-152019-07-172019-07-17
NCT03864601A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male ParticipantsCOMPLETEDPHASE12019-04-092019-06-142019-06-14
NCT03913377Ocular Characteristics in Contact Lens and Spectacle WearCOMPLETEDNA2019-04-092019-06-142019-06-14
NCT03953196A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy ParticipantsCOMPLETEDEARLY_PHASE12019-04-082019-12-262019-12-26
NCT03900598A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)COMPLETEDPHASE12019-04-032025-05-222025-05-22
NCT03871543Late Night Study 2: End-of-Day Assessment of Asymptomatic and Symptomatic Soft Lens WearersCOMPLETEDNA2019-04-012022-02-032022-02-03
NCT03915379A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)COMPLETEDPHASE12019-03-282022-03-282022-03-26
NCT03796858A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) TherapyCOMPLETEDPHASE32019-03-222020-11-112020-11-11
NCT03882255A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady StateCOMPLETEDPHASE12019-03-202019-08-262019-08-26
NCT03800550A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult ParticipantsCOMPLETEDPHASE12019-02-132019-06-042019-06-04
NCT03818035A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type PsoriasisCOMPLETEDPHASE32019-02-082025-01-072022-03-07
NCT03748641A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerACTIVE_NOT_RECRUITINGPHASE32019-01-252027-02-272021-10-08
NCT03606512A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of AgeCOMPLETEDPHASE1, PHASE22019-01-212021-11-022021-11-02
NCT03802682A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy ParticipantsCOMPLETEDPHASE12019-01-112019-04-112019-04-11
NCT03787472Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic PopulationCOMPLETEDNA2019-01-112019-03-222019-03-22
NCT03733925A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCOMPLETEDPHASE42019-01-072021-11-152021-11-15
NCT03795441A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF) Vaccine in AdultsCOMPLETEDPHASE12019-01-072019-07-282019-07-28
NCT03796026A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep ApneaCOMPLETEDPHASE12019-01-042019-06-142019-06-07
NCT03782376A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE32018-12-202023-01-102022-08-19
NCT03808259A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy ParticipantsCOMPLETEDPHASE12018-12-202019-09-042019-09-04
NCT03789669A Prospective, Multi-Center Evaluation of Corneal Flap Creation Using Cheetah Femtosecond Laser System and Cheetah Patient InterfaceCOMPLETEDNA2018-12-192023-03-312023-03-31
NCT03791619Post-Approval Study of the TECNIS SYMFONY® Toric LensesCOMPLETEDNA2018-12-132022-08-082022-08-08
NCT03772158Cetirizine Chewable Bioequivalence and Food Effect StudyCOMPLETEDPHASE12018-12-112019-02-032019-02-03
NCT03587363A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of ErdafitinibTERMINATEDPHASE12018-12-062020-12-222020-12-22
NCT03787212MiBo ThermoFlo Lid Temperature EvaluationTERMINATEDNA2018-12-062019-01-282019-01-28
NCT03768609A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsCOMPLETEDPHASE12018-12-062019-03-122019-03-06
NCT03697889A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult VolunteersCOMPLETEDPHASE12018-12-032019-01-212018-12-17
NCT03656510Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus InfectionTERMINATEDPHASE22018-11-292022-04-182022-04-18
NCT03635528Evaluating Accommodative Responses of Soft Contact Lenses for Myopia ControlCOMPLETEDNA2018-11-292019-07-182019-07-18
NCT03662542A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE22018-11-202021-11-152020-12-01
NCT03649971A Study of Guselkumab in Participants With Familial Adenomatous PolyposisCOMPLETEDPHASE12018-11-192022-03-232021-09-13
NCT03782571Influence of Lens Design on Particulate Exchange in the Post-lens Tear FilmCOMPLETEDNA2018-11-162019-03-252019-03-25
NCT03733899An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens DiscomfortCOMPLETEDNA2018-11-072019-02-072019-02-07
NCT03664232A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum DisorderCOMPLETEDPHASE22018-11-072022-10-282022-10-17
NCT03652064A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial TherapyACTIVE_NOT_RECRUITINGPHASE32018-11-062026-01-092024-05-07
NCT03755882Clinical Comparison of Two Marketed Reusable Cosmetic Contact LensesCOMPLETEDNA2018-11-052018-12-262018-12-26
NCT03502694Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human MetapneumovirusWITHDRAWNPHASE22018-11-052020-10-282019-04-30
NCT03742271Evaluation of Senofilcon A With New UV-blocker on a Neophyte PopulationCOMPLETEDNA2018-10-302019-03-312019-03-31
NCT03596645A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE32018-10-292027-02-202023-11-21
NCT03723746A Study to Evaluate the Safety and Tolerability of JNJ-67670187 in Healthy ParticipantsCOMPLETEDPHASE12018-10-252019-12-162019-12-16
NCT03713658A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare FacilitiesCOMPLETEDPHASE42018-10-182019-12-022019-12-02
NCT03693391A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupancy of JNJ-64140284 With Newly Developed Transmembrane AMPA Receptor Regulatory Protein (TARP)-Gamma 8 Positron Emission Tomography (PET) [18F]JNJ-64511070 in Healthy MenTERMINATEDPHASE12018-10-172019-03-132019-03-02
NCT03708367A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery PracticeCOMPLETEDNA2018-10-162020-01-132020-01-13
NCT03713281Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic PopulationCOMPLETED2018-10-042019-02-192019-02-19
NCT03696459A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult ParticipantsCOMPLETEDPHASE12018-10-022019-12-132019-12-13
NCT03682380A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy ParticipantsCOMPLETEDPHASE12018-10-012019-08-232019-08-23
NCT03707821Design Validation of Senofilcon A With New UV-blocking AdditiveCOMPLETEDNA2018-10-012018-11-012018-11-01
NCT03689153A Study of JNJ-63733657 in Healthy Japanese ParticipantsCOMPLETEDPHASE12018-09-282019-07-112019-07-11
NCT03610581Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the CervixTERMINATEDPHASE1, PHASE22018-09-272020-10-152020-10-15
NCT03384641A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary LeprosyCOMPLETEDPHASE22018-09-262024-01-092023-01-13
NCT04696536A Twelve Week Study of Supervised Mouth Rinse and FlossingCOMPLETEDPHASE42018-09-262018-12-212018-12-21
NCT03563742A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTERMINATEDPHASE32018-09-242021-06-282021-06-28
NCT03701516Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2COMPLETEDNA2018-09-242019-04-012019-04-01
NCT03585556AAVCAGsCD59 for the Treatment of Wet AMDCOMPLETEDPHASE12018-09-132022-01-182020-01-29
NCT03628924A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)COMPLETEDPHASE22018-09-042020-05-222020-05-22
NCT03523442A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate CancerACTIVE_NOT_RECRUITINGPHASE12018-08-312026-12-312019-07-09
NCT03547037A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid CancersCOMPLETEDPHASE12018-08-312022-07-042022-07-04
NCT03679741Initial Evaluation of Investigational Lenses Manufactured on a New Production LineCOMPLETEDNA2018-08-292018-10-312018-10-31
NCT03649997A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy ParticipantsCOMPLETEDPHASE12018-08-282018-12-142018-12-14
NCT03617016Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional DyspepsiaCOMPLETEDPHASE42018-08-272020-07-312020-07-31
NCT03670277Evaluation of On-eye Optical Performances of the RMY-100 LensCOMPLETEDNA2018-08-222019-02-192019-02-19
NCT03566979Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental PainCOMPLETEDPHASE32018-08-132019-04-152019-03-26
NCT03618160A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian ParticipantsTERMINATEDPHASE12018-08-062019-06-212019-06-21
NCT03593954A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy ParticipantsCOMPLETEDPHASE12018-07-312018-09-192018-09-19
NCT03607513A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Female ParticipantsCOMPLETEDPHASE12018-07-312019-08-092019-08-09
NCT03566940A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization ScheduleCOMPLETEDPHASE22018-07-312019-10-172019-08-07
NCT03559192A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of DepressionCOMPLETEDPHASE22018-07-162020-05-062020-05-06
NCT03573310A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDSACTIVE_NOT_RECRUITINGPHASE12018-07-132025-12-312025-12-31
NCT03606057A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)COMPLETEDPHASE12018-07-132019-02-282019-02-08
NCT03451851A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric ParticipantsACTIVE_NOT_RECRUITINGPHASE32018-07-112026-12-182023-07-19
NCT03581916A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy ParticipantsCOMPLETEDPHASE12018-07-112018-11-022018-11-02
NCT03502707A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and OlderCOMPLETEDPHASE1, PHASE22018-07-062022-05-162022-05-16
NCT03605303Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding ProcessTERMINATEDNA2018-07-032018-07-052018-07-05
NCT03548207A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE1, PHASE22018-06-292022-08-232022-08-23
NCT03597178Contact Lens Insertion and Removal in a Senior Subject DemographicCOMPLETEDNA2018-06-292018-07-122018-07-12
NCT03586843A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple DoseCOMPLETEDPHASE12018-06-292019-03-172019-03-17
NCT03551782A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE12018-06-282021-11-112021-11-11
NCT03500198Clinical Investigation of the Next Generation Intraocular LensCOMPLETEDNA2018-06-282019-06-052019-06-05
NCT03586830A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22018-06-262019-04-052019-04-05
NCT03512275A Study of Bermekimab in Patients With Hidradenitis SuppurativaCOMPLETEDPHASE22018-06-202019-01-142019-01-14
NCT03586648Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2COMPLETEDNA2018-06-142018-08-202018-08-20
NCT03564379A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12018-06-122018-08-132018-08-13
NCT03547024A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl EstradiolCOMPLETEDPHASE12018-06-082018-08-302018-08-30
NCT03581825Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic PopulationCOMPLETEDNA2018-06-082018-08-202018-08-20
NCT03546205A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal FunctionCOMPLETEDPHASE12018-06-062018-12-172018-12-17
NCT03550950A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy ParticipantsCOMPLETEDPHASE12018-06-012019-02-052019-02-05
NCT03536325A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese ParticipantsCOMPLETEDPHASE12018-05-312018-10-252018-10-25
NCT03587376Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)COMPLETEDEARLY_PHASE12018-05-302018-08-232018-08-23
NCT03434041A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCOMPLETEDPHASE32018-05-252021-04-132021-04-13
NCT03496974A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE22018-05-212018-12-112018-12-04
NCT03556579The Effects of Contact Lenses With Experimental Dye on Visual FunctionCOMPLETEDNA2018-05-152018-09-202018-09-20
NCT03384654A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCOMPLETEDPHASE22018-05-142022-09-272022-09-22
NCT03403348A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy ParticipantsCOMPLETEDPHASE12018-05-092019-11-242019-11-24
NCT03500679A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and OlderCOMPLETEDPHASE22018-05-092019-06-112018-11-05
NCT03474679A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)COMPLETEDPHASE32018-05-012021-11-292021-11-29
NCT03412565A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment RegimensCOMPLETEDPHASE22018-04-262024-04-182020-08-12
NCT03463369A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically SuppressedCOMPLETEDPHASE12018-04-182021-03-232021-03-23
NCT03462719A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)ACTIVE_NOT_RECRUITINGPHASE32018-04-172029-04-052021-02-26
NCT03517722A Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusTERMINATEDPHASE32018-04-162020-11-052020-11-05
NCT03466411A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE2, PHASE32018-04-132028-01-282023-10-20
NCT03494907A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult ParticipantsCOMPLETEDPHASE12018-04-092018-08-132018-08-13
NCT02895815Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)WITHDRAWNPHASE22018-04-092022-08-192021-02-20
NCT03473743A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22018-04-052026-10-302022-09-30
NCT03842189A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)COMPLETEDPHASE22018-04-052024-08-052024-08-05
NCT03464136Safety and Efficacy of Adalimumab Versus Ustekinumab for One YearCOMPLETEDPHASE32018-03-292021-05-212020-12-15
NCT03486392A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese ParticipantsCOMPLETEDPHASE22018-03-262019-03-082019-03-08
NCT03390504A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsACTIVE_NOT_RECRUITINGPHASE32018-03-232026-11-012024-04-15
NCT03437590A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739COMPLETEDPHASE12018-03-152018-10-192018-10-19
NCT03468777A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult ParticipantsTERMINATEDPHASE12018-03-062018-07-092018-07-09
NCT03307915A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral TreatmentCOMPLETEDPHASE12018-03-052021-11-052021-11-05
NCT03431350A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerACTIVE_NOT_RECRUITINGPHASE22018-03-022025-12-312021-08-31
NCT03439436A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.COMPLETEDPHASE32018-02-262018-05-022018-05-02
NCT03475875Contact Lenses With New UV-blocker Manufactured With Different TechniquesCOMPLETEDPHASE2, PHASE32018-02-192018-04-182018-04-18
NCT03361956An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus InfectionCOMPLETEDPHASE22018-02-132020-08-132019-09-05
NCT03438461A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted ConditionsCOMPLETEDPHASE12018-02-092018-05-302018-05-30
NCT03466086Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing PatientsCOMPLETEDPHASE42018-02-092018-05-162018-05-16
NCT03441529A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult ParticipantsCOMPLETEDPHASE12018-02-092018-05-032018-05-03
NCT03466060Clinical Evaluation of 3 Contact Lens Materials With 3 Solution TypesCOMPLETEDNA2018-02-072018-06-192018-06-19
NCT03379675A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial VirusCOMPLETEDPHASE22018-02-062019-12-262019-11-27
NCT03358706A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative ColitisTERMINATEDPHASE12018-02-022021-11-222021-11-22
NCT03432923A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.COMPLETEDPHASE32018-02-022018-04-212018-04-21
NCT03381196A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing ComplicationsTERMINATEDPHASE32018-01-212020-08-242020-05-28
NCT03431441Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid StyleCOMPLETEDNA2018-01-162018-02-142018-02-14
NCT03457857Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.COMPLETEDNA2018-01-102018-05-112018-05-11
NCT03374475A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive DisorderCOMPLETEDPHASE12018-01-052019-04-292019-04-29
NCT03332459A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus InfectionCOMPLETEDPHASE22018-01-052020-04-132020-04-13
NCT03376321A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A InfectionTERMINATEDPHASE32018-01-032020-04-302020-03-31
NCT03405441A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male ParticipantsCOMPLETEDPHASE12018-01-022018-09-042018-09-04
NCT03371381An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the LungTERMINATEDPHASE1, PHASE22018-01-022018-10-092018-10-09
NCT03408444Evaluating Soft Contact Lens Prototypes for Myopia ControlCOMPLETED2017-12-272019-05-252019-05-25
NCT03375697A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's DiseaseCOMPLETEDPHASE12017-12-222019-12-162019-12-16
NCT03398876A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese SmokersCOMPLETEDPHASE12017-12-222018-04-162018-04-16
NCT03399799Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12017-12-162029-03-302022-07-07
NCT03321526A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyCOMPLETEDPHASE22017-12-122019-06-272019-06-13
NCT03220867Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy ParticipantsWITHDRAWNPHASE12017-12-112018-04-272018-01-02
NCT03339713A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable HealthCOMPLETEDPHASE22017-12-072018-07-232018-07-23
NCT03388138Clinical Evaluation of Etafilcon A With KetotifenCOMPLETEDPHASE22017-12-062018-02-092018-02-09
NCT03234972A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE32017-11-302024-02-272019-10-07
NCT03339726Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common ColdTERMINATEDPHASE22017-11-302018-04-162018-04-16
NCT03303625A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of AgeCOMPLETEDPHASE1, PHASE22017-11-292020-04-212020-04-21
NCT03356561A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult VolunteersCOMPLETEDPHASE12017-11-262019-09-232019-09-23
NCT03333317A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial VirusTERMINATEDPHASE22017-11-242018-03-232018-03-23
NCT03375203A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia DisorderCOMPLETEDPHASE22017-11-232019-04-032019-04-03
NCT03217812A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)COMPLETEDPHASE32017-11-232024-03-082020-07-02
NCT03345342A Study of Paliperidone Palmitate 6-Month FormulationCOMPLETEDPHASE32017-11-202020-05-082020-05-08
NCT03404791A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical CystectomyCOMPLETEDPHASE12017-11-202022-09-152019-12-23
NCT03428997Human Comedogenicity TestCOMPLETEDNA2017-11-202018-02-052018-02-05
NCT03365934Evaluation of Changes to Skin Microbiome With Tape-Stripped WoundsCOMPLETEDNA2017-11-202018-02-122018-02-12
NCT03357952A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE2, PHASE32017-11-162021-11-192018-10-24
NCT03450070Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100COMPLETEDNA2017-11-152017-12-222017-12-22
NCT03346122A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy ParticipantsCOMPLETEDPHASE12017-11-152018-11-202018-11-20
NCT03251482A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement SurgeryCOMPLETEDPHASE22017-11-132018-11-052018-11-05
NCT03301220A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE32017-11-072026-01-052024-05-01
NCT03196531A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne TabletsCOMPLETEDPHASE12017-11-072018-03-312018-03-31
NCT03060629A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan AfricaTERMINATEDPHASE22017-11-032022-02-022022-02-02
NCT03277105A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE32017-10-272024-01-122019-06-27
NCT03267576An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on MetforminCOMPLETEDPHASE42017-10-272018-10-012018-10-01
NCT03301207A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell MalignancyCOMPLETEDPHASE12017-10-202018-12-042018-07-17
NCT03334695An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old AdultsCOMPLETEDPHASE22017-10-162018-11-272018-07-10
NCT03298542A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 DiabetesCOMPLETEDPHASE12017-10-162021-06-012020-12-21
NCT03320707A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy ParticipantsCOMPLETEDPHASE12017-10-162019-08-272019-08-27
NCT03032588A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy AdultsCOMPLETEDPHASE12017-10-092018-05-182018-05-18
NCT03312543Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial WrinklesCOMPLETEDNA2017-10-092018-04-062018-01-12
NCT03201965A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) AmyloidosisCOMPLETEDPHASE32017-10-052024-11-192020-02-14
NCT03185819Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideCOMPLETEDPHASE22017-10-052023-03-312023-03-31
NCT03319212Clinical Characterization of Symptomatic PopulationsCOMPLETEDNA2017-09-292018-08-152018-08-15
NCT03330275Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving PerformanceCOMPLETEDPHASE22017-09-272017-12-112017-12-11
NCT03298906A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy ParticipantsCOMPLETEDPHASE12017-09-262017-11-272017-11-27
NCT03274297A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult WomenCOMPLETEDPHASE42017-09-202018-05-072018-05-07
NCT03451240A Mixed Methods Evaluation of HPI Resilience Intervention StudyCOMPLETEDNA2017-09-162017-12-312017-12-31
NCT03270579A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070COMPLETEDPHASE12017-09-122018-02-062018-02-06
NCT03322423Evaluation of Two Marketed Multifocal Contact LensesCOMPLETEDNA2017-09-112017-11-042017-11-04
NCT03277755A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic FunctionWITHDRAWNPHASE12017-09-112017-12-222017-12-22
NCT03239561Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy ParticipantsCOMPLETEDEARLY_PHASE12017-09-062018-04-302018-04-30
NCT03162796A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)COMPLETEDPHASE32017-08-242019-11-182019-03-14
NCT02399046A Clinical Trial Study of Knee System in Primary Total Knee Arthroplasty in ChinaCOMPLETEDNA2017-08-172019-10-252019-07-10
NCT03227224A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyCOMPLETEDPHASE22017-08-162019-01-192019-01-12
NCT03249402A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult ParticipantsCOMPLETEDPHASE12017-08-142017-11-242017-11-24
NCT03259607Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy SmokersCOMPLETEDPHASE12017-08-142018-01-092017-12-25
NCT03242889A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12017-08-102023-02-102017-11-01
NCT03235219A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12017-08-012018-02-192018-02-19
NCT03227861A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of CareCOMPLETEDPHASE32017-07-312019-09-042019-01-03
NCT03170518A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes MellitusCOMPLETEDPHASE32017-07-212023-09-202023-09-20
NCT03224403Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental PainCOMPLETEDPHASE32017-07-192018-04-122018-04-04
NCT03228212Evaluation of Approved and Investigational Contact LensesCOMPLETEDNA2017-07-142017-09-182017-09-18
NCT03158285A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE32017-07-122020-11-102019-02-25
NCT03189498A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal FunctionCOMPLETEDPHASE12017-07-112017-12-062017-12-06
NCT03142984UK Baby Study Using a Baby Wash and Lotion RegimenTERMINATEDNA2017-07-042020-06-042020-06-04
NCT03213353A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold SymptomsCOMPLETEDPHASE12017-07-032017-07-172017-07-17
NCT02920424A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus ErythematosusWITHDRAWNPHASE12017-06-302019-09-262019-02-01
NCT03198000A Study to Evaluate the Efficacy of Investigational OTC Eye DropsCOMPLETEDPHASE32017-06-282017-07-212017-07-21
NCT03080987A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese ParticipantsCOMPLETEDPHASE12017-06-272018-06-252018-06-25
NCT03222037Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens WearersCOMPLETEDPHASE42017-06-272017-08-042017-08-04
NCT0309713354135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideCOMPLETEDPHASE32017-06-152019-04-112019-04-11
NCT03208088Clinical Evaluation of Multifocal Toric Contact LensesCOMPLETEDNA2017-06-122017-07-212017-07-21
NCT03305887Symmetric on Total Knee Arthroplasty (TKA)COMPLETEDNA2017-06-122018-05-212018-04-13
NCT0303919254135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideCOMPLETEDPHASE32017-06-092018-12-182018-12-18
NCT03151720A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne TabletsCOMPLETEDPHASE12017-06-012017-07-082017-07-08
NCT03180762A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy ParticipantsTERMINATEDPHASE12017-05-302017-09-252017-09-25
NCT03264677An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)COMPLETEDNA2017-05-182017-07-252017-07-25
NCT03089918A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human BrainCOMPLETEDPHASE12017-05-172018-08-242018-08-24
NCT03139500A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy ParticipantsTERMINATEDPHASE12017-05-172018-04-052018-04-05
NCT03145181Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE12017-05-162027-05-282021-11-09
NCT03155893A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy ParticipantsCOMPLETEDPHASE12017-05-122017-10-272017-10-27
NCT03151486A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female ParticipantsCOMPLETEDPHASE12017-05-032018-03-082018-03-08
NCT03168542Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2COMPLETEDNA2017-05-012017-05-042017-05-04
NCT03128723A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne VulgarisCOMPLETEDNA2017-04-302017-06-082017-06-08
NCT03139578Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact LensesCOMPLETEDNA2017-04-282017-10-222017-10-22
NCT03090100A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type PsoriasisCOMPLETEDPHASE32017-04-272018-09-202018-08-02
NCT03127189A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy ParticipantsCOMPLETEDPHASE12017-04-202018-04-102018-04-10
NCT03107793Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With UstekinumabCOMPLETEDPHASE32017-04-192021-07-202020-04-30
NCT03135106A Study to Evaluate the Effect of Fluconazole and Itraconazole on Erdafitinib Pharmacokinetics in Healthy Adult ParticipantsCOMPLETEDPHASE12017-04-142017-09-012017-09-01
NCT03123848A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE42017-04-142017-05-192017-05-19
NCT03126097A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy FemalesTERMINATEDPHASE12017-04-132017-05-262017-05-26
NCT03099135A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) InfectionTERMINATEDPHASE32017-04-102018-02-132018-02-01
NCT03124381A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate AcneCOMPLETEDNA2017-04-082017-09-062017-09-06
NCT03105986A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy AdultsCOMPLETEDPHASE12017-04-052017-06-162017-06-16
NCT02935686A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected AdultsCOMPLETEDPHASE1, PHASE22017-03-312023-11-222023-11-22
NCT03144999Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59COMPLETEDPHASE12017-03-292019-12-092017-12-06
NCT03150485Clinical Evaluation of Fitting Investigational Contact LensesCOMPLETEDNA2017-03-272017-03-312017-03-31
NCT03111511A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)COMPLETEDPHASE12017-03-272017-08-232017-08-23
NCT03088644A Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron Emission Tomography (PET) Tracer 18F-JNJ-64413739COMPLETEDPHASE12017-03-242017-11-142017-11-14
NCT03130179A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.COMPLETEDPHASE12017-03-202017-06-292017-06-19
NCT03066687A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy ParticipantsCOMPLETEDPHASE12017-03-142017-05-122017-05-12
NCT03058419A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy SubjectsCOMPLETEDPHASE12017-03-142017-05-152017-05-15
NCT03086447Evaluation of Astigmatic Contact LensesCOMPLETEDNA2017-03-012017-05-042017-05-04
NCT02905331Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisCOMPLETEDPHASE32017-02-282018-02-062018-02-06
NCT03059303Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)TERMINATEDPHASE12017-02-202017-04-242017-04-24
NCT03047317A Pharmacokinetic Study of MABp1 in Healthy VolunteersCOMPLETEDPHASE12017-02-152017-03-312017-03-08
NCT03011034Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) TreatmentCOMPLETEDPHASE22017-02-142021-10-052019-01-23
NCT02927925A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal TypeCOMPLETEDPHASE22017-02-142020-01-072020-01-02
NCT03023852A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult ParticipantsCOMPLETEDPHASE12017-02-142017-04-142017-04-14
NCT03010059A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept FormulationsCOMPLETEDPHASE12017-02-062017-05-292017-05-29
NCT03571685Sustainable Early Episode Clinic Study (SEEC)COMPLETEDNA2017-01-312019-12-202019-12-20
NCT03059810Clinical Evaluation of Investigational Multifocal Contact LensesCOMPLETEDNA2017-01-272017-04-252017-04-25
NCT03002779A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male ParticipantsCOMPLETEDPHASE12017-01-262017-03-202017-03-10
NCT02993237Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo TabletsCOMPLETEDPHASE12017-01-232017-05-252017-05-25
NCT02968108A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE12017-01-182022-03-182018-09-19
NCT03025022A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy SubjectsCOMPLETEDPHASE12017-01-172017-02-272017-02-27
NCT03002025A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male ParticipantsCOMPLETEDPHASE12017-01-102017-09-092017-09-09
NCT03007693A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy ParticipantsCOMPLETEDPHASE12017-012017-102017-10
NCT03023423A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22016-12-232019-09-262018-05-17
NCT02993250A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naiveCOMPLETEDPHASE22016-12-212018-05-072018-05-07
NCT02996435Smartphones to Improve Rivaroxaban ADHEREnce in Atrial FibrillationCOMPLETEDPHASE42016-12-212018-03-222018-03-22
NCT02918318A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant DepressionCOMPLETEDPHASE22016-12-122019-12-132019-08-19
NCT02951533A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32016-12-122019-02-062017-09-13
NCT02984852Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult ParticipantsCOMPLETEDPHASE12016-122017-022017-02
NCT02895529A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyTERMINATEDPHASE42016-11-302018-05-022018-05-02
NCT02951845Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy ParticipantsWITHDRAWNPHASE12016-11-222017-02-172017-02-17
NCT02908906A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced CancersACTIVE_NOT_RECRUITINGPHASE1, PHASE22016-11-212026-12-312023-11-17
NCT02846532Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan ProcedureCOMPLETEDPHASE32016-11-162020-07-162020-07-16
NCT02949206A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male SubjectsCOMPLETEDPHASE12016-11-142017-08-092017-08-09
NCT02945020A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy ParticipantsCOMPLETEDPHASE12016-11-102017-01-202017-01-09
NCT02961660A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of OdalasvirCOMPLETEDPHASE12016-11-092018-04-092018-04-09
NCT02951819A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple MyelomaCOMPLETEDPHASE22016-11-092020-08-172018-03-08
NCT02765490Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C InfectionCOMPLETEDPHASE22016-11-092017-11-162017-08-09
NCT02945007A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Concept Formulation Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of Oral Concept FormulationCOMPLETEDPHASE12016-11-082020-01-162020-01-16
NCT02926430A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable HealthCOMPLETEDPHASE12016-11-082019-01-292018-03-14
NCT02935673Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial VirusTERMINATEDPHASE22016-10-252018-07-172018-07-17
NCT02902601A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive DisorderCOMPLETEDPHASE12016-10-172017-06-072017-06-02
NCT02933580A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12016-10-122017-02-042017-02-04
NCT02919579A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive DisorderCOMPLETEDPHASE12016-10-072018-06-292018-06-29
NCT02924766A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)COMPLETEDPHASE12016-10-032019-07-192019-07-18
NCT02982018Clinical Evaluation of Approved and Investigational Contact Lenses Using New UV AdditiveCOMPLETEDNA2016-10-012017-02-182017-02-18
NCT02930694A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female ParticipantsCOMPLETEDPHASE12016-102016-122016-12
NCT02906605A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate CancerWITHDRAWNPHASE22016-102018-092018-09
NCT02811978Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple MyelomaCOMPLETEDPHASE32016-09-272018-11-102018-05-07
NCT02852837Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic TherapyCOMPLETEDPHASE12016-09-262019-12-132019-12-13
NCT02829099A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage TumorsCOMPLETEDPHASE12016-09-212021-07-292021-07-01
NCT02894905A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335COMPLETEDPHASE12016-09-132017-08-162017-08-08
NCT02889367A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy ParticipantsCOMPLETEDPHASE12016-09-122017-03-042017-03-04
NCT02933762A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and PlasmaCOMPLETEDPHASE12016-092016-112016-11
NCT02918331A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell TransplantationCOMPLETEDPHASE12016-092020-032017-10
NCT02919306Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected AdultsCOMPLETEDPHASE1, PHASE22016-092018-092018-09
NCT02854436An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair AnomaliesCOMPLETEDPHASE22016-08-312023-08-162021-01-26
NCT02810522OneTouch Select® [Brand Name]Plus Blood Glucose Monitoring System(BGMS) Registration StudyWITHDRAWNNA2016-08-312017-03-312016-11-30
NCT02874742Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE22016-08-292022-04-082019-01-25
NCT02877225Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA CapsuleCOMPLETEDPHASE12016-08-292016-11-112016-11-11
NCT02846545A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 DiabetesCOMPLETEDPHASE22016-08-262021-01-052019-05-21
NCT02877134Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE22016-08-252022-01-242020-12-10
NCT02852395A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274COMPLETEDPHASE12016-08-132018-05-022018-05-02
NCT02857777Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese SubjectsCOMPLETEDPHASE12016-08-092017-01-272017-01-27
NCT02860806Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy AdultsCOMPLETEDPHASE12016-08-082017-06-102017-06-06
NCT02846506A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted ParticipantsCOMPLETEDPHASE12016-082016-102016-10
NCT02865668A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCOMPLETEDPHASE12016-082016-102016-10
NCT02851095A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCOMPLETEDPHASE12016-082016-112016-11
NCT02886923Evaluation of Vision Effects of a Cosmetic Tinted Hydrogel Contact LensCOMPLETEDNA2016-08-012017-01-232017-01-23
NCT02860650A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy AdultsCOMPLETEDPHASE12016-082018-012017-05
NCT02885454To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female ParticipantsCOMPLETEDPHASE12016-082016-122016-12
NCT02851212A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCOMPLETEDPHASE12016-082016-102016-10
NCT02743546Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in LymphomaWITHDRAWNPHASE12016-07-202020-03-312018-09-30
NCT02862431Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)TERMINATEDPHASE12016-07-122016-12-052016-11-29
NCT02788045Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected AdultsCOMPLETEDPHASE1, PHASE22016-07-082022-04-252022-04-25
NCT02699606A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or CholangiocarcinomaCOMPLETEDPHASE22016-07-082024-03-152021-10-12
NCT02812251Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy ParticipantsCOMPLETEDPHASE12016-07-072016-11-172016-11-17
NCT02703272A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin LymphomaTERMINATEDPHASE32016-07-012021-06-112021-06-11
NCT02737605A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy ParticipantsCOMPLETEDPHASE12016-07-012017-02-232017-02-23
NCT02821858Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese ParticipantsCOMPLETEDPHASE12016-06-142016-09-302016-09-09
NCT02782104A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionCOMPLETEDPHASE32016-06-092022-12-302022-12-30
NCT02837692A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy AdultsCOMPLETEDPHASE12016-06-082017-09-112017-09-07
NCT02833831Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy ParticipantsCOMPLETEDPHASE12016-06-022017-02-242017-02-17
NCT02813460Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult ParticipantsCOMPLETEDPHASE12016-062016-082016-08
NCT02715011Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)COMPLETEDPHASE12016-06-012021-03-262021-03-26
NCT02841150Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA CapsulesCOMPLETEDPHASE12016-062016-082016-08
NCT02835508Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese ParticipantsCOMPLETEDPHASE12016-062016-122016-12
NCT02661464Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-FiloTERMINATEDPHASE32016-05-312021-12-132021-12-13
NCT03041064Multiday Beach StudyCOMPLETEDNA2016-05-272016-06-012016-06-01
NCT02609776Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE12016-05-242026-12-312026-12-31
NCT02354014Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TBRECRUITINGPHASE22016-05-032027-02-112027-02-11
NCT02824315Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese ParticipantsCOMPLETEDPHASE12016-052016-102016-10
NCT02816853Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy ParticipantsCOMPLETEDPHASE12016-052016-082016-08
NCT02698475An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of AgeCOMPLETEDPHASE32016-052020-102017-12
NCT02735122Study of Acetaminophen (ACM) in Post-operative Dental PainCOMPLETEDPHASE32016-04-302016-10-052016-10-05
NCT02713282A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month FormulationCOMPLETEDPHASE32016-04-282018-03-262018-03-26
NCT02801396Clinical Evaluation of Investigational Contact LensesCOMPLETEDNA2016-04-242016-05-222016-05-22
NCT02760810Clinical Evaluation of An Approved Contact LensCOMPLETEDNA2016-04-122016-04-262016-04-26
NCT02756078Clinical Performance Evaluation of Two Silicone Hydrogel LensesCOMPLETEDNA2016-04-082017-10-022017-10-02
NCT02611518A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy ParticipantsCOMPLETEDPHASE12016-04-052016-06-142016-06-14
NCT02670395A Study to Investigate the Safety, Tolerability, Food Effect, and Pharmacokinetics of JNJ-54416076 in Healthy ParticipantsCOMPLETEDPHASE12016-042016-092016-09
NCT02566889An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel DiseaseTERMINATEDPHASE42016-042019-072019-07
NCT02759692Clinical Evaluation of Two Approved Contact LensesCOMPLETEDNA2016-04-012016-06-012016-06-01
NCT02758392A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy ParticipantsCOMPLETEDPHASE12016-042017-012017-01
NCT02748967A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12016-042016-082016-08
NCT02698436A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.COMPLETEDNA2016-03-312016-08-312016-08-31
NCT02952235Evaluation of Sunscreens Under Actual Use ConditionsCOMPLETEDNA2016-03-312016-03-312016-03-31
NCT02685020Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected AdultsCOMPLETEDPHASE12016-03-282019-01-032018-01-05
NCT02682225Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug UsersCOMPLETEDPHASE12016-03-252017-01-092017-01-09
NCT02729467A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy AdultsCOMPLETEDPHASE12016-032016-062016-06
NCT02674295A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male ParticipantsCOMPLETEDPHASE12016-032016-082016-08
NCT02692677A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male ParticipantsCOMPLETEDPHASE12016-032016-082016-08
NCT02846519Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered EsketamineCOMPLETEDPHASE12016-02-262016-05-282016-05-28
NCT02699593Clinical Evaluation of Approved Contact LensesCOMPLETEDNA2016-02-012016-04-012016-04-01
NCT02691507Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With EczemaCOMPLETEDPHASE22016-022016-042016-04
NCT02660372Efficacy and Safety of Two Simeticone Brands in Adults With Functional DyspepsiaCOMPLETEDPHASE32016-022016-122016-10
NCT02638116A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy AdultsCOMPLETEDPHASE12016-012016-032016-03
NCT02661893A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922COMPLETEDPHASE12016-012016-022016-02
NCT02658825A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy ParticipantsCOMPLETEDPHASE12016-012016-042016-04
NCT02671955A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced CancerTERMINATEDPHASE12016-012017-072017-01
NCT02669095Clinical Evaluation of Approved and Investigational Contact LensesCOMPLETEDNA2016-012016-032016-03
NCT02708524Clinical Study of Approved and Investigational Contact LensesCOMPLETEDNA2016-012016-032016-03
NCT02641028A Study in a Human Laboratory Model of Smoking BehaviorCOMPLETEDPHASE22015-12-312016-12-312016-09-13
NCT02662712A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)COMPLETEDPHASE12015-12-172018-06-292018-06-29
NCT02641730An Efficacy and Safety of Guselkumab in Participants With Palmoplantar PustulosisCOMPLETEDPHASE32015-12-152018-07-172017-03-28
NCT02532283A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A InfectionCOMPLETEDPHASE22015-12-112017-03-152017-02-24
NCT02598388Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-FiloCOMPLETEDPHASE22015-12-102018-12-122018-12-12
NCT02625857Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate CancerCOMPLETEDPHASE12015-12-102018-07-032018-07-03
NCT02699385A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute GastroenteritisTERMINATEDPHASE32015-12-072017-08-032017-08-03
NCT02659098A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic AtrophyCOMPLETEDPHASE22015-12-042019-06-052019-06-05
NCT02606084A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineCOMPLETEDPHASE12015-12-042018-02-022018-02-02
NCT02593851A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) InfectionTERMINATEDPHASE12015-12-042017-11-102017-03-21
NCT02592967Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung CancerTERMINATEDPHASE12015-12-022018-10-222018-08-14
NCT02609789A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus ErythematosusCOMPLETEDPHASE12015-122018-092018-09
NCT02659735A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet FormulationCOMPLETEDPHASE12015-122016-042016-04
NCT02652650A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and NorethindroneCOMPLETEDPHASE12015-122016-062016-06
NCT02611505A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineCOMPLETEDPHASE12015-11-302017-02-272017-02-27
NCT02608320A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy ParticipantsCOMPLETEDPHASE12015-11-172016-04-132016-04-13
NCT02546960A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860COMPLETEDPHASE22015-11-122019-06-212016-09-12
NCT02634463Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneCOMPLETEDPHASE12015-11-092016-11-092016-11-09
NCT02564523Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) AdultsCOMPLETEDPHASE22015-11-062019-02-122019-02-12
NCT02578550A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy ParticipantsCOMPLETEDPHASE12015-112016-022016-02
NCT02617758Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy ParticipantsCOMPLETEDPHASE12015-112016-062016-06
NCT02623491Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy ParticipantsCOMPLETEDPHASE12015-112016-092016-09
NCT02578472Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy ParticipantsCOMPLETEDPHASE12015-112016-022016-02
NCT02617810A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy ParticipantsCOMPLETEDPHASE12015-112016-022016-02
NCT02595268A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy ParticipantsCOMPLETEDPHASE12015-112016-012016-01
NCT02569398An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's DementiaTERMINATEDPHASE2, PHASE32015-10-292018-12-202018-12-20
NCT04510103A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry SkinCOMPLETEDNA2015-10-232016-04-072016-03-25
NCT02519452A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12015-10-222023-04-032017-12-13
NCT02349061A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus ErythematosusCOMPLETEDPHASE22015-10-152019-03-132017-05-15
NCT02584660A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency DepartmentCOMPLETEDPHASE42015-10-152017-03-222017-03-22
NCT02498392An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious DistressCOMPLETEDPHASE22015-10-072019-02-042019-02-04
NCT02493868A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionCOMPLETEDPHASE32015-10-012018-02-162018-02-15
NCT02568176Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy ParticipantsCOMPLETEDPHASE12015-102016-022016-02
NCT02561936Relative Bioavailability of Three Oral Formulations Candidates of Rilpivirine for Potential Pediatric Use Compared to Oral TabletCOMPLETEDPHASE12015-102016-042016-04
NCT02625220Dispensing Evaluation of Investigational Contact LensesCOMPLETEDNA2015-102015-112015-11
NCT02625233Clinical Long-Term Evaluation of Approved and Investigational Contact LensesCOMPLETEDNA2015-10-012016-02-012016-02-01
NCT02497287A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionCOMPLETEDPHASE32015-09-302017-10-282017-10-28
NCT02509494Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-FiloCOMPLETEDPHASE32015-09-302019-07-032019-06-28
NCT02570373A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy ParticipantsCOMPLETEDPHASE12015-09-252016-01-122016-01-12
NCT02543567A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult ParticipantsCOMPLETEDPHASE32015-09-212016-11-292016-06-07
NCT02555124A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12015-09-122015-10-312015-10-31
NCT02555878A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsCOMPLETEDPHASE32015-09-112018-08-242018-08-24
NCT02437162A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial SpondyloarthritisTERMINATEDPHASE32015-09-032017-09-062017-03-22
NCT02568254Evaluation of Three Daily Disposable Contact LensesCOMPLETEDNA2015-09-032016-01-182016-01-18
NCT02413489An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular LymphomaTERMINATEDPHASE22015-09-022017-06-012017-06-01
NCT02595502Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact LensesCOMPLETEDNA2015-09-012015-11-012015-11-01
NCT02561923A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy ParticipantsCOMPLETEDPHASE12015-08-272016-06-172016-06-17
NCT02422186A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionCOMPLETEDPHASE32015-08-202017-08-102017-08-10
NCT02547870A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on PharmacokineticsCOMPLETEDPHASE12015-08-142016-04-262016-04-26
NCT02417064A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCOMPLETEDPHASE32015-08-102018-02-202018-02-20
NCT02418585A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCOMPLETEDPHASE32015-08-072017-11-062017-06-01
NCT02472145An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyCOMPLETEDPHASE2, PHASE32015-08-042018-01-252018-01-25
NCT02515955A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male ParticipantsCOMPLETEDPHASE12015-082016-032016-03
NCT02540122Pilot Clinical Evaluation of Approved Contact LensesCOMPLETEDPHASE12015-082016-062016-06
NCT02530060A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male ParticipantsCOMPLETEDPHASE42015-082015-092015-09
NCT02438787A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial SpondyloarthritisTERMINATEDPHASE32015-07-312017-08-312017-08-31
NCT02464046Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric ComorbidityCOMPLETEDPHASE22015-07-272015-12-022015-12-02
NCT02473289An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive DisorderCOMPLETEDPHASE22015-07-232018-05-222018-05-22
NCT02505568A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's DiseaseCOMPLETEDPHASE32015-07-222018-07-132018-07-13
NCT02407223An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial SpondyloarthritisTERMINATEDPHASE32015-07-132017-09-262017-09-26
NCT02336698Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002COMPLETEDPHASE32015-07-132016-09-152016-09-15
NCT02289716Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003COMPLETEDPHASE32015-07-102016-10-102016-10-10
NCT02407236A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE32015-07-102021-11-302018-08-10
NCT02497378A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12015-07-102018-03-062018-03-06
NCT02431702A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformCOMPLETEDPHASE32015-07-082019-11-122019-11-12
NCT02336685Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001COMPLETEDPHASE32015-07-072016-09-162016-09-16
NCT02494986A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric StudiesACTIVE_NOT_RECRUITINGPHASE22015-07-062027-06-302027-06-30
NCT02431247A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected SubjectsCOMPLETEDPHASE32015-07-062020-09-302017-03-02
NCT02556892A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCOMPLETEDPHASE12015-07-032018-08-202018-08-20
NCT02406027An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease SpectrumTERMINATEDPHASE22015-07-022018-06-282018-06-28
NCT02537522Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact LensesCOMPLETEDPHASE42015-07-012015-07-012015-07-01
NCT02679976Marketed Contact Lens Real World Through Focus CurveCOMPLETEDNA2015-072015-082015-08
NCT02515994Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact LensCOMPLETEDNA2015-072015-112015-11
NCT02397382Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With PsoriasisCOMPLETEDPHASE12015-06-182016-08-312016-08-31
NCT02416453A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy AdultsCOMPLETEDPHASE22015-06-152018-01-192018-01-19
NCT02454270A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesTERMINATEDPHASE12015-06-152018-07-262018-07-26
NCT02432703A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety DisorderCOMPLETEDPHASE22015-06-112018-08-092018-08-09
NCT02476058A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive DisorderCOMPLETEDPHASE12015-06-112016-01-042016-01-04
NCT02399007A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in ChinaCOMPLETEDNA2015-06-072018-01-172017-12-04
NCT02466815A Study to Assess the Relative Bioavailability of JNJ-42756493 TabletsCOMPLETEDPHASE12015-062015-082015-08
NCT02475148A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy ParticipantsCOMPLETEDPHASE12015-062015-102015-10
NCT02475161A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy ParticipantsCOMPLETEDPHASE12015-062015-072015-07
NCT02543528A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One WeekCOMPLETEDNA2015-06-012016-11-082016-11-08
NCT02475135Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose CombinationCOMPLETEDPHASE12015-06-012015-08-142015-08-14
NCT02421185Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular CarcinomaCOMPLETEDPHASE1, PHASE22015-05-252019-05-162019-05-13
NCT02316106A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaCOMPLETEDPHASE22015-05-202024-06-032023-06-02
NCT02421211A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 InfectionCOMPLETEDPHASE22015-05-192016-01-272015-11-10
NCT02381080Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell MalignancyCOMPLETEDPHASE12015-05-192016-06-242016-06-24
NCT02455856Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male ParticipantsCOMPLETEDPHASE12015-05-182015-06-192015-06-19
NCT02448004Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male ParticipantsCOMPLETEDPHASE12015-05-112015-06-242015-06-24
NCT02387606Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.COMPLETEDPHASE22015-05-072015-10-022015-09-21
NCT02462473A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTERMINATEDPHASE22015-052016-012016-01
NCT02478333A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12015-052015-072015-07
NCT02418559A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12015-052015-072015-07
NCT02397395An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.WITHDRAWNPHASE22015-052016-052016-02
NCT02385071A Crossover Study to Evaluate Relative Bioavailability of Simeprevir Age-appropriate Oral Formulation Candidates Compared With 150-milligram (mg) Oral Capsule in Healthy Adult ParticipantsCOMPLETEDPHASE12015-04-282015-09-092015-09-09
NCT02365597An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial CancerACTIVE_NOT_RECRUITINGPHASE22015-04-222026-10-302022-09-15
NCT02293395A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary SyndromeCOMPLETEDPHASE22015-04-202016-10-142016-10-14
NCT02405858A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade TherapyCOMPLETEDPHASE42015-04-102017-12-312017-12-31
NCT02398591A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult ParticipantsCOMPLETEDPHASE12015-04-012015-07-152015-07-15
NCT02450747Performance of a Multifocal Contact Lens - Presbyopia StudyCOMPLETEDNA2015-042015-092015-09
NCT02319759Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)COMPLETEDPHASE22015-03-272017-01-172016-05-31
NCT03673059Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With ItchCOMPLETEDNA2015-03-272016-06-132016-06-13
NCT02301234Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007COMPLETEDPHASE32015-03-252016-09-192016-09-19
NCT02329847A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic MalignanciesCOMPLETEDPHASE1, PHASE22015-03-112022-02-092022-02-09
NCT02426632Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy ParticipantsCOMPLETEDPHASE12015-03-042015-04-242015-04-24
NCT02269917Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected ParticipantsCOMPLETEDPHASE32015-032020-102017-02
NCT02404493Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy SkinTERMINATEDNA2015-032016-032016-03
NCT02427477A Comparison of Two Daily Disposable Soft Contact LensesCOMPLETEDNA2015-032015-042015-04
NCT02390609A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy AdultsCOMPLETEDPHASE12015-032015-112015-11
NCT02320695Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping InjuryCOMPLETEDNA2015-032015-032015-03
NCT02365623An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)COMPLETEDPHASE22015-02-182018-11-082018-11-08
NCT02252172Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple MyelomaCOMPLETEDPHASE32015-02-162024-10-022018-09-24
NCT02360657Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer DementiaCOMPLETEDPHASE12015-02-162015-09-082015-09-08
NCT02394756Investigation of Ocular Signs & Symptoms in Wearers Fitted With Contact Lenses Following Digital Device UseCOMPLETEDNA2015-022015-092015-09
NCT02355665Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement TherapyCOMPLETEDPHASE32015-01-312016-02-102015-09-30
NCT02343744An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCOMPLETEDPHASE32015-01-192018-11-022015-12-04
NCT02325050A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy ParticipantsCOMPLETEDPHASE12015-01-082017-05-082015-07-02
NCT02365298Clinical and Laboratory Study of Lysozyme Deposition on Daily Disposable Contact LensesCOMPLETEDNA2015-01-012015-06-012015-06-01
NCT02394925Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional EmmetropesCOMPLETEDNA2015-01-012015-09-012015-09-01
NCT02355561A Crossover Study to Evaluate the Relative Oral Bioavailability and Food Effect After Single Dose Administration of JNJ-54861911 Tablet in Healthy Elderly ParticipantsCOMPLETEDPHASE12015-012015-032015-03
NCT023948082-week Evaluation of Marketed Silicone Hydrogel Contact Lenses in Indian PopulationCOMPLETEDNA2015-01-012015-09-012015-09-01
NCT02268864A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected ParticipantsCOMPLETEDPHASE22015-012016-042016-01
NCT02289703A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance HemodialysisCOMPLETEDPHASE12015-012015-032015-03
NCT02349048Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 InfectionCOMPLETEDPHASE22015-012016-052016-02
NCT02357940Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With EczemaCOMPLETEDNA2015-012016-012016-01
NCT02250807Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus InfectionCOMPLETEDPHASE32015-012015-122015-12
NCT02343783A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCOMPLETEDEARLY_PHASE12015-012015-092015-09
NCT02343289A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy ParticipantsCOMPLETEDPHASE12015-012015-042015-04
NCT02320708Study of Acetaminophen (ACE) in Post-operative Dental PainCOMPLETEDPHASE22014-12-312015-04-302015-04-30
NCT02277444A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate TherapyCOMPLETEDPHASE32014-12-222024-09-272018-07-09
NCT02315703Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) PreventionCOMPLETEDPHASE1, PHASE22014-12-222022-03-282017-08-29
NCT02325219An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type PsoriasisCOMPLETEDPHASE32014-12-192019-02-082016-03-02
NCT02342249Study of Acute Uncomplicated Seasonal Influenza A in Adult SubjectsCOMPLETEDPHASE22014-12-112016-05-252016-05-25
NCT02195479A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple MyelomaCOMPLETEDPHASE32014-12-092024-08-072017-11-21
NCT02307864Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy ParticipantsCOMPLETEDPHASE12014-12-042015-08-272015-08-22
NCT02345148Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult ParticipantsCOMPLETEDPHASE12014-122015-012015-01
NCT02349438Assessment of Contact Lens Wettability Using Wavefront AberrometryCOMPLETEDNA2014-122015-052015-05
NCT02345720Effects of Multifocal Contact Lens on Ocular TissueCOMPLETEDNA2014-122015-052015-05
NCT02278419An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus InfectionCOMPLETEDPHASE22014-122015-102015-10
NCT02034162A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric ParticipantsCOMPLETEDPHASE32014-122015-092015-09
NCT02268890A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple MyelomaCOMPLETEDPHASE42014-122015-072015-07
NCT02207231A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisCOMPLETEDPHASE32014-11-262020-06-172015-09-29
NCT02295865A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type PsoriasisCOMPLETEDPHASE22014-11-172016-03-112016-03-11
NCT02207244A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentCOMPLETEDPHASE32014-11-032020-07-012015-10-01
NCT02260674A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's DiseaseCOMPLETEDPHASE22014-112016-062016-06
NCT02310126Handling Comparison Between Two Contact Lens TypesCOMPLETEDNA2014-11-012014-12-012014-12-01
NCT02328937Central Corneal Swelling With Silicone Hydrogel MaterialsCOMPLETEDNA2014-112015-042015-04
NCT02280018A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male ParticipantsCOMPLETEDPHASE12014-112014-122014-12
NCT01798745A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor AutoantibodiesWITHDRAWNPHASE22014-112015-122015-12
NCT02228616Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic ConstipationCOMPLETEDPHASE42014-10-142016-09-282016-09-28
NCT02203032A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to UstekinumabCOMPLETEDPHASE32014-10-072016-05-242015-12-25
NCT02201251A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With EpilepsyCOMPLETEDPHASE32014-10-062020-04-302020-04-30
NCT02271438A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy ParticipantsCOMPLETEDPHASE12014-102015-052015-04
NCT02243189Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent AsthmaTERMINATEDPHASE12014-102014-122014-12
NCT02230046Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male ParticipantsCOMPLETEDPHASE12014-102014-112014-11
NCT02218073Pharmacokinetic Study of JNJ-42756493 in Healthy ParticipantsCOMPLETEDPHASE12014-102014-122014-12
NCT02262728An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver DiseaseCOMPLETEDPHASE22014-09-302018-04-252015-08-13
NCT02217566Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol TherapyCOMPLETEDPHASE22014-09-232018-10-262018-10-26
NCT02009488Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12014-09-082017-01-032017-01-03
NCT02181673A Study of Golimumab in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE32014-09-082017-03-222016-05-05
NCT02186873A Study of Golimumab in Participants With Active Ankylosing SpondylitisCOMPLETEDPHASE32014-09-032016-10-112015-12-15
NCT02243202Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese ParticipantsCOMPLETEDPHASE22014-092015-062015-06
NCT02211079A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 SubstratesCOMPLETEDPHASE12014-092014-112014-11
NCT02231489Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy ParticipantsCOMPLETEDPHASE12014-092014-112014-11
NCT02228239Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy ParticipantsCOMPLETEDPHASE12014-092014-122014-12
NCT02136134Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE32014-08-152024-01-102016-01-11
NCT02345928A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCOMPLETEDPHASE12014-08-052017-03-162017-03-16
NCT02169180Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell LymphomaCOMPLETEDPHASE22014-082016-122016-11
NCT02209181A Dental Pain Study to Test the Effectiveness of a New Pain Reliever MedicineCOMPLETEDPHASE22014-082015-042015-04
NCT02165189An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantCOMPLETEDPHASE22014-082015-112015-11
NCT02081495A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCOMPLETEDPHASE12014-082015-112015-11
NCT02223754Evaluation of an Investigational Multifocal LensCOMPLETEDNA2014-082014-112014-11
NCT02233998A Clinical Trial to Test the Effect of Marketed Mouth Rinses on Decreasing Plaque and Gum InflammationCOMPLETEDNA2014-082014-092014-09
NCT02221180Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted ParticipantsCOMPLETEDPHASE12014-082014-112014-11
NCT02220218Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted ParticipantsCOMPLETEDPHASE12014-082014-102014-10
NCT02221726Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy AdultsCOMPLETEDEARLY_PHASE12014-082014-082014-08
NCT02138422A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal CancerCOMPLETEDPHASE32014-07-312015-11-302015-11-30
NCT02076009A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE32014-07-232024-11-212016-03-07
NCT02212301Comparison of Two Marketed Lenses in a Controlled EnvironmentCOMPLETEDNA2014-072014-122014-12
NCT02252185A Clinical Study of a Spine Fusion System in Vertebral Body Fusion SurgeryCOMPLETEDNA2014-072015-122015-09
NCT02262715A Study to Assess the Drug-Drug Interaction Between VX-787 and OseltamivirCOMPLETEDPHASE12014-072014-102014-10
NCT02152332A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy ParticiantsCOMPLETEDPHASE12014-072014-102014-10
NCT02197884A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male ParticipantsCOMPLETEDPHASE12014-072014-092014-09
NCT02162836A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE12014-06-272019-05-272019-05-27
NCT02154334Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal EsketamineCOMPLETEDPHASE12014-062014-102014-10
NCT02151058A Clinical Trial to Test the Effect of a Marketed Mouth Rinse on Stain RemovalCOMPLETEDNA2014-062014-072014-07
NCT02094378A Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy SubjectsCOMPLETEDPHASE12014-062014-082014-08
NCT02180269A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male ParticipantsCOMPLETEDPHASE12014-062014-082014-08
NCT02133001A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for SuicideCOMPLETEDPHASE22014-05-232016-02-012016-02-01
NCT02173535Quantitative Study of New Limbal Ring PrototypesCOMPLETEDNA2014-05-012014-06-012014-06-01
NCT02147093CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance EvaluationCOMPLETEDNA2014-05-012014-08-012014-08-01
NCT02230878A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy ParticipantsCOMPLETEDPHASE12014-052014-112014-11
NCT02139943A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)COMPLETEDPHASE22014-052015-062015-06
NCT02156375A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial FormulationsCOMPLETEDPHASE12014-052014-122014-12
NCT01821261A Clinical Trial to Test the Effect of an Experimental Mouth Rinse on Gum DiseaseWITHDRAWNNA2014-04-302014-07-312014-04-30
NCT02019472A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid ArthritisCOMPLETEDPHASE32014-04-042016-08-172016-08-17
NCT02116569A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12014-042015-092015-09
NCT02114151Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and CirrhosisCOMPLETEDPHASE32014-042015-042015-01
NCT02114177Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without CirrhosisCOMPLETEDPHASE32014-042015-042015-01
NCT02071355A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese ParticipantsCOMPLETEDPHASE12014-042014-062014-06
NCT02117505A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult ParticipantsCOMPLETEDPHASE12014-042014-062014-06
NCT02000700A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes MellitusCOMPLETEDPHASE12014-032016-042016-04
NCT02120833A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy SkinCOMPLETEDPHASE32014-032014-112014-11
NCT01870843A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety SymptomCOMPLETEDPHASE42014-032015-052015-05
NCT02079545Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male ParticipantsCOMPLETEDPHASE12014-032015-012015-01
NCT01600963A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium TuberculosisWITHDRAWNPHASE32014-032022-112016-07
NCT02113579Test on a New Experimental Mouth Rinse for Relieving Tooth SensitivityCOMPLETEDNA2014-032014-052014-05
NCT02077803A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed ParticipantsCOMPLETEDPHASE12014-032014-072014-07
NCT02065414A Clinical Trial to Test the Effect of Experimental Mouth Rinse on Gum DiseaseCOMPLETEDPHASE42014-032014-062014-06
NCT02129088A Pharmacokinetic, Safety and Tolerability Study of Esketamine in Healthy Elderly and Adult ParticipantsCOMPLETEDPHASE12014-032014-052014-05
NCT01998971A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCOMPLETEDPHASE12014-02-182024-01-112019-01-31
NCT02065791Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyCOMPLETEDPHASE32014-02-172018-10-302018-10-30
NCT02081677One Month Daily Wear Clinical Evaluation of New Prototype Contact Lenses in Habitual and Neophyte Contact Lens WearersCOMPLETEDNA2014-02-062014-06-252014-06-25
NCT01957410A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive DisorderTERMINATEDPHASE22014-022015-092015-09
NCT02025907A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and SitagliptinCOMPLETEDPHASE42014-022015-092015-09
NCT02067299A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With AntidepressantsCOMPLETEDPHASE12014-022014-122014-12
NCT02087579Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric ParticipantsCOMPLETEDPHASE12014-022014-122014-10
NCT02169973A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279COMPLETEDPHASE12014-022014-072014-07
NCT02073227A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCOMPLETEDPHASE12014-022014-062014-06
NCT02071368A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed ParticipantsCOMPLETEDPHASE12014-022014-052014-05
NCT02065752A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCOMPLETEDPHASE12014-022014-042014-04
NCT02051738A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy ParticipantsCOMPLETEDPHASE12014-022014-042014-04
NCT02064842A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese ParticipantsCOMPLETEDPHASE12014-022014-042014-04
NCT01965613A Phase II Open Label Study of Xilonix in Subjects With Pyoderma GangrenosumCOMPLETEDPHASE22014-01-312016-12-312016-12-31
NCT01974440A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin LymphomaCOMPLETEDPHASE32014-01-312023-06-212022-05-30
NCT01998958A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant DepressionCOMPLETEDPHASE22014-01-272015-09-252015-07-21
NCT01989754A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE42014-01-162017-02-232017-02-23
NCT02111564A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsCOMPLETEDPHASE32014-01-072018-05-032018-03-06
NCT02036320A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian EyesCOMPLETEDNA2014-012014-022014-02
NCT02061592Evaluation of Etafilcon A Daily Disposable LensesCOMPLETEDNA2014-012014-032014-03
NCT02039258Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With FoodCOMPLETEDPHASE12014-012014-032014-03
NCT02039245Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose CombinationCOMPLETEDPHASE12014-012014-032014-02
NCT02065739A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male ParticipantsCOMPLETEDPHASE12014-012014-032014-03
NCT01938625A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver TransplantationCOMPLETEDPHASE22013-12-122015-07-282015-04-27
NCT01988961A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE22013-122016-012015-02
NCT02015533A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy ParticipantsWITHDRAWNPHASE12013-122014-042014-01
NCT02016066A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy ParticipantsWITHDRAWNPHASE12013-122014-042014-01
NCT01978548A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's DiseaseCOMPLETEDPHASE12013-122015-042015-04
NCT02008279A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian ParticipantsCOMPLETEDPHASE12013-122014-082014-08
NCT01959282A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE22013-11-152015-12-052015-05-20
NCT01966549A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE22013-112015-092015-09
NCT01990664Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact LensesCOMPLETEDNA2013-112014-042014-04
NCT01998165A Study to Evaluate the Safety and Efficacy of Ultiva (Remifentanil Hydrochloride) in Pediatric Participants General AnesthetisedCOMPLETEDPHASE32013-112014-112014-11
NCT01964872A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male ParticipantsCOMPLETEDPHASE12013-112014-052014-05
NCT01980303A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian VolunteersCOMPLETEDPHASE12013-112014-012014-01
NCT01973387A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/LymphomaCOMPLETEDPHASE32013-10-282017-08-112015-12-01
NCT01853228A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid LeukemiaTERMINATEDPHASE1, PHASE22013-10-222017-08-282017-08-28
NCT01846611A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerCOMPLETEDPHASE32013-10-162018-11-162018-01-18
NCT01709084A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line TreatmentCOMPLETEDPHASE32013-10-022020-07-022015-10-22
NCT01962974A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)TERMINATEDPHASE32013-102014-122014-12
NCT01939496Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsCOMPLETEDPHASE42013-102015-042015-04
NCT01960114Study of Long-Acting Acetaminophen in Postoperative Dental PainCOMPLETEDPHASE22013-102014-042014-04
NCT01964651Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly ParticipantsCOMPLETEDPHASE12013-102014-102014-10
NCT02018536A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.COMPLETEDPHASE12013-102014-032014-03
NCT02060929A Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal DeviceCOMPLETEDPHASE12013-102014-012014-01
NCT01969266A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With FoodCOMPLETEDPHASE12013-102013-112013-11
NCT01985126An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiDCOMPLETEDPHASE22013-09-272017-05-302015-01-09
NCT01877915A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureCOMPLETEDPHASE32013-09-102018-04-192018-04-19
NCT01804686A Long-term Extension Study of PCI-32765 (Ibrutinib)RECRUITINGPHASE32013-09-092027-01-292026-12-31
NCT01867762An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE22013-09-092014-09-012014-08-06
NCT01855750A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell LymphomaCOMPLETEDPHASE32013-09-032019-04-052018-02-26
NCT01823016A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent AsthmaCOMPLETEDPHASE22013-092015-072015-07
NCT01857102Toric Eye Strain and Stability StudyCOMPLETEDNA2013-092014-062014-06
NCT02980497Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month StudyCOMPLETEDNA2013-092014-032014-03
NCT01846832A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV InfectionCOMPLETEDPHASE32013-092015-082015-08
NCT01951703Senofilcon A Investigational Manufacturing ProcessCOMPLETEDNA2013-092013-122013-12
NCT01947803A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With SchizophreniaCOMPLETEDPHASE42013-092015-032015-03
NCT01945086A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic DermatitisCOMPLETEDPHASE22013-092014-122014-12
NCT02260700A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male ParticipantsCOMPLETEDPHASE12013-092013-112013-11
NCT01962532A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or LymphomaCOMPLETEDPHASE12013-08-212016-01-282016-01-28
NCT01900574A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative ColitisCOMPLETEDPHASE12013-08-092022-09-012015-02-18
NCT01856309Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003COMPLETEDPHASE32013-08-072018-04-302018-04-30
NCT01882465Corneal Staining Associated With Daily Disposable Beauty Contact LensesTERMINATEDNA2013-082013-082013-08
NCT01947920A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy VolunteersCOMPLETEDPHASE12013-082013-112013-11
NCT01826786The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male VolunteersCOMPLETEDPHASE12013-082014-082014-08
NCT01867710Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to ChemotherapyCOMPLETEDPHASE22013-07-162018-06-052015-04-20
NCT01902550A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy ParticipantsWITHDRAWNPHASE12013-072014-052013-10
NCT01862224A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyTERMINATEDPHASE22013-072014-072014-07
NCT01809353To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian ParticipantsCOMPLETEDPHASE12013-072014-092014-09
NCT01897389A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male ParticipantsCOMPLETEDPHASE12013-072013-092013-09
NCT01877889A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy VolunteersCOMPLETEDPHASE12013-072014-032014-03
NCT01809327A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseCOMPLETEDPHASE32013-06-042014-12-022014-12-02
NCT02981056A Clinical Assessment of the Efficacy and Effects of Different Skincare Regimens on InfantsCOMPLETEDNA2013-062013-112013-11
NCT01875471Clinical Evaluation of Two Daily Disposable Contact LensesCOMPLETEDNA2013-062013-082013-08
NCT01909427An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCOMPLETEDPHASE22013-062015-052014-12
NCT01840943A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTERMINATEDPHASE32013-062014-082014-05
NCT01845987A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar PustulosisCOMPLETEDPHASE22013-062014-092014-09
NCT01809340The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With DepressionTERMINATEDPHASE22013-062014-072014-07
NCT02127593A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different FacilitiesCOMPLETEDPHASE12013-062014-092014-09
NCT01866033A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy ParticipantsCOMPLETEDPHASE12013-062013-082013-08
NCT01776840A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell LymphomaCOMPLETEDPHASE32013-05-162024-06-242021-06-30
NCT01830543A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary InterventionCOMPLETEDPHASE32013-05-102016-07-282016-07-28
NCT01866007A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy ParticipantsCOMPLETEDPHASE12013-05-092013-10-092013-09-20
NCT01895634Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)COMPLETEDNA2013-052014-112014-11
NCT01815294A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCOMPLETEDPHASE12013-052014-122014-12
NCT01873001A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male ParticipantsCOMPLETEDPHASE12013-052013-072013-07
NCT01887535A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly ParticipantsCOMPLETEDPHASE12013-052013-122013-12
NCT01779791A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular LymphomaCOMPLETEDPHASE22013-04-172016-05-182016-05-18
NCT01910987Study to Evaluate Optimized Retreatment and Prolonged Therapy With BortezomibCOMPLETEDPHASE32013-042016-022016-02
NCT02164396Impact of Soft Contact Lenses on Lid-Parallel Conjunctival FoldsCOMPLETEDNA2013-042013-122013-12
NCT01863784A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic FunctionCOMPLETEDPHASE12013-042013-112013-11
NCT01840501A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male ParticipantsCOMPLETEDPHASE12013-042014-042014-04
NCT01803373A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult ParticipantsCOMPLETEDPHASE12013-042013-082013-08
NCT01767857A Phase III Study of Xilonix in Patients With Advanced Colorectal CancerTERMINATEDPHASE32013-03-312017-06-302017-06-30
NCT01804166A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)COMPLETEDPHASE42013-03-212020-02-282020-02-28
NCT01863771A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.COMPLETEDPHASE32013-03-152016-01-292016-01-29
NCT01819194Contact Lens Comfort Relative to Meibomian Gland StatusCOMPLETEDNA2013-032013-082013-08
NCT01827982A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With PlaceboCOMPLETEDPHASE12013-032013-072013-07
NCT01820936A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765COMPLETEDPHASE12013-032013-062013-06
NCT01804244A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese ParticipantsCOMPLETEDPHASE42013-032013-032013-03
NCT01715285A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)COMPLETEDPHASE32013-02-122022-02-132016-10-31
NCT01791517Clinical and Laboratory Evaluation of 3 Contact Lenses With 4 Contact Lens SolutionsCOMPLETEDNA2013-02-012014-02-012014-02-01
NCT01729871A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation TherapyCOMPLETEDPHASE32013-022014-102014-10
NCT01670071A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With SchizophreniaTERMINATEDPHASE42013-012015-062015-06
NCT01813890A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With PlaceboCOMPLETEDPHASE32013-012014-012014-01
NCT01770860A Test of Different Kinds of Bandages on Healing of WoundsCOMPLETEDNA2013-012013-022013-02
NCT01646021Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior TherapyCOMPLETEDPHASE32012-12-102016-12-152015-06-05
NCT01765972Open Eye Corneal Swelling With Daily Disposable Contact Lenses and no Lens WearCOMPLETEDNA2012-122013-052013-05
NCT01727258A Test on a New Experimental Mouth Rinse for Relieving Tooth SensitivityCOMPLETEDNA2012-122013-022013-02
NCT01767948A Study to Evaluate the Pharmacokinetics of PCI-32765 in Participants With Varying Degrees of Hepatic ImpairmentCOMPLETEDPHASE12012-122013-112013-11
NCT01778075A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted ConditionCOMPLETEDPHASE12012-122013-022013-02
NCT01780259A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy ParticipantsCOMPLETEDPHASE12012-122013-052013-05
NCT01763021A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy ParticipantsCOMPLETEDPHASE12012-122013-012013-01
NCT01689532A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or SulfasalazineCOMPLETEDPHASE32012-112015-032015-03
NCT01763047Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic PopulationCOMPLETEDNA2012-112013-022013-02
NCT01656018A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative ParticipantsCOMPLETEDPHASE12012-112016-012016-01
NCT01685931A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral AntipsychoticsCOMPLETEDPHASE42012-112014-122014-12
NCT01725529An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected PatientsCOMPLETEDPHASE32012-112014-112014-08
NCT01788436A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy VolunteersCOMPLETEDEARLY_PHASE12012-112014-052014-05
NCT01679951A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With MethotrexateTERMINATEDPHASE22012-10-312014-07-032014-04-17
NCT01636557A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid ArthritisCOMPLETEDPHASE12012-10-112013-10-192013-10-19
NCT01724086A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C VirusCOMPLETEDPHASE22012-102014-122014-09
NCT01704040A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16COMPLETEDPHASE12012-102014-112014-11
NCT01707342A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male PatientsCOMPLETEDPHASE12012-102012-112012-11
NCT01719614A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy ParticipantsCOMPLETEDPHASE12012-102013-012013-01
NCT01970020A Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 After a Single Oral Dose in Healthy Male Participants.COMPLETEDPHASE12012-102012-122012-12
NCT01690286Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy VolunteersCOMPLETEDPHASE12012-102012-122012-12
NCT01611090A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCOMPLETEDPHASE32012-09-192019-01-232019-01-23
NCT01704963A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell NeoplasmsCOMPLETEDPHASE12012-09-122017-02-012015-11-20
NCT01624675A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic DisorderCOMPLETEDPHASE32012-092014-102014-10
NCT01582815A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety SymptomsCOMPLETEDPHASE22012-092013-112013-11
NCT01665638Effects of Canagliflozin on C-peptide Clearance in Healthy VolunteersCOMPLETEDPHASE12012-092012-102012-10
NCT01604343A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)COMPLETEDPHASE32012-08-152016-12-062015-09-02
NCT01695135A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based ChemotherapyCOMPLETEDPHASE32012-08-092018-05-082014-06-20
NCT01692678A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or LeiomyosarcomaCOMPLETEDPHASE32012-08-072016-10-112016-10-11
NCT01627782A Study of Ketamine in Patients With Treatment-resistant DepressionCOMPLETEDPHASE22012-08-062013-09-122013-09-12
NCT01606761A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)COMPLETEDPHASE32012-08-062016-01-122015-03-17
NCT01631513An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)WITHDRAWNPHASE42012-082013-042012-08
NCT01645280A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate TherapyCOMPLETEDPHASE22012-082014-052013-12
NCT01599949A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib TherapyCOMPLETEDPHASE22012-082015-052015-05
NCT01669629Comparison of Two Daily Disposable Contact Lenses Over 1-week of WearCOMPLETEDNA2012-082012-112012-11
NCT01579045Effect of Head and Gaze Position on Soft Toric Contact Lens PerformanceCOMPLETEDNA2012-082013-032013-03
NCT01674322A Study to Determine the Absorption, Metabolism, and Routes of Excretion of (14C) Radiolabeled Ibrutinib in Healthy Male ParticipantsCOMPLETEDPHASE12012-082012-092012-09
NCT01651767Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382TERMINATEDPHASE12012-082013-062013-06
NCT01717157A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy VolunteersCOMPLETEDPHASE12012-082012-112012-11
NCT01732237A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male ParticipantsCOMPLETEDPHASE12012-082012-102012-10
NCT01572519A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin LymphomaCOMPLETEDPHASE12012-07-172013-08-132013-08-13
NCT01656330A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult VolunteersCOMPLETEDPHASE12012-072012-082012-08
NCT01592201A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugTERMINATEDPHASE42012-072013-062013-06
NCT01597739A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug TherapyCOMPLETEDPHASE22012-072013-042013-04
NCT01678573A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male ParticipantsCOMPLETEDPHASE12012-072012-092012-09
NCT01662661A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy ParticipantsCOMPLETEDPHASE12012-072012-092012-08
NCT01643889A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy VolunteersCOMPLETEDPHASE12012-072012-112012-11
NCT01631487A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male ParticipantsCOMPLETEDPHASE12012-072013-032013-03
NCT01640080A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant DepressionCOMPLETEDPHASE22012-06-272013-06-032013-06-03
NCT01615029Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple MyelomaCOMPLETEDPHASE1, PHASE22012-06-262024-10-232015-10-02
NCT01527305A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute SchizophreniaCOMPLETEDPHASE42012-06-222013-12-312013-12-31
NCT01703481A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or LymphomaCOMPLETEDPHASE12012-06-152017-07-052017-07-05
NCT01569750A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin LymphomaCOMPLETEDPHASE12012-06-142014-09-042014-09-04
NCT01756638A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate CancerCOMPLETEDPHASE22012-06-062014-10-172014-10-17
NCT01500616Telaprevir Open-Label Study in Co-Infected PatientsCOMPLETEDPHASE32012-062014-082014-08
NCT01795703A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelCOMPLETEDPHASE22012-062014-102014-10
NCT01181765The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera EndoscopyCOMPLETEDPHASE42012-062013-012013-01
NCT01600976A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic ImpairmentCOMPLETEDPHASE12012-062012-112012-10
NCT01626651A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy ParticipantsCOMPLETEDPHASE12012-062012-082012-08
NCT01689623A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy ParticipantsCOMPLETEDPHASE12012-062012-082012-08
NCT01707316A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese VolunteersCOMPLETEDPHASE12012-062012-082012-08
NCT01586325A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected PatientsTERMINATEDPHASE12012-05-252014-04-212014-04-21
NCT01529515A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32012-052014-042014-04
NCT01515423Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32012-052015-032015-02
NCT01533285Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder PatientsCOMPLETEDEARLY_PHASE12012-052013-112013-11
NCT01635829A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and TelaprevirCOMPLETEDPHASE12012-052012-092012-08
NCT01799603A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435COMPLETEDPHASE12012-052012-072012-07
NCT01640093A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial TabletCOMPLETEDPHASE12012-052012-072012-07
NCT01513941An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)COMPLETEDPHASE32012-042014-062014-03
NCT01551290A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative ColitisCOMPLETEDPHASE32012-042014-102014-03
NCT01615614A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy ParticipantsCOMPLETEDPHASE12012-042012-092012-09
NCT01582035Study to Examine Multiple Doses of TMC647055 in Combination With TelaprevirCOMPLETEDPHASE12012-042013-112013-11
NCT01619527A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted ConditionsCOMPLETEDPHASE12012-042012-082012-08
NCT01517802A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateCOMPLETEDPHASE32012-03-282021-04-222021-04-22
NCT01591122Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE32012-03-272019-01-312016-12-31
NCT01567735A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected PatientsCOMPLETEDPHASE32012-03-272014-03-202014-03-20
NCT01448707A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current TreatmentCOMPLETEDPHASE32012-03-152015-03-182014-06-11
NCT01484275A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple MyelomaCOMPLETEDPHASE22012-03-012019-08-212015-05-12
NCT01550744A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque PsoriasisCOMPLETEDPHASE32012-032015-072015-05
NCT01366651A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of AgeTERMINATEDPHASE12012-032012-062012-05
NCT01571570A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.COMPLETEDPHASE12012-032012-052012-05
NCT01493882Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled AsthmaWITHDRAWNPHASE22012-032015-062015-06
NCT01474798Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne VulgarisCOMPLETEDPHASE22012-02-292012-12-312012-10-31
NCT01571583An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver TransplantationCOMPLETEDPHASE32012-022014-072014-04
NCT01702090Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 PatientsCOMPLETEDPHASE42012-022012-062012-06
NCT01485991TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin TherapyCOMPLETEDPHASE32012-022014-042014-04
NCT01552876Comparative Clinical Evaluation of Soft Toric Lens DesignsCOMPLETEDNA2012-022012-042012-04
NCT01607762A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCOMPLETEDPHASE12012-022012-102012-04
NCT01555476Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in StoresCOMPLETEDPHASE12012-022012-032012-03
NCT01539083Velcade (Bortezomib) Consolidation After TransplantCOMPLETEDPHASE32012-01-132018-01-092015-12-30
NCT01500629Study of a Topical Nasal Spray to Ease the Symptoms of HayfeverCOMPLETEDEARLY_PHASE12012-012012-122012-12
NCT01498068Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis CCOMPLETEDPHASE32012-012013-032012-04
NCT01466790A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive PatientsCOMPLETEDPHASE22012-012014-012013-11
NCT01682161A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone PalmitateCOMPLETEDPHASE42012-012013-092013-09
NCT01516047A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic FunctionCOMPLETEDPHASE12012-012012-092012-09
NCT01516008A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From BunionectomyCOMPLETEDPHASE32012-012013-022013-02
NCT01575587A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese MenCOMPLETEDPHASE12012-012012-052012-05
NCT01519128A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of DigoxinCOMPLETEDPHASE12012-012012-042012-04
NCT01655147A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male ParticipantsCOMPLETEDPHASE12012-012012-032012-03
NCT01508182A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy VolunteersCOMPLETEDPHASE12012-012012-032012-03
NCT01508195A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy VolunteersCOMPLETEDPHASE12012-012012-032012-03
NCT01588782A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult MenCOMPLETEDPHASE12012-012012-022012-02
NCT01488604A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common ColdCOMPLETEDNA2012-012012-052012-05
NCT01480388A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With MethotrexateWITHDRAWNPHASE22011-122014-032014-03
NCT01323244A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 StudyCOMPLETEDPHASE32011-122015-032015-03
NCT01483781A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12011-122012-082012-08
NCT01824524A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With CancerCOMPLETEDPHASE12011-122012-082012-08
NCT01528319Open-Label Study for Shoulder Dislocation Using MG-1COMPLETEDNA2011-122012-112012-08
NCT01495910A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase DeficiencyCOMPLETEDPHASE12011-122013-022013-02
NCT01621100Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean PatientsCOMPLETEDPHASE42011-122012-092012-09
NCT01476683Study to Compare the Pharmacokinetics Profiles of Four Racecadotril ProductsCOMPLETEDPHASE12011-122011-122011-12
NCT01516970Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)COMPLETEDPHASE32011-11-252013-09-282013-08-01
NCT01483599A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type PsoriasisCOMPLETEDPHASE22011-11-102013-08-052012-11-27
NCT01462110A Four-Week Study to Measure the Effectiveness of an Experimental Mouthwash Used After Teeth CleaningCOMPLETEDNA2011-11-012011-12-022011-12-02
NCT01486277A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell LymphomaCOMPLETEDPHASE22011-112016-072014-11
NCT01484028Evaluation of the Performance of Two Contact Lenses Compared to a Marketed LensCOMPLETEDNA2011-112012-022012-02
NCT01484054Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed LensCOMPLETEDNA2011-112012-022012-02
NCT01513317A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic SyndromeTERMINATEDPHASE22011-112012-092012-09
NCT01520142Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male ParticipantsCOMPLETEDPHASE12011-112012-042012-04
NCT01482611A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382COMPLETEDPHASE12011-112012-042012-04
NCT01484067Study of a Cold Sore Patch for the Treatment of Herpes LabialisCOMPLETEDNA2011-112012-032012-03
NCT01478230An Exploratory Study Comparing Two Nicotine InhalersCOMPLETEDEARLY_PHASE12011-112011-122011-12
NCT01482819Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A LensesCOMPLETEDNA2011-10-012011-12-012011-12-01
NCT01464450Pharmacokinetics Study of Oral Rivaroxaban in Healthy ParticipantsCOMPLETEDPHASE12011-102011-122011-12
NCT01400646A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy VolunteersCOMPLETEDPHASE12011-102012-052012-05
NCT01381809An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic SyndromesCOMPLETEDPHASE32011-102016-012015-01
NCT01497119A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic DermatitisTERMINATEDPHASE22011-102012-022012-02
NCT01479868A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1COMPLETEDPHASE32011-102013-082013-08
NCT01424930A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE22011-102013-052013-04
NCT01134536Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and AdolescentsCOMPLETEDPHASE22011-102013-032013-03
NCT01493245A Study of JNS020QD in Patients With Chronic PainCOMPLETEDPHASE32011-102013-032013-03
NCT01487564Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 GeneCOMPLETEDPHASE12011-102012-012012-01
NCT01459094Effect of Food on a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy VolunteersCOMPLETEDPHASE12011-102011-122011-12
NCT01384630Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe PsoriasisCOMPLETEDPHASE22011-09-302012-08-312012-07-31
NCT01464112A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple MyelomaCOMPLETEDPHASE12011-09-162013-11-192013-11-19
NCT01369355A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)COMPLETEDPHASE32011-09-132019-10-012015-06-10
NCT01389973A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic AcidCOMPLETEDPHASE22011-092013-062013-06
NCT01437319Mucin Balls and Corneal Inflammation EventsCOMPLETEDPHASE1, PHASE22011-092014-022014-02
NCT01422330A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected PatientsCOMPLETEDPHASE42011-092013-112013-11
NCT01448720Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone PalmitateCOMPLETEDPHASE32011-092013-122013-12
NCT01478633Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From DonepezilCOMPLETEDPHASE42011-092013-062013-06
NCT01436188A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's DiseaseCOMPLETEDEARLY_PHASE12011-092013-06
NCT01454622A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy VolunteersCOMPLETEDPHASE12011-092011-112011-11
NCT01442532A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of MidazolamCOMPLETEDPHASE12011-092012-072012-07
NCT01463774A Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy VolunteersCOMPLETEDPHASE12011-092011-122011-12
NCT01518712A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy VolunteersCOMPLETEDPHASE12011-092011-112011-11
NCT01463228A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy VolunteersCOMPLETEDPHASE12011-092012-012012-01
NCT01685983A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate CancerCOMPLETEDPHASE22011-08-302018-03-062013-01-24
NCT01381874A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyCOMPLETEDPHASE22011-08-242018-08-082014-07-28
NCT01484587A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE12011-08-222013-04-112013-04-11
NCT01281813TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRVCOMPLETEDPHASE32011-08-082021-07-292021-07-29
NCT01273389An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus NephritisCOMPLETEDPHASE22011-082013-092013-09
NCT01650597A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male ParticipantsCOMPLETEDPHASE12011-082012-052012-05
NCT01381900A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a SulphonylureaCOMPLETEDPHASE32011-082012-112012-11
NCT01442545A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsCOMPLETEDPHASE12011-082011-12
NCT01492647A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne VulgarisCOMPLETEDPHASE12011-082011-102011-10
NCT01494714A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male ParticipantsCOMPLETEDPHASE12011-082011-092011-09
NCT01362699Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent AdultsWITHDRAWNPHASE22011-082012-08
NCT01428284A Study to Assess the Effects of Multiple-Dose Probenecid on the Multiple-Dose Pharmacokinetics of Canagliflozin in Healthy VolunteersCOMPLETEDPHASE12011-082011-102011-10
NCT01419626A Study to Determine the Effects of Adding an Experimental Device With Mouthrinse to Oral Care RegimenCOMPLETEDNA2011-07-312011-08-312011-08-31
NCT013494653-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus InfectionCOMPLETEDPHASE32011-07-042016-01-052016-01-05
NCT01369342A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)COMPLETEDPHASE32011-072014-102014-08
NCT01369329A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)COMPLETEDPHASE32011-072013-072013-06
NCT01340664An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin MonotherapyCOMPLETEDPHASE22011-072012-042012-04
NCT01395927A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy VolunteersCOMPLETEDPHASE12011-072011-082011-08
NCT01800682A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy ParticipantsCOMPLETEDPHASE12011-072011-092011-09
NCT01454245A Study to Evaluate the Bioavailability and Food Effect of JNJ-39439335 in Healthy Adult Male VolunteersCOMPLETEDPHASE12011-072012-042012-04
NCT01270945Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.COMPLETEDPHASE22011-06-302014-04-302013-09-30
NCT01427699A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 DiabetesCOMPLETEDPHASE22011-06-302012-10-31
NCT01343277A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or LeiomyosarcomaCOMPLETEDPHASE32011-062016-042015-01
NCT01662310An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With SchizophreniaCOMPLETEDPHASE32011-062013-042013-04
NCT01450982A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsCOMPLETEDPHASE12011-062011-10
NCT01381887A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12011-062011-112011-11
NCT01314118IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenCOMPLETEDPHASE22011-05-042024-12-022013-12-24
NCT01323205Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With SchizophreniaCOMPLETEDPHASE22011-052012-122012-11
NCT01181921The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's DiseaseTERMINATEDPHASE42011-052011-062011-06
NCT01366638A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE32011-052012-112012-11
NCT01357993A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity DisorderCOMPLETEDPHASE32011-052013-032013-03
NCT01340677A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy VolunteersCOMPLETEDPHASE12011-052011-082011-08
NCT01260545Study of CA-18C3 in Subjects With Advanced Hematologic MalignanciesCOMPLETEDPHASE12011-04-302012-09-302012-06-30
NCT01400503A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's DiseaseCOMPLETEDPHASE22011-04-012017-03-012017-03-01
NCT01345292A Study of the Relief of Tooth Sensitivity of an Experimental Mouthrinse DeviceCOMPLETEDNA2011-042011-052011-05
NCT01366664A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking TerazosinCOMPLETEDPHASE12011-042012-042012-04
NCT01371227A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12011-042012-052012-05
NCT01343290The Effect of Food on the Administration of Canagliflozin in Healthy Adult VolunteersCOMPLETEDPHASE12011-042011-062011-06
NCT01368016Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine GumCOMPLETEDNA2011-042011-072011-07
NCT01434277Safety Evaluation of a New Preservative in a Lubricating Eye DropCOMPLETEDNA2011-042011-042011-04
NCT01114698A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive DisorderTERMINATEDPHASE22011-032012-022012-01
NCT01290679An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected ParticipantsCOMPLETEDPHASE32011-032013-022013-02
NCT01323192An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity DisorderCOMPLETEDPHASE32011-032012-042012-04
NCT01876966Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / LumefantrineCOMPLETEDPHASE12011-032011-072011-07
NCT01535820The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy WomenCOMPLETEDPHASE12011-032011-072011-07
NCT01487512Effect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese ParticipantsCOMPLETEDPHASE12011-032011-072011-07
NCT01294631A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy VolunteersCOMPLETEDPHASE12011-032011-072011-07
NCT01343303A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With OsteoarthritisCOMPLETEDPHASE12011-032011-12
NCT01326910Human Testing of an Over-the-Counter (OTC) Cream in Children With EczemaCOMPLETEDNA2011-032011-062011-05
NCT01296698Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit SmokingTERMINATEDPHASE32011-032011-062011-04
NCT01266902A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1COMPLETEDPHASE32011-022020-022020-02
NCT01203631Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE22011-022013-052013-05
NCT01267084A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced MalignanciesCOMPLETEDPHASE1, PHASE22011-022012-112012-11
NCT01309438A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney FunctionCOMPLETEDPHASE12011-022012-032012-03
NCT01289782An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected PatientsCOMPLETEDPHASE32011-022013-012013-01
NCT01281839An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous TherapyCOMPLETEDPHASE32011-022013-022013-02
NCT01292239A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected PatientsCOMPLETEDPHASE32011-022012-102012-10
NCT01288209A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based TherapyCOMPLETEDPHASE32011-022012-092012-09
NCT01288196A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy VolunteersCOMPLETEDPHASE12011-022011-082011-08
NCT01718652A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy VolunteersCOMPLETEDPHASE12011-022011-042011-04
NCT01309425A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male VolunteersCOMPLETEDPHASE12011-022011-05
NCT01316978A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference TreatmentsCOMPLETEDPHASE12011-022011-032011-03
NCT01321931Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCOMPLETEDPHASE12011-022011-062011-05
NCT01322282To Test Bioequivalence Between Two Tablet Formulations in the Treatment of AllergyCOMPLETEDPHASE12011-022011-032011-03
NCT00799864A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 YearsCOMPLETEDPHASE22011-012022-082022-08
NCT01284387Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22011-012014-022014-01
NCT01444313Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact LensesCOMPLETEDNA2011-012013-03
NCT01309412A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple MyelomaTERMINATEDPHASE12011-012012-122012-12
NCT01290731A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based TherapyCOMPLETEDPHASE32011-012012-082012-08
NCT01273558A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12011-012011-07
NCT01281579A Single and Multiple Dose Study of Canagliflozin in Healthy VolunteersCOMPLETEDPHASE12011-012011-042011-04
NCT01302093Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in AdultsCOMPLETEDPHASE12011-012011-012011-01
NCT01286103A Pharmacokinetic and Pharmacodynamic Study of Once-Daily and Twice-Daily Dosing With Canagliflozin in Healthy Adult VolunteersCOMPLETEDPHASE12011-012011-05
NCT01230827A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)TERMINATEDPHASE32010-122014-052013-09
NCT01273493A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic DysfunctionCOMPLETEDPHASE12010-122014-042014-04
NCT01273480A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced MalignanciesCOMPLETEDPHASE12010-122012-102012-10
NCT01110382A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal InfectionsTERMINATEDPHASE32010-122013-092013-09
NCT01110408A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract InfectionsTERMINATEDPHASE32010-122013-062013-06
NCT01110421A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial PneumoniaTERMINATEDPHASE32010-122012-032012-03
NCT01241760VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE32010-122012-112012-08
NCT01254773Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22010-122013-032013-01
NCT01273467A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)COMPLETEDPHASE12010-122013-07
NCT01230749A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE22010-122011-062011-06
NCT01271036Safety Study of a Sensitive Sensual Touch and Personal LubricantCOMPLETEDNA2010-122011-012011-01
NCT01273571A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult VolunteersCOMPLETEDPHASE12010-122011-02
NCT01273506A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg TabletCOMPLETEDPHASE12010-122011-02
NCT01273532A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 50-mg Tablets Relative to One 100-mg TabletCOMPLETEDPHASE12010-122011-03
NCT01359852A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult VolunteersCOMPLETEDPHASE12010-122011-072011-07
NCT01241422A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge ModelCOMPLETEDPHASE22010-112011-062011-06
NCT01190839A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of RecurrenceTERMINATEDPHASE32010-112014-122014-12
NCT01281527Paliperidone Palmitate Flexible Dosing in SchizophreniaCOMPLETEDPHASE32010-112013-112012-11
NCT01358006A Dose-Ranging Study of JNJ-40411813 in Healthy Male VolunteersCOMPLETEDPHASE12010-112011-032011-03
NCT01173549A Study of 28431754 (Canagliflozin) on Gastrointestinal Glucose Absorption and Metabolism in Healthy VolunteersCOMPLETEDPHASE12010-112011-09
NCT01226628A Safety Study of CNTO 2476 in Patients With Age-Related Macular DegenerationCOMPLETEDPHASE1, PHASE22010-10-212017-05-312015-03-31
NCT01138605TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRVCOMPLETEDPHASE22010-10-132017-11-232017-11-23
NCT01244893Study of ACUVUE® ADVANCE® PLUS Contact Lenses.COMPLETEDNA2010-102010-11
NCT01228591Pilot Dispensing Evaluation of a Plus Power LensCOMPLETEDNA2010-102010-112010-11
NCT01219010A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple MyelomaCOMPLETEDPHASE12010-102014-032012-06
NCT01258920A Study of Paliperidone Palmitate in Japanese Patients With SchizophreniaCOMPLETEDPHASE32010-102012-112012-11
NCT01299389An Efficacy and Safety Study of Paliperidone Palmitate in Participants With SchizophreniaCOMPLETEDPHASE32010-102012-052012-05
NCT01241409A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult VolunteersCOMPLETEDPHASE12010-102010-122010-12
NCT01234896Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement ProductsCOMPLETEDNA2010-102010-122010-11
NCT01224158Study of an Experimental Toothbrush for Treatment and Prevention of GingivitisCOMPLETEDNA2010-09-132010-10-292010-10-29
NCT01244516Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact LensesCOMPLETEDNA2010-09-012010-11-012010-11-01
NCT01244529Comparison of Lens Fit and Lens Power of a New Contact Lens to Two Marketed Contact Lenses in a Population of Soft Contact Lens WearersCOMPLETEDNA2010-09-012010-11-012010-11-01
NCT01193153A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderCOMPLETEDPHASE32010-092013-102013-10
NCT01226459Clinical Trial in Females for Female Pattern Hair LossCOMPLETEDPHASE32010-092011-082011-08
NCT01202734A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male VolunteersCOMPLETEDPHASE12010-092010-112010-10
NCT01195324A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult VolunteersCOMPLETEDPHASE12010-092010-122010-12
NCT01556217A Pharmacokinetic Study to Characterize JNJ-39393406 in the Cerebrospinal Fluid of Healthy VolunteersCOMPLETEDPHASE12010-092010-112010-11
NCT01181050Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)COMPLETEDPHASE22010-082012-042012-04
NCT01192542Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A LensCOMPLETEDNA2010-082010-09
NCT01159821A Drug Interaction Study of 31001074 and Paroxetine in Healthy VolunteersCOMPLETEDPHASE12010-082010-10
NCT01165281A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer PainCOMPLETEDPHASE32010-082012-082012-08
NCT01193166Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalWITHDRAWNPHASE42010-082012-092012-09
NCT01186588A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) FunctionCOMPLETEDPHASE12010-082011-042011-04
NCT01309386A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese ParticipantsCOMPLETEDPHASE32010-082012-012012-01
NCT01186497A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult VolunteersCOMPLETEDPHASE12010-082010-112010-11
NCT01180777Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)COMPLETEDNA2010-07-012010-08-012010-08-01
NCT01183624A Controlled Study of an Herbal Topical Patch in Treating Osteoarthritis (OA) of the KneeCOMPLETEDPHASE42010-072011-042011-04
NCT01183117A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery DiseaseCOMPLETEDPHASE32010-072014-082012-09
NCT01137812The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)COMPLETEDPHASE32010-072012-032012-03
NCT01274507A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary DiseaseCOMPLETEDEARLY_PHASE12010-072014-072014-07
NCT02019485A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy SubjectsCOMPLETEDPHASE12010-072010-082010-08
NCT01981278A Study to Assess Bioequivalence of a New Tapentadol Extended-Release 250-mg Tablet With Respect to a Tapentadol Extended-Release 250-mg Tablet in Healthy ParticipantsCOMPLETEDPHASE12010-072010-082010-08
NCT01900587A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) TabletCOMPLETEDPHASE12010-072010-082010-08
NCT01186484Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate CancerCOMPLETEDPHASE12010-06-012014-10-022014-10-02
NCT01180985Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact LensCOMPLETEDNA2010-06-012010-07-012010-07-01
NCT01180998Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens UsersCOMPLETEDNA2010-06-012010-10-012010-10-01
NCT01189617Safety Study for an All-in-One Body and Personal LubricantCOMPLETEDNA2010-062010-082010-06
NCT01128452Safety and Efficacy of EVT 101 in Treatment-Resistant DepressionTERMINATEDPHASE22010-062011-032011-03
NCT01156376Oral Irritation Study of Two Experimental MouthrinsesCOMPLETEDNA2010-062010-072010-07
NCT01106651A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusCOMPLETEDPHASE32010-062013-052011-11
NCT01145625Clinical Trial in Females With Female Pattern Hair LossCOMPLETEDPHASE32010-062012-022012-02
NCT01147887A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy VolunteersCOMPLETEDPHASE12010-062010-08
NCT01124617A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic NeuralgiaCOMPLETEDPHASE22010-062011-042011-04
NCT01064414An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCOMPLETEDPHASE32010-062012-082011-12
NCT01120210A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart FailureCOMPLETEDPHASE22010-062011-092011-09
NCT01106690The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)COMPLETEDPHASE32010-062012-072011-11
NCT01115673To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After SurgeryCOMPLETEDPHASE32010-062011-012011-01
NCT01063881The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation TherapyCOMPLETEDPHASE32010-05-222011-06-142011-06-14
NCT01116206An Efficacy and Safety Study of Prucalopride in Participants With Chronic ConstipationCOMPLETEDPHASE32010-052011-032011-03
NCT01133379Tooth Sensitivity Relief by Two MouthrinsesCOMPLETEDNA2010-052010-072010-07
NCT0115735115 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedCOMPLETEDPHASE42010-052013-122013-12
NCT01090427A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)COMPLETEDPHASE32010-052014-012013-01
NCT01105780JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) StudyCOMPLETEDPHASE12010-052010-08
NCT01157000A Pharmacokinetic and Bioavailability Study of 28431754 (Canagliflozin) in Healthy Male VolunteersCOMPLETEDPHASE12010-052010-06
NCT01932333A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-40411813 in Male and Female Elderly PatientsCOMPLETEDPHASE12010-052010-082010-08
NCT01106677The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)COMPLETEDPHASE32010-052012-052011-10
NCT01106625The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)COMPLETEDPHASE32010-052012-042011-09
NCT01118702A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy VolunteersCOMPLETEDPHASE12010-052010-06
NCT01186471The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic PatientsCOMPLETEDEARLY_PHASE12010-052011-03
NCT01181934The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.COMPLETEDEARLY_PHASE12010-052011-02
NCT01051531A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With SchizophreniaCOMPLETEDPHASE32010-04-222013-05-172013-05-17
NCT01094262A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From OsteoarthritisTERMINATEDPHASE22010-04-202011-07-012011-07-01
NCT01060254A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder PainTERMINATEDPHASE22010-04-062011-06-242011-06-24
NCT01648699Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer PainTERMINATEDPHASE42010-042010-092010-09
NCT01124604An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain ParticipantsCOMPLETEDPHASE22010-042010-122010-12
NCT01054573VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir PlaceboCOMPLETEDPHASE32010-042012-052012-03
NCT01063855Concomitant Use of PriLigy in Men Treated for Erectile DysfunctionCOMPLETEDPHASE32010-042011-092011-08
NCT01021072A First in Man Study of MABp1 in Patients With Advanced CancersCOMPLETEDPHASE12010-03-312013-08-312012-10-31
NCT01024036A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's DiseaseCOMPLETEDPHASE22010-03-182017-02-242013-03-25
NCT01155323Two Week Cross-Over Study Comparing Two Daily Disposable Contact LensesCOMPLETEDNA2010-03-012010-06-012010-06-01
NCT01094886Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee ReplacementCOMPLETEDPHASE32010-032010-122010-12
NCT01050478IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute AgitationCOMPLETEDPHASE42010-032011-122011-12
NCT01829230Myopia Progression After Ceasing Myopia Control Contact Lens WearCOMPLETEDNA2010-032011-102011-10
NCT01077362A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF AgentsCOMPLETEDPHASE32010-032012-112012-03
NCT01081834The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) TrialCOMPLETEDPHASE32010-032012-032011-08
NCT01128985A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12010-032010-07
NCT01112462To Test Bioequivalence Between Two Formulations of Paracetamol/PhenylephrineCOMPLETEDPHASE12010-032010-062010-06
NCT01088685Hydrogel Blister Patch Prototype Treatment for Foot Blisters on the HeelCOMPLETEDNA2010-032010-112010-11
NCT01120782Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens TypesCOMPLETEDNA2010-02-012010-02-012010-02-01
NCT01094743Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact LensCOMPLETEDNA2010-02-012010-03-012010-03-01
NCT01151371Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement LensCOMPLETEDNA2010-02-012010-04-012010-04-01
NCT01094730Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact LensCOMPLETEDNA2010-02-012010-04-012010-04-01
NCT01081769Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral AntipsychoticsCOMPLETEDPHASE32010-022013-022013-02
NCT01101659Ketamine Challenge Study With JNJ-40411813COMPLETEDPHASE12010-022010-07
NCT01106469Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male ParticipantsCOMPLETEDPHASE12010-022010-07
NCT01173562A Safety Study of Mebendazole in Children 2 to 10 Years of AgeCOMPLETEDPHASE32010-022010-032010-03
NCT01814085A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCOMPLETEDPHASE42010-022012-032012-02
NCT01081821Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese DescentCOMPLETEDPHASE12010-022010-122010-12
NCT01054352A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal AllergiesCOMPLETEDPHASE12010-022011-03
NCT01932320A Study to Evaluate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813COMPLETEDPHASE12010-022010-052010-05
NCT01627860First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical PatientsCOMPLETEDPHASE42010-022011-012011-01
NCT01068223A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male VolunteersCOMPLETEDPHASE12010-022010-05
NCT00941707An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid ArthritisTERMINATEDPHASE22010-022010-112010-11
NCT01075659Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ LozengeCOMPLETEDPHASE22010-022010-052010-05
NCT01093625Assessment of Daily Disposable Silicone Hydrogel Lens WearCOMPLETEDNA2010-012011-042011-04
NCT01444287Daytime Corneal Swelling During Wear of Narafilcon B LensesCOMPLETEDNA2010-012010-032010-02
NCT01055132Dispensing Evaluation of New Daily Disposable Toric Soft Contact Lens.COMPLETEDNA2010-012010-022010-02
NCT01949610A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male ParticipantsCOMPLETEDPHASE12010-012010-032010-03
NCT01951053A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male PatientsCOMPLETEDPHASE12010-012010-052010-05
NCT01054014A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy VolunteersCOMPLETEDPHASE12010-012011-01
NCT01017939A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE12010-012012-042010-06
NCT01063868A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)TERMINATEDPHASE32010-012010-062010-04
NCT00980538TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected ParticipantsACTIVE_NOT_RECRUITINGPHASE32009-12-092032-01-012020-11-25
NCT01032629CANVAS - CANagliflozin cardioVascular Assessment StudyCOMPLETEDPHASE32009-12-092017-02-222017-02-22
NCT01004432Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)COMPLETEDPHASE32009-122013-102013-07
NCT01009086A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisCOMPLETEDPHASE32009-122013-052011-10
NCT01933880A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) ParticipantsCOMPLETEDPHASE42009-122010-112010-11
NCT01205126An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related PainCOMPLETEDPHASE32009-122011-022011-02
NCT01054118A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and SitagliptinCOMPLETEDPHASE12009-122010-02
NCT01041859A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral NeuropathyCOMPLETEDPHASE32009-122011-032011-03
NCT01009047An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With SchizophreniaCOMPLETEDPHASE32009-122012-062012-06
NCT01152749Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® GumCOMPLETEDNA2009-122010-052010-03
NCT01055457Vistakon Investigational Multi-purpose Contact Lens Care Solution.COMPLETEDNA2009-11-012010-05-012010-05-01
NCT01054807Non-Dispensing Evaluation of an Investigational Galyfilcon A Soft Contact LensCOMPLETEDNA2009-11-012010-03-012010-03-01
NCT01055613Investigational Multi-purpose Contact Lens Care Solution.COMPLETEDNA2009-112010-05
NCT00993018A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful NeuropathyTERMINATEDPHASE22009-112011-062011-06
NCT01814878A Study Comparing the Effectiveness and Safety of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen With Immediate Release (IR) Tramadol HCl/Acetaminophen in Participants With Moderate to Severe Postoperative PainCOMPLETEDPHASE32009-112011-022011-01
NCT00992589Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)COMPLETEDPHASE32009-112011-112011-11
NCT00924469A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate CancerCOMPLETEDPHASE22009-112012-032012-02
NCT00989300Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of ClopidogrelCOMPLETEDPHASE12009-112010-032010-03
NCT00915746A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy VolunteersCOMPLETEDPHASE12009-112009-12
NCT01016652Clinical Evaluation of a Multifocal Contact Lens on Symptomatic PatientsCOMPLETEDNA2009-10-012009-12-012009-12-01
NCT01031004Vistakon Investigational Lens Worn as a Single Use Daily WearCOMPLETEDNA2009-10-012009-12-012009-12-01
NCT00929188A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related PainCOMPLETEDPHASE22009-102015-012015-01
NCT01009554Oral Tissue Tolerance of a MouthrinseCOMPLETEDNA2009-102009-122009-12
NCT01059773A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to MethotrexateCOMPLETEDPHASE42009-102011-082010-11
NCT01381848A Study of Doripenem in Infants Less Than 12 Weeks of AgeCOMPLETEDPHASE12009-102012-042012-04
NCT01050582A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in ChildrenCOMPLETEDPHASE42009-102011-072011-07
NCT01165294The Effect of Ketamine on AttentivenessCOMPLETEDPHASE12009-102010-05
NCT00973141A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related PainTERMINATEDPHASE22009-09-162011-06-302011-06-30
NCT00968812CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideCOMPLETEDPHASE32009-092013-012011-12
NCT00973024A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back PainTERMINATEDPHASE22009-092011-052011-05
NCT01286077Velcade Consolidation Bone StudyCOMPLETEDPHASE22009-092014-042012-11
NCT00964990A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)TERMINATEDPHASE22009-092011-072011-07
NCT00910871To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.COMPLETEDPHASE22009-092013-012011-03
NCT00934635A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy ControlsTERMINATEDPHASE42009-092009-122009-12
NCT00986180NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainCOMPLETEDPHASE32009-092010-122010-12
NCT00975585Clinical Performance Comparison of Two Contact LensesCOMPLETEDNA2009-08-012009-10-012009-10-01
NCT01751867An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic SyndromeCOMPLETEDPHASE32009-082013-042011-05
NCT00946569A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent AsthmaCOMPLETEDPHASE22009-082010-092010-09
NCT02012049Bioequivalence Test for Risperdal 2mg of Janssen KoreaCOMPLETEDPHASE12009-082009-082009-08
NCT00896051TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV PatientsCOMPLETEDPHASE22009-082012-042012-04
NCT01387542Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia ParticipantsCOMPLETEDPHASE42009-082010-092010-09
NCT01137799The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic PatientsTERMINATEDPHASE12009-082011-03
NCT01227720Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.COMPLETEDNA2009-082010-012009-12
NCT00933582A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the KneeCOMPLETEDPHASE12009-082010-062010-06
NCT00986102PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific RegionCOMPLETEDPHASE42009-07-172011-09-092011-09-05
NCT01814098An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety SymptomsCOMPLETEDPHASE42009-07-072011-11-302011-05-31
NCT02224118Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12009-072010-032010-03
NCT00996476A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected PatientsCOMPLETEDPHASE22009-072011-012011-01
NCT00937352A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's DiseaseTERMINATEDPHASE32009-072012-092012-09
NCT00937040Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE42009-072010-022010-02
NCT00855361A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE12009-072011-122011-12
NCT00946972A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes MellitusTERMINATEDPHASE12009-072009-11
NCT00927927First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid ArthritisCOMPLETEDPHASE12009-062011-122011-12
NCT00911859A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma PatientsCOMPLETEDPHASE22009-062013-042013-04
NCT00965848A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract InfectionsCOMPLETEDPHASE42009-062010-072010-07
NCT01928316A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy VolunteersCOMPLETEDPHASE12009-062009-062009-06
NCT01391013A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected PatientsCOMPLETEDPHASE22009-062011-042011-04
NCT00903682A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected PatientsCOMPLETEDPHASE22009-062011-012010-02
NCT01714206A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.COMPLETEDPHASE12009-062009-092009-09
NCT0094698528-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 YearsTERMINATEDPHASE42009-062010-032010-03
NCT01006304An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental ModelCOMPLETEDPHASE12009-062010-06
NCT00915434A Study to Characterize the Pharmacokinetics and Effect of Food on JNJ-31001074 in Healthy VolunteersCOMPLETEDPHASE12009-062009-11
NCT00912028Clinical Performance Comparison of Several Different Contact LensesCOMPLETEDNA2009-05-012010-02-012010-02-01
NCT02103985A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy ParticipantsCOMPLETEDPHASE12009-052009-062009-06
NCT01986491A Study of Solid Formulations of JNJ-39393406 in Healthy Male ParticipantsCOMPLETEDPHASE12009-052009-082009-08
NCT00915512A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With SchizophreniaCOMPLETEDPHASE42009-052011-102011-10
NCT01112267An Efficacy and Safety Study of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen in Participants With Chronic Low-Back PainCOMPLETEDPHASE32009-052009-102009-10
NCT00910754A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE12009-052012-052009-11
NCT00880217A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22009-052010-012010-01
NCT00890292A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE12009-052009-122009-12
NCT00890240A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE12009-052009-112009-11
NCT00887198Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE32009-04-282017-05-252014-03-31
NCT00855335A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenCOMPLETEDPHASE32009-04-092016-08-112016-08-11
NCT00886587To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in ChildrenCOMPLETEDNA2009-042009-062009-06
NCT00871507A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes MellitusCOMPLETEDPHASE12009-042009-072009-07
NCT02049697A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male ParticipantsCOMPLETEDPHASE12009-042009-052009-05
NCT01942382A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With SchizophreniaCOMPLETEDPHASE12009-042010-032010-03
NCT01208298Study to Evaluate Using a Cold Sore Patch to Treat Herpes LabialisCOMPLETEDNA2009-042009-082009-08
NCT01084603Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement ProductCOMPLETEDNA2009-032009-062009-05
NCT00882375Efficacy and Safety Following Use of a Novel Nicotine Replacement TherapyCOMPLETEDNA2009-032010-062010-06
NCT01177800A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type PsoriasisCOMPLETEDPHASE32009-022010-092010-02
NCT01094249A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective DisorderCOMPLETEDPHASE12009-022009-042009-04
NCT00749463Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch TreatmentCOMPLETEDPHASE42009-022009-112009-11
NCT00869674GeneSearch™ Breast Lymph Node (BLN) Assay China Registration StudyTERMINATEDPHASE32009-022009-112009-10
NCT00799487CONCERTA Lab School StudyCOMPLETEDPHASE42009-01-022009-06-262009-06-26
NCT00813150Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple MyelomaCOMPLETEDPHASE32009-012013-012013-01
NCT00872521A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple MyelomaCOMPLETEDPHASE22009-012011-112011-03
NCT02023255A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy ParticipantsCOMPLETEDPHASE12009-012009-062009-06
NCT01008618A Confirmatory Study of Fentanyl in Participants With Osteoarthritis or Low Back PainCOMPLETEDPHASE32009-012010-022010-02
NCT01795898An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back PainCOMPLETEDPHASE42009-012009-092009-09
NCT01362439Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 YearsCOMPLETEDPHASE42009-012010-032010-03
NCT01769339An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar CandidiasisCOMPLETEDPHASE42009-012009-062009-06
NCT00787891A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric PatientsCOMPLETEDPHASE32009-012011-012011-01
NCT01060228A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy MenCOMPLETEDPHASE12009-012009-02
NCT01084707Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.COMPLETEDNA2009-012009-042009-03
NCT00913523Clinical Evaluation of Effects of an Investigational Tampon on Vaginal MicrofloraCOMPLETEDNA2009-012009-082009-08
NCT00891774Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VICOMPLETEDNA2008-12-312009-11-302009-11-30
NCT00821600Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With SchizophreniaCOMPLETEDPHASE12008-122009-062009-06
NCT00799409Lab School Day Study for CONCERTA of Older Children With ADHDCOMPLETEDPHASE42008-122009-062009-06
NCT01796548Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor OveractivityTERMINATEDPHASE42008-122010-122010-12
NCT01466673An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne TreatmentCOMPLETEDPHASE42008-122010-032010-03
NCT01008553A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain SyndromeCOMPLETEDPHASE32008-122010-032010-03
NCT00814580Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder SurgeryCOMPLETEDPHASE32008-122010-032010-03
NCT00676728A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic SyndromeTERMINATEDPHASE12008-122011-092011-09
NCT00808340Comparison of Three Soft Bifocal Contact LensesCOMPLETEDNA2008-11-012008-12-012008-12-01
NCT00796120An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)COMPLETEDPHASE32008-112014-082012-08
NCT00809965An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary SyndromeCOMPLETEDPHASE32008-112011-092011-09
NCT00728195An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With SchizophreniaCOMPLETEDPHASE22008-112010-022010-02
NCT00804687An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic RhinitisCOMPLETEDPHASE22008-112009-022009-02
NCT00803283A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer PainTERMINATEDPHASE32008-112008-122008-12
NCT00788372An Efficacy and Safety Study of Fentanyl in Participants With Chronic PainCOMPLETEDPHASE32008-112010-112010-11
NCT00805142Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain ParticipantsCOMPLETEDPHASE22008-112009-072009-07
NCT00807326A Comparison of Three Medications to Treat Diarrhea in Adults.COMPLETEDPHASE42008-112009-112009-08
NCT01152736Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® GumCOMPLETEDNA2008-112009-012008-12
NCT00806299Loperamide Grapefruit Juice Interaction PK TrialCOMPLETEDPHASE12008-112008-112008-11
NCT00910923A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male VolunteersCOMPLETEDPHASE12008-112009-042009-04
NCT00766402An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)TERMINATEDPHASE42008-102009-032009-02
NCT00771199An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer PainCOMPLETEDPHASE42008-102008-112008-11
NCT00786838A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the ElectrocardiogramCOMPLETEDPHASE22008-102009-122009-12
NCT00766831An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer PainCOMPLETEDPHASE42008-102010-062010-06
NCT01006356An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With CancerCOMPLETEDPHASE42008-102009-082009-08
NCT00766675An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia PainCOMPLETEDPHASE42008-102009-042009-03
NCT01774929An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Participants With OsteoarthritisCOMPLETEDPHASE42008-102009-042009-04
NCT00764439Pilot Study of a New Nicotine Replacement TherapyCOMPLETEDPHASE22008-102008-122008-12
NCT00784277A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint DiseaseCOMPLETEDPHASE32008-102009-072009-07
NCT00685607Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden DiarrheaCOMPLETEDPHASE42008-102008-102008-10
NCT00813761Clinical Evaluation of the Long-Term Effects of Contact Lens Care SystemsCOMPLETEDNA2008-09-012009-08-012009-08-01
NCT00771758Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With OsteoporosisCOMPLETEDPHASE32008-092009-122009-12
NCT01012622An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE42008-092009-082009-08
NCT01877226Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy ParticipantsCOMPLETEDPHASE12008-092008-102008-10
NCT01113424Bioequivalence Between Nicotine Replacement Products and Nicorette® GumCOMPLETEDNA2008-092008-122008-11
NCT00762567Phenylephrine Pediatric Pharmacokinetic StudyCOMPLETEDPHASE12008-092008-112008-11
NCT00762749Study to Evaluate Diphenhydramine in Children and AdolescentsCOMPLETEDPHASE12008-092008-112008-11
NCT01748526A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin (JNJ-28431754) in Healthy Indian VolunteersCOMPLETEDPHASE12008-082008-092008-09
NCT00775021A Clinical Comparison of Two Daily Disposable Contact Lenses.COMPLETEDNA2008-082009-012009-01
NCT01101646A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult VolunteersCOMPLETEDPHASE12008-082008-092008-09
NCT00779038Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic SurgeryTERMINATEDPHASE42008-082008-092008-09
NCT00662675A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic InsufficiencyCOMPLETEDPHASE32008-082009-022009-02
NCT00698451A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal CancersCOMPLETEDPHASE22008-082010-102010-10
NCT00744757An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)COMPLETEDPHASE22008-082012-082010-09
NCT01742897Efficacy and Safety Study of Transdermal Therapeutic System (TTS) Fentanyl in Participants With Osteoarthritis Knee PainCOMPLETEDPHASE42008-082008-112008-11
NCT01821027A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy VolunteersCOMPLETEDPHASE12008-082008-092008-09
NCT01774903An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Severe Chronic Low Back PainCOMPLETEDPHASE42008-082009-062009-06
NCT01238640Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® MicrotabCOMPLETEDNA2008-082008-112008-11
NCT00724945Comparison of Two Soft Bifocal Contact LensesCOMPLETEDNA2008-072008-082008-08
NCT00727558A Comparison of Daily Disposable Contact Lenses.COMPLETEDNA2008-072008-102008-10
NCT00706953A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With BortezomibWITHDRAWNPHASE22008-072010-062010-06
NCT01812642A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable SchizophreniaCOMPLETEDPHASE22008-072008-122008-12
NCT01577186Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)COMPLETEDPHASE42008-072009-062009-06
NCT00796003A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic SyndromeCOMPLETEDPHASE12008-072010-102010-10
NCT00985959A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)COMPLETEDPHASE12008-072010-062010-06
NCT01060150An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE42008-072010-042010-04
NCT01541371A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With SchizophreniaCOMPLETEDPHASE32008-072009-092009-09
NCT01733108A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy VolunteersCOMPLETEDPHASE12008-072008-092008-09
NCT00676702A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)COMPLETEDPHASE12008-072009-012009-01
NCT00708032Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.COMPLETEDNA2008-06-012009-12-012009-12-01
NCT01787357A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)COMPLETEDPHASE12008-062008-092008-09
NCT00708643Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing PopulationCOMPLETEDNA2008-062008-092008-09
NCT00721500A Comparison of Two Daily Disposable Contact Lenses.COMPLETEDNA2008-062008-072008-07
NCT00679627A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's DiseaseTERMINATEDPHASE32008-062012-052012-04
NCT00814658The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of LifeCOMPLETEDPHASE42008-062009-102009-10
NCT00736853An Efficacy and Safety Study of Acetaminophen Plus Tramadol Hydrochloride (JNS013) in Participants With Chronic PainCOMPLETEDPHASE32008-062009-012009-01
NCT00695396A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for TransfusionTERMINATEDPHASE32008-062010-012010-01
NCT01689649A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With EpilepsyCOMPLETEDPHASE42008-05-022010-01-192010-01-19
NCT00771251A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)COMPLETEDPHASE32008-052011-102011-10
NCT00697190Clinical Performance of Atypical Contact Lens Powers on Subjects With AstigmatismCOMPLETEDNA2008-052008-092008-09
NCT00700752A Comparison of Two Contact LensesCOMPLETEDNA2008-052008-072008-07
NCT00908232Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VDCOMPLETEDPHASE22008-052011-082011-08
NCT00736957A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic PainCOMPLETEDPHASE32008-052009-112009-10
NCT01577160A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With SchizophreniaCOMPLETEDPHASE42008-052009-042009-04
NCT01177163A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12008-052009-03
NCT00727987A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCOMPLETEDPHASE32008-052011-122011-12
NCT01810887A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese ParticipantsCOMPLETEDPHASE42008-052008-072008-07
NCT00650806A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have DiabetesCOMPLETEDPHASE22008-052008-092008-09
NCT00766506An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic SurgeryTERMINATEDPHASE42008-052008-092008-09
NCT00745901Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active FemalesCOMPLETEDPHASE42008-052008-102008-10
NCT01234792Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.COMPLETEDNA2008-052008-062008-06
NCT01829191Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)COMPLETEDNA2008-04-012010-05-012010-05-01
NCT00761605Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic ParticipantsCOMPLETEDPHASE42008-042010-102010-09
NCT00761579Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic RemissionCOMPLETEDPHASE42008-042010-122010-10
NCT00784238Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic ParticipantsCOMPLETEDPHASE42008-042011-012010-12
NCT00642278An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 DiabetesCOMPLETEDPHASE22008-042009-012009-01
NCT00589693To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated PneumoniaTERMINATEDPHASE32008-042011-062011-06
NCT00574288Daratumumab (HuMax®-CD38) Safety Study in Multiple MyelomaCOMPLETEDPHASE22008-03-262017-04-032015-01-09
NCT00737048A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction PainCOMPLETEDPHASE32008-032008-092008-09
NCT00723528An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque PsoriasisCOMPLETEDPHASE32008-032010-032009-01
NCT00758160The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE42008-032008-062008-06
NCT00757705An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With SchizophreniaCOMPLETEDPHASE42008-032009-052009-05
NCT01804673A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery PainTERMINATEDPHASE42008-032008-092008-09
NCT01759576A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney FunctionCOMPLETEDPHASE12008-032008-112008-11
NCT01782729An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCOMPLETEDPHASE42008-032008-112008-11
NCT01152723Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® GumCOMPLETEDNA2008-032008-052008-05
NCT00747695A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, InclusiveCOMPLETEDPHASE12008-032009-09
NCT01559272A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With SchizophreniaCOMPLETEDPHASE12008-02-212014-05-242014-04-09
NCT00944671A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)COMPLETEDPHASE12008-022008-032008-03
NCT00638846Performance of Two Silicone Hydrogel Toric Contact LensesCOMPLETEDNA2008-022008-052008-05
NCT00639379Comparison of Two Toric Contact Lenses on Current Toric WearersCOMPLETEDNA2008-022008-062008-06
NCT00639353Silicone Hydrogel Contact Lenses on Low Astigmatism in JapanTERMINATEDNA2008-022008-06
NCT00714688A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity DisorderCOMPLETEDPHASE32008-022009-042009-04
NCT00613938A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.COMPLETEDPHASE32008-022008-102008-10
NCT00761189PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute SchizophreniaCOMPLETEDPHASE42008-022010-072010-07
NCT01010776A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With RisperidoneCOMPLETEDPHASE42008-022009-122009-12
NCT00783835Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE42008-022008-102008-10
NCT00651365A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.TERMINATEDPHASE12008-022010-122010-12
NCT01724359Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With SchizophreniaCOMPLETEDPHASE42008-022009-112009-11
NCT01041677A Study of the Safety of R256918 in Obese PatientsCOMPLETEDPHASE22008-022008-102008-10
NCT01714193A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy VolunteersCOMPLETEDPHASE12008-022008-032008-03
NCT00634101A Comparison of Two Daily Disposable Contact LensesTERMINATEDNA2008-01-012008-03-012008-03-01
NCT00630305Endothelial Bleb Response With Toric LensesCOMPLETEDNA2008-012008-072008-07
NCT00604123A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in AdultsCOMPLETEDPHASE22008-012008-022008-02
NCT00784368A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal InfectionCOMPLETEDPHASE32008-012009-052009-04
NCT00604279A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With SchizophreniaCOMPLETEDPHASE32008-012009-012009-01
NCT00641667An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer PainCOMPLETEDPHASE32008-012008-062008-06
NCT00779025A Safety Evaluation of Personal Lubricant Product When Used by Couples in Home-use ConditionsCOMPLETEDNA2008-012008-022008-02
NCT00600080A Comparison of Two Daily Disposable Contact LensesCOMPLETEDNA2007-122008-032008-03
NCT00594516Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back PainCOMPLETEDPHASE32007-122008-052008-04
NCT00566202A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe DepressionCOMPLETEDPHASE22007-122008-122008-12
NCT00672386A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 DiabetesCOMPLETEDPHASE22007-122008-092008-09
NCT00566449A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.COMPLETEDPHASE22007-122008-072008-07
NCT00576732A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic DisorderCOMPLETEDPHASE42007-122010-032009-09
NCT00992407An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE42007-122010-122010-12
NCT01867164A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious VaginosisCOMPLETEDPHASE32007-122008-122008-12
NCT00574132Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)COMPLETEDPHASE32007-122012-062012-06
NCT00575055Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)COMPLETEDPHASE32007-122012-042012-04
NCT00747526A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, InclusiveCOMPLETEDPHASE12007-122012-022012-02
NCT00644787A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer PainCOMPLETEDPHASE2, PHASE32007-122008-102008-10
NCT01606228A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With SchizophreniaCOMPLETEDPHASE32007-122008-122008-12
NCT00778934In-Home Use Study to Evaluate Use of an Intimate Health Product in FemalesCOMPLETEDNA2007-122008-042008-02
NCT00583908Evaluation of Orientation and Visual Acuity of Four Toric Soft Contact Lenses When Head is Tilted at 90 DegreesCOMPLETEDNA2007-112008-012008-01
NCT00622765A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese PatientsCOMPLETEDPHASE22007-112008-062008-06
NCT01855074An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersCOMPLETEDPHASE42007-112009-022009-02
NCT01828879An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCOMPLETEDPHASE42007-112009-122009-06
NCT01756417A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy VolunteersCOMPLETEDPHASE12007-102007-112007-11
NCT00584831Effect of Eye Movement on Toric Lens Orientation and Visual AcuityCOMPLETEDNA2007-102008-022008-02
NCT00544440An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow PlasmaCOMPLETEDPHASE22007-102012-082012-08
NCT00535145Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseCOMPLETEDPHASE42007-102009-022009-02
NCT00645099A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With SchizophreniaCOMPLETEDPHASE32007-102009-042009-04
NCT00535132Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to PaliperidoneCOMPLETEDPHASE42007-102008-072008-07
NCT00980798Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the KneeCOMPLETEDPHASE32007-102008-112008-11
NCT00718640An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney FunctionTERMINATEDPHASE22007-102010-012009-12
NCT01728246An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic OsteoarthritisCOMPLETEDPHASE42007-102008-052008-05
NCT01586507A Study of ULTRAM ER at Two Dose Levels in Adolescents With PainCOMPLETEDPHASE12007-102008-092008-09
NCT01586494A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With PainCOMPLETEDPHASE12007-102009-062009-06
NCT00579384A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive EpilepsyCOMPLETEDPHASE22007-102008-072008-07
NCT00515034A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or PneumoniaCOMPLETEDPHASE22007-102008-112008-11
NCT00488631An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE32007-092015-022011-10
NCT00584220Evaluation of Two Toric Soft Contact Lenses After Two Weeks of WearCOMPLETEDNA2007-092007-122007-12
NCT01163760Clinical Evaluation of Two Daily Disposable Contact LensesCOMPLETEDNA2007-092007-092007-09
NCT00584727In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact LensCOMPLETEDNA2007-092007-112007-11
NCT01150448A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With SchizophreniaCOMPLETEDPHASE12007-092009-062009-06
NCT00524043An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With SchizophreniaCOMPLETEDPHASE42007-092008-112008-11
NCT00613327An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder ParticipantsCOMPLETEDPHASE42007-092008-062008-06
NCT01843660An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back PainCOMPLETEDPHASE42007-092008-052008-05
NCT01238627Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mgCOMPLETEDNA2007-092007-112007-11
NCT01228617Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCOMPLETEDNA2007-092007-102007-10
NCT01791231A Study to Investigate the Absorption, Metabolism, and Excretion of Canagliflozin (JNJ-28431754) in Healthy Male VolunteersCOMPLETEDPHASE12007-082007-102007-09
NCT00717249Vistakon Investigational Contact Lenses Worn for Daily WearCOMPLETEDNA2007-082008-042008-04
NCT00762385Clinical Comparison of Two Silicone-Hydrogel Contact LensesCOMPLETEDNA2007-082007-102007-10
NCT00762996The Clinical Evaluation of Two Daily Disposable Contact LensesCOMPLETEDNA2007-082007-102007-10
NCT00487539An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE2, PHASE32007-082010-102010-10
NCT01799590Continuous Treatment Study of Topiramate in Migraine ParticipantsCOMPLETEDPHASE22007-082009-112009-11
NCT01814982An Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of JNJ-17299425 in Participants With Traumatic Brain InjuryTERMINATEDPHASE22007-082008-082008-08
NCT00488774An Efficacy and Safety Study of Golimumab in Participants With Ulcerative ColitisTERMINATEDPHASE2, PHASE32007-082009-052009-05
NCT00677105A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.COMPLETEDPHASE12007-082011-092011-09
NCT00518323A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent PatientsCOMPLETEDPHASE32007-082009-032009-03
NCT00530166Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.TERMINATEDPHASE22007-072008-072008-07
NCT00440466PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD PatientsCOMPLETEDPHASE32007-072009-032009-03
NCT01110330An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's FootTERMINATEDPHASE32007-072008-102008-10
NCT00526877An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentCOMPLETEDPHASE42007-072009-012009-01
NCT00566631An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With SchizophreniaCOMPLETEDPHASE32007-072009-052008-05
NCT00492661A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on TacrolimusCOMPLETEDPHASE42007-072010-062010-06
NCT01756404Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese VolunteersCOMPLETEDPHASE12007-06-142007-12-052007-12-05
NCT00762502Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear PeriodCOMPLETEDNA2007-062008-012008-01
NCT00487435An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic PainCOMPLETEDPHASE32007-062009-062009-06
NCT00449644TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).COMPLETEDPHASE22007-062012-102010-03
NCT00963768A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12007-062007-122007-12
NCT01662648Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With SchizophreniaCOMPLETEDPHASE32007-062009-042008-04
NCT00580112An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerCOMPLETEDPHASE22007-062011-082011-08
NCT00488319Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.COMPLETEDPHASE32007-062012-072012-07
NCT00896168An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid ArthritisCOMPLETEDPHASE42007-062008-042008-04
NCT01823289An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal InfectionsCOMPLETEDPHASE42007-062009-012008-12
NCT00458302Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/RitonavirCOMPLETEDPHASE32007-062011-012009-02
NCT00752661An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back PainCOMPLETEDPHASE22007-062007-112007-11
NCT01008696An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux EsophagitisCOMPLETEDPHASE42007-052008-082008-08
NCT00635349A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee OsteoarthritisCOMPLETEDPHASE42007-052009-042009-04
NCT00460512An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaCOMPLETEDPHASE32007-04-252020-03-042009-01-22
NCT01787760Controlling Myopia Progression With Soft Contact LensesCOMPLETEDNA2007-04-012010-04-012010-04-01
NCT00762970Controlling Myopia Progression With Soft Contact LensesCOMPLETEDNA2007-04-012010-02-012010-02-01
NCT00579501Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell LiposarcomaCOMPLETEDPHASE22007-042010-012010-01
NCT01060124An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic AnalgesicsCOMPLETEDPHASE42007-042009-022009-02
NCT00455429An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic DermatitisTERMINATEDPHASE22007-042009-032009-03
NCT00455520A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral NeuropathyCOMPLETEDPHASE32007-042008-082008-08
NCT01081795A Dose-Finding Study of Topiramate (JNS019) in Participants With MigraineCOMPLETEDPHASE22007-042009-012009-01
NCT01664728An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001COMPLETEDPHASE12007-042012-092009-02
NCT00473434An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With SchizophreniaCOMPLETEDPHASE32007-042009-082009-08
NCT00589914Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With SchizophreniaCOMPLETEDPHASE32007-032009-062009-06
NCT00590577Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With SchizophreniaCOMPLETEDPHASE32007-032008-032008-03
NCT00490724An Exploratory Study of Nesiritide in Participants With Acute Heart FailureCOMPLETEDPHASE22007-032008-072008-06
NCT00791193A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IRCOMPLETEDPHASE12007-032007-05
NCT00790777A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and VacavilleCOMPLETEDPHASE12007-032007-05
NCT00762788Clinical Trial of Several Contact Lenses in Extended WearCOMPLETEDNA2007-022009-092009-09
NCT00814801An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's DiseaseCOMPLETEDPHASE32007-022008-092008-09
NCT00449176A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back PainCOMPLETEDPHASE32007-022008-052008-05
NCT00871728Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole CapsulesCOMPLETEDPHASE42007-012009-122009-05
NCT01606254A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With SchizophreniaCOMPLETEDPHASE22007-012008-042008-04
NCT00378144Efficacy and Safety of Sinutab on Subjects in the Setting of a Common ColdCOMPLETEDPHASE42007-012008-032008-03
NCT00421928Tapentadol (CG5503)COMPLETEDPHASE32007-012008-122008-07
NCT00416273A Study of Bortezomib as Consolidation Therapy in Patients With Multiple MyelomaCOMPLETEDPHASE32006-122013-052013-05
NCT00425321Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCOMPLETEDPHASE22006-122008-012008-01
NCT00412373Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.COMPLETEDPHASE32006-122008-062008-06
NCT00403767An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationCOMPLETEDPHASE32006-122010-092010-09
NCT00441168Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple MyelomaTERMINATEDPHASE22006-122008-012008-01
NCT01881282A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of HemorrhoidsCOMPLETEDPHASE42006-122008-022008-02
NCT00634543A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic NeuropathyCOMPLETEDPHASE42006-122008-102008-10
NCT01801436A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple MyelomaCOMPLETEDPHASE32006-122008-042008-04
NCT00606476AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's DiseaseTERMINATEDPHASE22006-122012-092012-09
NCT00401843A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE22006-11-282019-09-242011-08-16
NCT00391222A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I DisorderCOMPLETEDPHASE32006-112009-042009-04
NCT00464308A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mgCOMPLETEDPHASE42006-112008-052008-05
NCT00361504A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic PainCOMPLETEDPHASE32006-112008-072008-07
NCT00402688An Effectiveness and Safety Study for Levofloxacin in Chronic ProstatitisCOMPLETEDPHASE32006-112008-092008-03
NCT00386152A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving ChemotherapyTERMINATEDPHASE22006-112008-052008-03
NCT00397033Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.COMPLETEDPHASE32006-112008-022008-02
NCT00402597Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)COMPLETEDPHASE22006-112008-102008-10
NCT00648973To Determine if Diphenhydramine Works for Nasal Congestion at Two Different DosesCOMPLETEDPHASE42006-112007-052007-05
NCT01177150A First-in-Human Study of JNJ-28431754 in Healthy Male VolunteersCOMPLETEDPHASE12006-112007-042007-04
NCT00676910A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.COMPLETEDPHASE12006-112010-02
NCT00416208Consolidation Therapy With Bortezomib in Elderly Patients With Multiple MyelomaCOMPLETEDPHASE32006-102013-052013-05
NCT00364533A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For SafetyTERMINATEDPHASE32006-102007-122007-12
NCT00813202An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart FailureCOMPLETEDPHASE32006-102007-062007-06
NCT01054976The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's DiseaseCOMPLETEDPHASE42006-102009-022009-02
NCT00662337Bioequivalence Between Two Oral Formulations of Diphenhydramine HydrochlorideCOMPLETEDPHASE12006-102006-112006-11
NCT00361582A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement SurgeryCOMPLETEDPHASE32006-102007-082007-08
NCT00440557An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney DiseaseCOMPLETEDPHASE32006-092008-022008-02
NCT00518232A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity DisorderCOMPLETEDPHASE42006-092007-062007-06
NCT00892125A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I DisorderCOMPLETEDPHASE12006-092007-03
NCT00350519The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic SurgeryTERMINATEDPHASE42006-082008-022008-02
NCT00676299A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.COMPLETEDPHASE12006-082008-07
NCT00396565A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With SchizophreniaCOMPLETEDPHASE32006-072007-112007-11
NCT01060111An Efficacy and Tolerability Study of Topiramate in Participants With MigraineCOMPLETEDPHASE42006-072008-072008-07
NCT00337935A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.COMPLETEDPHASE22006-072009-072009-07
NCT00364546A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic PainCOMPLETEDPHASE32006-072007-072007-06
NCT00431769An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple MyelomaCOMPLETEDPHASE22006-062010-012009-02
NCT00267007A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral NeuropathyTERMINATEDPHASE22006-062008-082008-08
NCT00473746Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate CancerCOMPLETEDPHASE1, PHASE22006-062012-122012-12
NCT01561898A Long-Term Study of JNS007ER in Patients With SchizophreniaCOMPLETEDPHASE32006-062008-102008-10
NCT00350467A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of SchizophreniaCOMPLETEDPHASE32006-062007-09
NCT00821782Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic MedicationsCOMPLETEDPHASE12006-062006-09
NCT00791167A Study of the Dose Proportionality of Extended Release PaliperidoneCOMPLETEDPHASE12006-062006-08
NCT00490971A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I DisorderCOMPLETEDPHASE32006-052010-042010-04
NCT01060137Fentanyl Matrix in Lung Cancer PainCOMPLETEDPHASE42006-052007-052007-05
NCT00309699A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderCOMPLETEDPHASE32006-042007-112007-09
NCT00378092A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic EpisodeCOMPLETEDPHASE42006-042010-032010-03
NCT00334126Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With SchizophreniaCOMPLETEDPHASE32006-042007-09
NCT00309686A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I DisorderCOMPLETEDPHASE32006-042007-08
NCT00338286A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard ChemotherapyCOMPLETEDPHASE32006-03-022017-01-312014-07-07
NCT00833560A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose ChemotherapyCOMPLETEDPHASE22006-032009-062009-06
NCT00261495A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.COMPLETEDPHASE32006-032008-042008-04
NCT00369239Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of PsychosisCOMPLETEDPHASE42006-032007-11
NCT00306267A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving ChemotherapyTERMINATEDPHASE22006-032007-05
NCT00791713A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ERCOMPLETEDPHASE12006-032006-07
NCT01902862An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular LymphomaTERMINATEDPHASE22006-022007-082007-08
NCT00299702Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With SchizophreniaCOMPLETEDPHASE42006-022009-012009-01
NCT00299715A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I DisorderCOMPLETEDPHASE32006-022007-062007-06
NCT00828958Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.COMPLETEDPHASE32006-022006-09
NCT01726335Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With SchizophreniaCOMPLETEDPHASE42006-012008-032008-03
NCT00307684Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE32006-012008-072008-07
NCT00256997A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationTERMINATEDPHASE42006-012009-042009-04
NCT01394991A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related AnemiaCOMPLETEDPHASE42006-012009-092009-09
NCT00791622A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineCOMPLETEDPHASE12006-012006-06
NCT00641589A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney DiseaseCOMPLETEDPHASE12006-012006-11
NCT00796081A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform DisorderCOMPLETEDPHASE12006-012006-08
NCT00257010A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine HeadachesCOMPLETEDPHASE32005-122007-122007-12
NCT00576173An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer PatientsCOMPLETEDPHASE42005-122007-02
NCT00266604A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCOMPLETEDPHASE42005-122007-06
NCT00216671Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute EpisodeCOMPLETEDPHASE42005-112009-122009-12
NCT00561743A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma PatientsCOMPLETEDPHASE22005-112007-052007-05
NCT02385058Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican PopulationCOMPLETEDPHASE42005-102006-012006-01
NCT01902524Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic PainCOMPLETEDPHASE42005-102006-112006-11
NCT00378287A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking PantoprazoleCOMPLETEDPHASE12005-102005-12
NCT00246298A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected PatientsTERMINATEDPHASE22005-102006-09
NCT00241280Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).COMPLETEDNA2005-092006-102006-10
NCT00921219Ivermectin Solution Bioequivalence Study - With Food (Repeat)COMPLETEDPHASE12005-092005-112005-11
NCT00843687A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.COMPLETEDPHASE32005-092007-032007-03
NCT00677001A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.COMPLETEDPHASE12005-092006-10
NCT00212875A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.COMPLETEDPHASE22005-092007-02
NCT00210626Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin AlfaTERMINATEDPHASE22005-082008-062008-06
NCT00269919An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With SchizophreniaCOMPLETEDPHASE42005-082008-082008-08
NCT00966901Photoirritation and Photoallergic Potential of a New Nicotine PatchCOMPLETEDPHASE12005-082005-102005-10
NCT00523887Fentanyl for Treatment Pain Caused by RadiotherapyCOMPLETEDPHASE42005-082006-09
NCT00838669A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS PaliperidoneCOMPLETEDPHASE12005-082005-12
NCT01063842A Study of the Tolerability of Titrated Dose Tramadol/Acetaminophen Combination Tablet in Korean Patients With OsteoarthritisCOMPLETEDPHASE42005-082006-05
NCT02340481Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and FlatulenceCOMPLETEDPHASE32005-072006-052006-05
NCT01440985A Study on the Effects of Two Nicotine Replacement Products on Tooth StainingCOMPLETEDNA2005-072005-112005-11
NCT00174499A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine GumCOMPLETEDPHASE42005-072005-092005-08
NCT01110317A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone PalmitateCOMPLETEDPHASE12005-072006-03
NCT00216528A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone MicrospheresCOMPLETEDPHASE42005-072007-04
NCT00219466Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper RashCOMPLETEDPHASE42005-062005-102005-10
NCT00233012A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset SeizuresCOMPLETEDPHASE12005-062007-10
NCT00210496Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineCOMPLETEDPHASE42005-062007-06
NCT00246233CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.COMPLETEDPHASE32005-062006-04
NCT00119756A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With SchizophreniaCOMPLETEDPHASE32005-062006-11
NCT00210535A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in ChildrenCOMPLETEDPHASE32005-062006-11
NCT00113815Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset SeizuresCOMPLETEDPHASE32005-052007-112007-06
NCT00967070Skin Sensitization Potential of a New Nicotine PatchCOMPLETEDPHASE12005-052005-082005-08
NCT00967174Cumulative Skin Irritation Potential of a New 25 mg Nicotine PatchCOMPLETEDPHASE12005-052005-062005-06
NCT00965913Cumulative Skin Irritation Potential of a New 15 mg Nicotine PatchCOMPLETEDPHASE12005-052005-062005-05
NCT00216684Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and PharmacokineticsCOMPLETEDPHASE32005-052006-09
NCT00210600Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving ChemotherapyCOMPLETEDPHASE22005-052006-08
NCT00709189Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.COMPLETEDPHASE12005-052005-08
NCT00709982A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.COMPLETEDPHASE12005-052005-07
NCT00113607An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian CancerCOMPLETEDPHASE32005-042010-112010-11
NCT00102609A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue SarcomaCOMPLETEDPHASE12005-042007-10
NCT00112073AAB-001 in Patients With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22005-042008-122008-11
NCT00210548A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With SchizophreniaCOMPLETEDPHASE32005-042006-06
NCT00709644Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.COMPLETEDPHASE12005-042005-08
NCT00216632A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)COMPLETEDPHASE42005-032007-072007-07
NCT00246207CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in AdultsCOMPLETEDPHASE32005-032005-12
NCT00921154Ivermectin Solution Bioequivalence Study - FastedCOMPLETEDPHASE12005-032005-092005-05
NCT00246220A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.COMPLETEDPHASE32005-032006-11
NCT00210561A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back PainTERMINATEDPHASE42005-032005-04
NCT00216697An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib TherapyCOMPLETEDPHASE22005-032006-10
NCT00210574A Pilot Study of Topiramate in Childhood Absence EpilepsyCOMPLETEDPHASE22005-032006-10
NCT00236405PROCRIT and Short-Term Outcomes in Orthopedic SurgeryTERMINATEDPHASE22005-032005-10
NCT00210704A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCOMPLETEDPHASE32005-032006-06
NCT00240734Treatment of Anemia in Diabetic Subjects With CKDTERMINATEDPHASE22005-032005-09
NCT00111189A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.COMPLETEDPHASE32005-022008-022007-02
NCT00132678A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood EpisodesCOMPLETEDPHASE32005-022007-122007-10
NCT00921674Ivermectin Solution Bioequivalence Study - With FoodCOMPLETEDPHASE12005-022005-042005-04
NCT00257023An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With SchizophreniaCOMPLETEDPHASE22005-022005-09
NCT00210587An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or RadiationCOMPLETEDPHASE32005-022005-12
NCT00105326Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia PatientsCOMPLETEDPHASE22005-022005-08
NCT00210717A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With SchizophreniaCOMPLETEDPHASE32005-022007-04
NCT00791349A Study of QT and QTc Intervals in Patients Administered Immediate Release PaliperidoneCOMPLETEDPHASE12005-022005-05
NCT00097981A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE32005-012009-102007-10
NCT01888107Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE32005-012007-042007-04
NCT00709332A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.COMPLETEDPHASE12005-012005-02
NCT00806247A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy SurgeryCOMPLETEDPHASE22005-012005-08
NCT00216645Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based ChemotherapyCOMPLETEDPHASE22005-012006-11
NCT01177059Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical TrialCOMPLETEDPHASE22004-12-062017-11-302017-11-30
NCT00103506Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple MyelomaCOMPLETEDPHASE32004-122014-062014-05
NCT00216658Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -COMPLETEDPHASE22004-122005-09
NCT00101634Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With SchizophreniaCOMPLETEDPHASE32004-122006-03
NCT00229073A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCOMPLETEDPHASE32004-122006-10
NCT00210613A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature EjaculationCOMPLETEDPHASE32004-112005-08
NCT00886002Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.COMPLETEDPHASE12004-112005-01
NCT00210509A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine HeadacheCOMPLETEDPHASE42004-112005-06
NCT00701493A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy AdultsCOMPLETEDPHASE12004-112004-12
NCT00216476A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE32004-102007-112007-11
NCT00246259A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early PsychosisCOMPLETEDPHASE42004-102008-122008-12
NCT00095134Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard TherapyCOMPLETEDPHASE32004-102005-11
NCT00216450Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.COMPLETEDPHASE42004-102006-02
NCT00645437A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.COMPLETEDPHASE12004-102006-04
NCT00709267Bioavailability Study of Folic Acid in Healthy WomenCOMPLETEDPHASE12004-102004-12
NCT00246272An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of RisperdoneCOMPLETEDPHASE32004-102006-05
NCT00210886A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.COMPLETEDPHASE32004-102006-04
NCT00892541A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS PaliperidoneCOMPLETEDPHASE12004-102004-11
NCT00097032Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I OutpatientsCOMPLETEDPHASE32004-102005-05
NCT00091442A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast CancerCOMPLETEDPHASE32004-092008-122008-12
NCT00216554The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar ManiaCOMPLETEDPHASE42004-092006-03
NCT00210860An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.COMPLETEDPHASE32004-092006-03
NCT00752635Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne VulgarisCOMPLETEDPHASE42004-092005-09
NCT00088075Investigate Risperidone for the Treatment of Schizophrenia in AdolescentsCOMPLETEDPHASE32004-082005-12
NCT00085748Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With SchizophreniaCOMPLETEDPHASE32004-082005-05
NCT00211016Doripenem in the Treatment of Ventilator-Associated PneumoniaCOMPLETEDPHASE32004-082006-10
NCT00791284A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver FunctionCOMPLETEDPHASE12004-082004-12
NCT01968018A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer PainCOMPLETEDPHASE42004-072007-042007-04
NCT00745069Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee OsteoarthritisCOMPLETEDPHASE22004-072005-08
NCT00553449Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.COMPLETEDPHASE32004-072005-09
NCT00892489A Bioequivalence Study of 15 mg ER OROS PaliperidoneCOMPLETEDPHASE12004-072004-12
NCT00796835A Dose-proportionality Study of Five Tablet Strengths of ER OROS PaliperidoneCOMPLETEDPHASE12004-072004-10
NCT00236678Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRITTERMINATEDPHASE22004-072006-01
NCT00996177A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or IntravenouslyCOMPLETEDPHASE42004-062005-042005-04
NCT0075242724-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With SchizophreniaCOMPLETEDPHASE32004-062005-11
NCT00210795A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic AnemiaTERMINATEDPHASE22004-062005-10
NCT00228995A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic AnemiaTERMINATEDPHASE22004-062005-09
NCT00210730The Duration StudyTERMINATEDPHASE32004-062005-07
NCT00240708A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With SchizophreniaCOMPLETEDPHASE32004-062006-04
NCT00210782A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug TreatmentCOMPLETEDPHASE32004-062007-08
NCT00258063A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)COMPLETEDPHASE12004-052004-09
NCT00210834An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.COMPLETEDPHASE22004-052005-09
NCT00211003Doripenem in the Treatment of Hospital-Acquired PneumoniaCOMPLETEDPHASE32004-052006-10
NCT00297310Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney TransplantationCOMPLETEDPHASE42004-052007-042006-10
NCT00752518A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma PatientsCOMPLETEDPHASE1, PHASE22004-052006-01
NCT00775086Bioequivalence Study of Patches With Different Equilibration ProfilesCOMPLETEDPHASE12004-052004-08
NCT00645307A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.COMPLETEDPHASE32004-052006-08
NCT00094926A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.COMPLETEDPHASE32004-052007-02
NCT00210743Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.COMPLETEDPHASE22004-052005-10
NCT00796276A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release PaliperidoneCOMPLETEDPHASE12004-052004-08
NCT00082602Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's DiseaseCOMPLETEDPHASE32004-052005-04
NCT00082095To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and OlderTERMINATEDPHASE32004-042005-122005-12
NCT01816243An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant PainCOMPLETEDPHASE42004-042008-032008-03
NCT00258076A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)COMPLETEDPHASE12004-042004-09
NCT00990886The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal WomenCOMPLETEDPHASE22004-042005-012005-01
NCT00921830Pharmacokinetics of 3 Formulations of Ibuprofen SuppositoriesCOMPLETEDPHASE12004-042004-112004-07
NCT00791401A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal FunctionCOMPLETEDPHASE12004-042005-02
NCT00083668Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32004-042005-05
NCT00216515The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeCOMPLETEDPHASE42004-032005-11
NCT00650793A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With SchizophreniaCOMPLETEDPHASE32004-032006-02
NCT00078039Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32004-032005-01
NCT00229060Doripenem in the Treatment of Complicated Intra-Abdominal InfectionsCOMPLETEDPHASE32004-032006-03
NCT00210925An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol DependenceCOMPLETEDPHASE22004-032006-08
NCT00210938Doripenem in the Treatment of Complicated Intra-Abdominal InfectionsCOMPLETEDPHASE32004-032006-01
NCT00086320A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.COMPLETEDPHASE32004-032005-08
NCT00210990Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or PyelonephritisCOMPLETEDPHASE32004-032006-04
NCT00892320A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese VolunteersCOMPLETEDPHASE12004-032004-05
NCT00758030Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults.COMPLETEDPHASE12004-032004-07
NCT00645190A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE32004-032005-02
NCT00216580A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset PsychosisCOMPLETEDPHASE32004-022006-12
NCT00819520Ivermectin in the Treatment of Head LiceCOMPLETEDPHASE32004-022004-102004-09
NCT00083434Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or RadiotherapyTERMINATEDPHASE32004-022004-10
NCT00083486Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or RadiotherapyTERMINATEDPHASE32004-022004-10
NCT00231647A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or MetforminCOMPLETEDPHASE22004-022004-10
NCT00210873An Open Label Extension of a Study of Topiramate in Chronic Migraine.COMPLETEDPHASE32004-022005-08
NCT00210821Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine HeadachesCOMPLETEDPHASE32004-022005-11
NCT00388336PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation TherapyCOMPLETEDPHASE22004-022005-03
NCT00210756Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.COMPLETEDPHASE22004-022006-02
NCT00668837A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.COMPLETEDPHASE32004-022006-06
NCT00093990Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)COMPLETEDPHASE32004-012007-10
NCT00072670A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate CancerCOMPLETEDPHASE22004-012008-112008-09
NCT00246246A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar DisorderCOMPLETEDPHASE32004-012006-04
NCT00210769A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With SchizophreniaCOMPLETEDPHASE32004-012005-12
NCT00077714Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With SchizophreniaCOMPLETEDPHASE32004-012005-01
NCT00216606The Effectiveness and Safety of Topiramate on Prevention of Chronic MigraineCOMPLETEDPHASE32003-122005-07
NCT00236535A Study of the Efficacy and Safety of Tramadol HCl/Acetaminophen, Hydrocodone Bitartrate/Acetaminophen and Placebo in Patients With Pain From an Ankle Sprain With a Partial Torn LigamentCOMPLETEDPHASE32003-122004-10
NCT00076115Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and AdolescentsCOMPLETEDPHASE32003-122005-12
NCT00210847A Study Comparing the Effectiveness and Safety of Tramadol HCl/Acetaminophen Versus Placebo for the Treatment of Painful Neuropathy in Diabetic PatientsCOMPLETEDPHASE32003-122005-05
NCT00216593Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled StudyCOMPLETEDPHASE32003-122008-032007-09
NCT00229021Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or PyelonephritisCOMPLETEDPHASE32003-122006-03
NCT00216619The Prolonged Use of Topiramate for Preventing Migraine HeadachesCOMPLETEDPHASE32003-112006-08
NCT00307619An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.COMPLETEDPHASE32003-112005-04
NCT00236652A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.COMPLETEDPHASE32003-112005-06
NCT00719498Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)COMPLETEDPHASE32003-112004-07
NCT00151515A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair LossCOMPLETEDPHASE32003-102004-072004-07
NCT00576017A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).COMPLETEDPHASE42003-102005-03
NCT00074477Safety and Efficacy of an Anti-Psychotic in Patients With SchizophreniaCOMPLETEDPHASE22003-102004-07
NCT00086684Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial CystitisTERMINATEDPHASE42003-092011-062011-06
NCT01281553A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux DiseaseTERMINATEDPHASE42003-092003-10
NCT00091910Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)COMPLETEDPHASE32003-092006-06
NCT00210808A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With ObesityCOMPLETEDPHASE2, PHASE32003-092005-03
NCT00210912A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine HeadachesCOMPLETEDPHASE32003-092005-04
NCT00796640A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release FormulationsCOMPLETEDPHASE12003-092003-11
NCT00254930A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled ChildrenCOMPLETEDPHASE32003-092006-06
NCT00216541A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving ChemotherapyCOMPLETEDPHASE42003-082006-09
NCT00073320Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With SchizophreniaCOMPLETEDPHASE32003-082004-05
NCT00338299Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced AnemiaCOMPLETEDPHASE22003-082004-04
NCT00796185As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release FormulationsCOMPLETEDPHASE12003-082004-01
NCT01286090An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes MellitusTERMINATEDPHASE42003-072003-10
NCT00261482Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.COMPLETEDPHASE42003-072004-12
NCT00236912A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated AppendicitisTERMINATEDPHASE42003-072004-09
NCT00210483A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in AdolescentsCOMPLETEDPHASE32003-072005-07
NCT00796029A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral DoseCOMPLETEDPHASE12003-072003-07
NCT00061802Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE42003-062004-02
NCT00236327Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer PainTERMINATEDPHASE42003-062004-05
NCT00645502Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.COMPLETEDPHASE12003-062003-07
NCT00341055A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.COMPLETEDPHASE32003-062004-05
NCT00796471A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release FormulationsCOMPLETEDPHASE12003-062003-08
NCT00060944A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced CancerCOMPLETEDPHASE22003-052008-052008-05
NCT00240838An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.COMPLETEDPHASE42003-052003-06
NCT00416169A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal DementiaCOMPLETEDPHASE22003-052004-07
NCT01281540An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment OptionsTERMINATEDPHASE42003-052003-11
NCT00240695A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentCOMPLETEDPHASE32003-052004-05
NCT00063297Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of SchizophreniaCOMPLETEDPHASE22003-052003-10
NCT00261469An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With TriptansCOMPLETEDPHASE22003-042004-11
NCT00297375A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine HeadacheCOMPLETEDPHASE42003-042003-08
NCT01281566A Study of Cisapride in Premature Infants With Feeding ProblemsTERMINATEDPHASE42003-032003-07
NCT00338416An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three WeeksCOMPLETEDPHASE22003-032005-01
NCT00216489A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE42003-032005-11
NCT00077727A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.COMPLETEDPHASE32003-032005-02
NCT00752466A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or SeparatelyCOMPLETEDPHASE12003-032004-03
NCT00791232A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With SchizophreniaCOMPLETEDPHASE12003-032003-06
NCT00796432A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS PaliperidoneCOMPLETEDPHASE12003-032003-06
NCT00307632An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl EstradiolCOMPLETEDPHASE42003-022004-122004-12
NCT00337948An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four WeeksCOMPLETEDPHASE22003-022005-02
NCT00074997An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 InfectionCOMPLETEDPHASE22002-122008-012008-01
NCT00050427A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerCOMPLETEDPHASE22002-122006-12
NCT00216567Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic EpilepsyCOMPLETEDPHASE42002-122006-02
NCT00364455Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.COMPLETEDPHASE32002-122006-03
NCT00051753Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis MediaCOMPLETEDPHASE32002-112005-05
NCT00044473A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to TreatCOMPLETEDPHASE32002-112003-07
NCT00236483A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral SurgeryCOMPLETEDPHASE42002-112003-02
NCT00653406A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic PatientsCOMPLETEDPHASE1, PHASE22002-112003-10
NCT00050414A Study of Trabectedin in Patients With Advanced Ovarian CancerCOMPLETEDPHASE22002-102005-09
NCT00044681A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCOMPLETEDPHASE32002-102004-03
NCT00601432A Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution FormulationCOMPLETEDPHASE12002-102002-12
NCT00602589A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy SubjectsCOMPLETEDPHASE12002-102002-11
NCT00236522A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.COMPLETEDPHASE32002-102004-04
NCT00653016An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive MethodCOMPLETEDPHASE42002-102003-08
NCT00050141Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast CancerCOMPLETEDPHASE22002-092008-012005-10
NCT00254865A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female VolunteersCOMPLETEDPHASE12002-082003-03
NCT00034736A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient SettingCOMPLETEDPHASE32002-082004-06
NCT00050440Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial CarcinomaCOMPLETEDPHASE22002-072004-07
NCT00050154Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)COMPLETEDPHASE22002-072006-05
NCT00236366A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With OsteoarthritisCOMPLETEDPHASE42002-062004-04
NCT00048503Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and OlderCOMPLETEDPHASE22002-062005-11
NCT00236353Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE32002-052003-12
NCT00240786An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or KneeCOMPLETEDPHASE32002-042003-03
NCT00287742A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTERMINATEDPHASE32002-032003-03
NCT00211120Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)TERMINATEDPHASE42002-032005-08
NCT00035802A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderCOMPLETEDPHASE32002-012002-04
NCT00236470A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCOMPLETEDPHASE32002-012004-07
NCT00236444A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCOMPLETEDPHASE32001-122003-09
NCT00036400Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by SurgeryCOMPLETEDPHASE32001-122003-12
NCT00236587A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With SchizophreniaCOMPLETEDPHASE32001-112004-02
NCT00042718A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.COMPLETEDPHASE32001-112003-08
NCT00236392A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)COMPLETEDPHASE32001-102002-10
NCT00035191A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular DementiaCOMPLETEDPHASE32001-102003-09
NCT00495118A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.COMPLETEDPHASE32001-102005-03
NCT00236496A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.COMPLETEDPHASE32001-102004-02
NCT00021723Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's DiseaseTERMINATEDPHASE22001-092003-09
NCT00034775A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.COMPLETEDPHASE32001-082002-10
NCT00216502A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's DiseaseCOMPLETEDPHASE32001-082005-11
NCT00231673A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral PolyneuropathyCOMPLETEDPHASE22001-072003-01
NCT00035230A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderCOMPLETEDPHASE32001-072002-11
NCT00524160A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or OsteoarthritisCOMPLETEDPHASE42001-072002-12
NCT00249171A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic PatientsCOMPLETEDPHASE42001-062003-02
NCT00338000EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal FailureCOMPLETEDPHASE42001-062005-05
NCT00231634A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea TherapyTERMINATEDPHASE32001-052002-11
NCT00236574A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCOMPLETEDPHASE32001-052003-11
NCT00236431A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCOMPLETEDPHASE32001-052003-12
NCT00231621A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaTERMINATEDPHASE32001-052002-06
NCT00354146A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.COMPLETEDPHASE22001-042003-07
NCT00301574An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.COMPLETEDPHASE32001-042004-02
NCT00236561A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of MigraineCOMPLETEDPHASE32001-042002-12
NCT00034749The Efficacy and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCOMPLETEDPHASE32001-042006-03
NCT00246285A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCOMPLETEDPHASE32001-042006-12
NCT02932774Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)COMPLETEDPHASE42001-032001-072001-07
NCT00249236A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCOMPLETEDPHASE32001-032001-12
NCT00253162A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With HaloperidolCOMPLETEDPHASE32001-032002-09
NCT00231595A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCOMPLETEDPHASE32001-032002-11
NCT00253214Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release FormulationCOMPLETEDPHASE32001-032002-07
NCT00236665A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionCOMPLETEDPHASE32001-032002-06
NCT00986128A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder PatientsCOMPLETEDPHASE12001-032002-10
NCT00236821A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With PneumoniaCOMPLETEDPHASE32001-032002-06
NCT00236509A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCOMPLETEDPHASE32001-022002-09
NCT00312871Effects of Early Correction of Anemia in Patients With Chronic Renal InsufficiencyTERMINATEDPHASE42001-022003-06
NCT00986336A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective DisordersCOMPLETEDPHASE12001-022002-11
NCT00378183A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.COMPLETEDPHASE42001-022002-05
NCT00037674A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderCOMPLETEDPHASE32001-012003-05
NCT00231530A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled DietCOMPLETEDPHASE32001-012002-05
NCT00257075A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I DisorderCOMPLETEDPHASE32000-122002-05
NCT00034762Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's DiseaseCOMPLETEDPHASE32000-122003-01
NCT00034788A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEXTERMINATEDPHASE32000-122004-02
NCT00236457A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE32000-112002-12
NCT00231660A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With MetforminCOMPLETEDPHASE32000-102002-06
NCT00240721A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderCOMPLETEDPHASE32000-102002-09
NCT00253175A Study of the Effectiveness and Safety of Topiramate for the Prevention of MigraineCOMPLETEDPHASE32000-102001-12
NCT00344422Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE32000-102004-06
NCT00236613A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityCOMPLETEDPHASE22000-092001-07
NCT00236600A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss ProgramCOMPLETEDPHASE32000-082002-06
NCT00236639A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityCOMPLETEDPHASE32000-072002-06
NCT00211133A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving ChemotherapyCOMPLETEDPHASE32000-062006-12
NCT00236808A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial ProstatitisCOMPLETEDPHASE32000-052001-11
NCT00236626A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 DiabetesCOMPLETEDPHASE22000-042002-05
NCT00304629Long-term Safety and Efficacy of Galantamine in Alzheimer's DiseaseCOMPLETEDPHASE32000-032002-03
NCT00261521A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis PatientsCOMPLETEDPHASE32000-022003-05
NCT00558298A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.COMPLETEDPHASE32000-022005-02
NCT00271466A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief TherapyCOMPLETEDPHASE32000-022002-04
NCT00249223A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic SchizophreniaCOMPLETEDPHASE32000-012000-12
NCT00210691A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE31999-122004-02
NCT00446576The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) DiseaseCOMPLETEDPHASE31999-112003-04
NCT00283465A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing ChemotherapyCOMPLETEDPHASE41999-112004-04
NCT00253136A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCOMPLETEDPHASE31999-112000-12
NCT00005648Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic CancerCOMPLETEDPHASE31999-112003-11
NCT00568295A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the KneeCOMPLETEDPHASE31999-102000-102000-10
NCT00261508A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)COMPLETEDPHASE31999-082001-12
NCT00231556A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCOMPLETEDPHASE31999-072003-09
NCT00271414A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief TherapyCOMPLETEDPHASE31999-032001-03
NCT00840242Smoking Reduction or Cessation With Nicotine Replacement TherapyCOMPLETEDPHASE31999-022000-052000-05
NCT00261573A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed DementiaCOMPLETEDPHASE31998-122000-12
NCT00231608A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal ObesityCOMPLETEDPHASE21998-122002-01
NCT00236886Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCOMPLETEDPHASE31998-052000-06
NCT00211146A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)COMPLETEDPHASE31998-042006-05
NCT00249158A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCOMPLETEDPHASE31998-032001-02
NCT00364260A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.COMPLETEDPHASE31997-122003-08
NCT00236834A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During HospitalizationCOMPLETEDPHASE31997-122001-06
NCT00236769A Study of Efficacy and Safety With the Transdermal Contraceptive System.COMPLETEDPHASE31997-111999-10
NCT00250367A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.COMPLETEDPHASE31997-101999-11
NCT00236782A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.COMPLETEDPHASE31997-101999-03
NCT00250354A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental RetardationCOMPLETEDPHASE31997-091999-08
NCT00236717A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With EpilepsyCOMPLETEDPHASE31997-092000-11
NCT00253227A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCOMPLETEDPHASE31997-071998-12
NCT00653952CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTERMINATEDPHASE31997-052000-04
NCT00253188A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCOMPLETEDPHASE31997-021998-12
NCT00249197A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin InfectionsCOMPLETEDPHASE31997-011998-07
NCT00236795A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.COMPLETEDPHASE31997-011999-03
NCT00270127Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum ChemotherapyCOMPLETEDPHASE31996-081998-09
NCT00253110A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCOMPLETEDPHASE41996-051998-09
NCT00269971A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.WITHDRAWNPHASE31996-051999-04
NCT00271453A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief TherapyCOMPLETEDPHASE31996-021998-10
NCT00230698A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset SeizureCOMPLETEDPHASE31995-112002-08
NCT00338117Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's DiseaseCOMPLETEDPHASE31995-081997-05
NCT00249145A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCOMPLETEDPHASE31995-041996-12
NCT00270166The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyCOMPLETEDPHASE31995-021998-05
NCT00270101The Effect of Epoetin Alfa on the Anemia of Patients With Multiple MyelomaCOMPLETEDPHASE31995-011996-09
NCT00236418A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCOMPLETEDPHASE31994-121996-12
NCT00236743A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyCOMPLETEDPHASE31994-062000-10
NCT00236704A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCOMPLETEDPHASE31994-031999-12
NCT00249210A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the SinusesCOMPLETEDPHASE31993-081994-07
NCT00269932A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by BacteriaCOMPLETEDPHASE31993-081994-05
NCT00236756A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut SyndromeCOMPLETEDPHASE31993-082001-02
NCT00258089A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract InfectionsCOMPLETEDPHASE31993-061995-01
NCT00270088A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.COMPLETEDPHASE31993-041994-08
NCT00258102A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract InfectionsCOMPLETEDPHASE31993-011995-01
NCT00257062A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the SkinCOMPLETEDPHASE31993-011994-04
NCT00266591A Study of the Efficacy and Safety of Topiramate Treatment in Patients With EpilepsyCOMPLETEDPHASE31992-101997-04
NCT00257036A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the SkinCOMPLETEDPHASE2, PHASE31991-071993-02
NCT00270036A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.COMPLETEDPHASE21991-041991-10
NCT00270049Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic LeukemiaCOMPLETEDPHASE21990-111994-01
NCT00270075A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel SurgeryCOMPLETEDPHASE2, PHASE31990-011992-05
NCT00236847A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.COMPLETEDPHASE21989-121993-07
NCT00236873A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.COMPLETEDPHASE21989-101993-05
NCT00270140A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.COMPLETEDPHASE31989-091991-08
NCT00270062A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.COMPLETEDPHASE31989-051991-07
NCT00236860A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresCOMPLETEDPHASE21989-051992-02
NCT00236691A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.COMPLETEDPHASE21988-071990-12
NCT00270283A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) TherapyCOMPLETEDPHASE21988-071990-04
NCT00236730A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control EpilepsyCOMPLETEDPHASE21988-061990-12
NCT00257049A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With PneumoniaCOMPLETEDPHASE2, PHASE31984-011995-01
NCT00240851An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon RaceCOMPLETEDPHASE42004-02
NCT00240864An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental PainCOMPLETEDPHASE42004-02
NCT00240825An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain.COMPLETEDPHASE42004-02
NCT00240799An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.COMPLETEDPHASE32004-10
NCT00240773A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or KneeCOMPLETEDPHASE32003-06
NCT00086112Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.COMPLETEDPHASE32005-06
NCT00301587A Study to Evaluate Folate Levels in Women Taking Oral ContraceptivesWITHDRAWNPHASE32004-12
NCT00364247A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.COMPLETEDPHASE32007-052007-05
NCT00240812A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime BedwettingCOMPLETEDPHASE22002-11
NCT00446602A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)WITHDRAWNPHASE22009-08
NCT00261560A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.COMPLETEDPHASE42004-02
NCT00261586A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the StomachCOMPLETEDPHASE42004-03
NCT00236379A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE42003-08
NCT00236548Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by InjectionCOMPLETEDPHASE32003-01
NCT00249119A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaCOMPLETEDPHASE31991-12
NCT00249132A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaCOMPLETEDPHASE31991-07
NCT00266552A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental RetardationCOMPLETEDPHASE31998-10
NCT00309725A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.COMPLETEDPHASE31999-10
NCT00253149A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar DisorderCOMPLETEDPHASE31999-04
NCT00253123A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With DementiaCOMPLETEDPHASE31997-03
NCT00253201A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCOMPLETEDPHASE31997-10
NCT00915668A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in WomenWITHDRAWNPHASE12011-03
NCT00246168ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.COMPLETEDPHASE42005-06
NCT00035204A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's DiseaseCOMPLETEDPHASE42003-05
NCT00270010A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCOMPLETEDPHASE21989-08
NCT00269945A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCOMPLETEDPHASE21989-01
NCT00269997A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy DrugCOMPLETEDPHASE21990-07
NCT00261430A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.COMPLETEDPHASE42004-10
NCT00270114A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)COMPLETEDPHASE2, PHASE31991-03
NCT00297388A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective DisorderCOMPLETEDPHASE32004-09
NCT00266617A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive ChemotherapyCOMPLETEDPHASE21990-06
NCT00270270A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) TherapyCOMPLETEDPHASE21989-07
NCT00304681An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder ChildrenCOMPLETEDPHASE32004-02
NCT00269958A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement SurgeryCOMPLETEDPHASE21991-12
NCT00270023A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.COMPLETEDPHASE2, PHASE31991-11
NCT00269984A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced CancerCOMPLETEDPHASE21990-06
NCT00270179A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.COMPLETEDPHASE31988-05
NCT00645554A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy VolunteersCOMPLETEDPHASE12004-09
NCT00073203A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive DisorderCOMPLETEDPHASE22004-05
NCT00002159A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or HistoplasmosisCOMPLETEDPHASE3
NCT00002370Study of Itraconazole in Patients With Advanced HIV InfectionCOMPLETEDNA
NCT00002133An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.COMPLETEDNA
NCT00002438A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected PatientsCOMPLETEDNA
NCT00002132Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.COMPLETEDNA
NCT00002341A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With FluconazoleCOMPLETEDNA
NCT00002278A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDSCOMPLETEDNA
NCT00002027Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)COMPLETEDNA
NCT00257140A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by BacteriaCOMPLETEDPHASE2, PHASE31931-061994-07